0001493152-23-003859.txt : 20230207 0001493152-23-003859.hdr.sgml : 20230207 20230207164115 ACCESSION NUMBER: 0001493152-23-003859 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 81 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20230207 DATE AS OF CHANGE: 20230207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: China Foods Holdings Ltd. CENTRAL INDEX KEY: 0001310630 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 910974149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32522 FILM NUMBER: 23595635 BUSINESS ADDRESS: STREET 1: SUITE 3102, EVERBRIGHT CENTER STREET 2: 108 GLOUCESTER ROAD CITY: WANCHAI STATE: K3 ZIP: 0000 BUSINESS PHONE: 852-3618-8608 MAIL ADDRESS: STREET 1: SUITE 3102, EVERBRIGHT CENTER STREET 2: 108 GLOUCESTER ROAD CITY: WANCHAI STATE: K3 ZIP: 0000 FORMER COMPANY: FORMER CONFORMED NAME: China Foods Holdings, Ltd. DATE OF NAME CHANGE: 20190513 FORMER COMPANY: FORMER CONFORMED NAME: Trafalgar Resources, Inc. DATE OF NAME CHANGE: 20041203 10-K/A 1 form10-ka.htm
0001310630 true FY 0001310630 2021-01-01 2021-12-31 0001310630 2021-06-30 0001310630 2022-03-31 0001310630 2021-12-31 0001310630 2020-12-31 0001310630 2020-01-01 2020-12-31 0001310630 us-gaap:CommonStockMember 2019-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001310630 us-gaap:RetainedEarningsMember 2019-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001310630 2019-12-31 0001310630 us-gaap:CommonStockMember 2020-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001310630 us-gaap:RetainedEarningsMember 2020-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001310630 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001310630 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001310630 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001310630 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001310630 us-gaap:CommonStockMember 2021-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001310630 us-gaap:RetainedEarningsMember 2021-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001310630 CFOO:EliteCreationGroupLimitedMember 2021-01-01 2021-12-31 0001310630 CFOO:AlphaWellnessHKLimitedMember 2021-01-01 2021-12-31 0001310630 CFOO:GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember 2021-01-01 2021-12-31 0001310630 CFOO:FurnitureFixtureAndEquipmentMember 2021-01-01 2021-12-31 0001310630 CFOO:FurnitureFixtureAndEquipmentMember 2021-12-31 0001310630 CFOO:MotorVehiclesMember srt:MinimumMember 2021-01-01 2021-12-31 0001310630 CFOO:MotorVehiclesMember srt:MaximumMember 2021-01-01 2021-12-31 0001310630 CFOO:MotorVehiclesMember 2021-12-31 0001310630 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001310630 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2021-01-01 2021-12-31 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2020-01-01 2020-12-31 0001310630 CFOO:SalesofHealthcareMember 2021-01-01 2021-12-31 0001310630 CFOO:SalesofHealthcareMember 2020-01-01 2020-12-31 0001310630 CFOO:SaleOfWineProductsMember 2021-01-01 2021-12-31 0001310630 CFOO:SaleOfWineProductsMember 2020-01-01 2020-12-31 0001310630 CFOO:YearEndHKUSExchangeRateMember 2021-12-31 0001310630 CFOO:YearEndHKUSExchangeRateMember 2020-12-31 0001310630 CFOO:AnnualAverageHKUSExchangeRateMember 2021-12-31 0001310630 CFOO:AnnualAverageHKUSExchangeRateMember 2020-12-31 0001310630 CFOO:YearEndRMBUSExchangeRateMember 2021-12-31 0001310630 CFOO:YearEndRMBUSExchangeRateMember 2020-12-31 0001310630 CFOO:AnnualAverageRMBUSExchangeRateMember 2021-12-31 0001310630 CFOO:AnnualAverageRMBUSExchangeRateMember 2020-12-31 0001310630 CFOO:HealthcareSegmentMember CFOO:ConsultingServiceIncomeMember 2021-01-01 2021-12-31 0001310630 CFOO:WineSegmentMember CFOO:ConsultingServiceIncomeMember 2021-01-01 2021-12-31 0001310630 CFOO:ConsultingServiceIncomeMember 2021-01-01 2021-12-31 0001310630 CFOO:HealthcareSegmentMember CFOO:SaleofHealthcareProductsMember 2021-01-01 2021-12-31 0001310630 CFOO:WineSegmentMember CFOO:SaleofHealthcareProductsMember 2021-01-01 2021-12-31 0001310630 CFOO:SaleofHealthcareProductsMember 2021-01-01 2021-12-31 0001310630 CFOO:HealthcareSegmentMember CFOO:SaleOfWineProductsMember us-gaap:MaterialReconcilingItemsMember 2021-01-01 2021-12-31 0001310630 CFOO:WineSegmentMember CFOO:SaleOfWineProductsMember us-gaap:MaterialReconcilingItemsMember 2021-01-01 2021-12-31 0001310630 CFOO:SaleOfWineProductsMember us-gaap:MaterialReconcilingItemsMember 2021-01-01 2021-12-31 0001310630 CFOO:HealthcareSegmentMember 2021-01-01 2021-12-31 0001310630 CFOO:WineSegmentMember 2021-01-01 2021-12-31 0001310630 CFOO:HealthcareSegmentMember CFOO:SaleOfWineProductsMember 2021-01-01 2021-12-31 0001310630 CFOO:WineSegmentMember CFOO:SaleOfWineProductsMember 2021-01-01 2021-12-31 0001310630 CFOO:HealthcareSegmentMember CFOO:ConsultingServiceIncomeMember 2020-01-01 2020-12-31 0001310630 CFOO:WineSegmentMember CFOO:ConsultingServiceIncomeMember 2020-01-01 2020-12-31 0001310630 CFOO:ConsultingServiceIncomeMember 2020-01-01 2020-12-31 0001310630 CFOO:HealthcareSegmentMember CFOO:SaleofHealthcareProductsMember 2020-01-01 2020-12-31 0001310630 CFOO:WineSegmentMember CFOO:SaleofHealthcareProductsMember 2020-01-01 2020-12-31 0001310630 CFOO:SaleofHealthcareProductsMember 2020-01-01 2020-12-31 0001310630 CFOO:HealthcareSegmentMember CFOO:SaleOfWineProductsMember us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-12-31 0001310630 CFOO:WineSegmentMember CFOO:SaleOfWineProductsMember us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-12-31 0001310630 CFOO:SaleOfWineProductsMember us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-12-31 0001310630 CFOO:HealthcareSegmentMember 2020-01-01 2020-12-31 0001310630 CFOO:WineSegmentMember 2020-01-01 2020-12-31 0001310630 CFOO:HealthcareSegmentMember CFOO:SaleOfWineProductsMember 2020-01-01 2020-12-31 0001310630 CFOO:WineSegmentMember CFOO:SaleOfWineProductsMember 2020-01-01 2020-12-31 0001310630 country:HK 2021-01-01 2021-12-31 0001310630 country:HK 2020-01-01 2020-12-31 0001310630 country:CN 2021-01-01 2021-12-31 0001310630 country:CN 2020-01-01 2020-12-31 0001310630 CFOO:MotorVehicleMember 2021-12-31 0001310630 CFOO:MotorVehicleMember 2020-12-31 0001310630 CFOO:FurnitureFixtureAndEquipmentMember 2020-12-31 0001310630 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001310630 CFOO:ForeignTranslationDifferenceMember 2021-12-31 0001310630 CFOO:ForeignTranslationDifferenceMember 2020-12-31 0001310630 srt:MinimumMember 2021-12-31 0001310630 srt:MaximumMember 2021-12-31 0001310630 CFOO:ShareExchangeAgreementMember us-gaap:CommonStockMember CFOO:EliteCreationGroupLimitedMember 2020-07-08 2020-07-09 0001310630 CFOO:ShareExchangeAgreementMember us-gaap:CommonStockMember CFOO:EliteCreationGroupLimitedMember 2020-07-08 2020-07-09 0001310630 CFOO:ShareExchangeAgreementMember us-gaap:CommonStockMember CFOO:EliteCreationGroupLimitedMember 2020-07-09 0001310630 CFOO:ShareExchangeAgreementMember us-gaap:CommonStockMember 2021-12-31 0001310630 CFOO:ShareExchangeAgreementMember us-gaap:CommonStockMember 2020-12-31 0001310630 country:US 2021-12-31 0001310630 country:US 2020-12-31 0001310630 country:CN 2021-12-31 0001310630 country:CN 2020-12-31 0001310630 us-gaap:ForeignPlanMember 2021-01-01 2021-12-31 0001310630 us-gaap:ForeignPlanMember 2020-01-01 2020-12-31 0001310630 CFOO:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001310630 CFOO:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001310630 CFOO:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001310630 CFOO:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001310630 CFOO:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001310630 CFOO:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001310630 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CFOO:CustomerMember 2021-12-31 0001310630 CFOO:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CFOO:CustomerMember 2020-12-31 0001310630 CFOO:VendorDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001310630 CFOO:VendorDMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001310630 CFOO:VendorAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:VendorAMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:VendorBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:VendorBMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:VendorCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:VendorCMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:VendorMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:VendorMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:HKD xbrli:pure iso4217:CNY CFOO:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

 

☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the fiscal year ended December 31, 2021

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the transition period from           to              

 

Commission file number: 001-32522

 

China Foods Holdings Ltd.

(Exact name of registrant as specified in its charter)

 

Delaware   84-1735478

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification Number)

 

Room 2301A, China Resources Building,

26 Harbour Road,

Wanchai, Hong Kong

   0000
(Address of Principal Executive Offices)   (Zip Code)

 

(852) 3618-8608

Registrant’s telephone number, including area code

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Name of each exchange on which registered
None   Not Applicable

 

Securities registered pursuant to Section 12(g) of the Act:

 

Class “A” Voting Common Stock, no par value

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined by Rule 405 of the Securities Act. ☐ Yes ☒ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.406 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer ☐   Smaller reporting company ☒
Emerging growth company ☐    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. The Registrant’s shares were last sold at a price of $1.01 per share. Although the Registrant’s stock has very few trades and limited volume, based on the last sales price of $1.01 shares held by non-affiliates would have a market value of $253,425.

 

As of March 31, 2022 the Registrant had 20,252,309 shares of common stock issued and outstanding.

 

No documents are incorporated into the text by reference.

 

 

 

 

 

 

Table of Contents

 

    Pages
     
PART I    
Item 1. Business 4
Item 2. Properties 10
Item 3. Legal Proceedings 10
Item 4. Mine Safety Disclosures 10
     
PART II    
Item 5. Market for Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities 11
Item 6. Selected Financial Data 12
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 12
Item 7A. Quantitative And Qualitative Disclosures About Market Risk 32
Item 8. Financial Statements and Supplementary Data 33
Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosures 55
Item 9A. Controls and Procedures 55
Item 9B. Other Information 55
     
PART III    
Item 10. Directors and Executive Officers, Promoters, Control Persons, and Corporate Governance 56
Item 11. Executive Compensation 59
Item 12. Security Ownership of Certain Beneficial Owners and Management 60
Item 13. Certain Relationships and Related Transactions, and Director Independence 61
Item 14. Principal Accountant Fees and Services 61
     
PART IV    
Item 15. Exhibits, Financial Statement Schedules 62
     
Signatures   63

 

2

 

 

EXPLANATORY NOTE

 

This amendment to our filing on Form 10-K for the annual period ended December 31, 2021 is filed primarily to update on our wine business and to address how the Holding Foreign Companies Accountable Act (“HFCAA”) and related regulations will affect our company.

 

3

 

 

PART I

 

ITEM 1. BUSINESS

 

China Foods Holdings Ltd. (the “Company”, “CFOO”, or “we”) was incorporated in Delaware on January 10, 2019. On January 23, 2019, the Company entered into an Agreement and Plan of Merger (the “Agreement”) with Trafalgar Resources, Inc., a Utah corporation (“Trafalgar”). Pursuant to the Agreement, the Company merged with Trafalgar (the “Merger”) with the Company as the surviving entity. Prior to the Merger, Trafalgar had not commenced operations for several years that had resulted in significant revenue and Trafalgar’s efforts had been devoted primarily to activities related to raising capital and attempting to acquire an operating entity.

 

The Company is a Delaware holding company and we conduct our business through our wholly owned subsidiary Guangzhou Xiao Xiang Health Industry Company Limited, a limited liability company organized under the laws of China on March 8, 2017 (“GXXHIC”).   GXXHIC is wholly owned by Alpha Wellness (HK) Limited, a limited liability company organized under the laws of Hong Kong on April 24, 2019, which is in turn wholly owned by Elite Creation Group, a limited liability company formed under the laws of the British Virgin Islands formed on September 5, 2018. Alpha Wellness (HK) Limited and Elite Creation Group are holding companies without operations and are wholly owned by the Company.

 

Substantially all of our operations are conducted in China, and are governed by Chinese laws, rules and regulations. Our subsidiary, GXXHIC, is subject to Chinese laws, rules, and regulations. Uncertainties with respect to the interpretation and enforcement of Chinese laws, rules and regulations could have a material adverse effect on us. Risks and uncertainties arising from the legal system in China, including risks and uncertainties regarding that the rules and regulations in China can change quickly with little advance notice and that the Chinese government may intervene or influence our operations at any time, could result in a material adverse change in our operations and the value of our securities.

 

Our History

 

Prior to the Merger, Trafalgar’s majority stockholder who owned 5,000,000 shares (approximately 95.2%) of the 5,251,309 outstanding shares of Trafalgar’s common stock, par value $0.0001, signed a written consent approving the Merger and the related transactions. Such approval and consent were sufficient under Utah law and Trafalgar’s Bylaws to approve the Merger. The boards of directors and shareholders of the Company and Trafalgar approved the Merger.

 

Pursuant to the Merger, each share of Trafalgar’s common stock was converted into one share of the Company’s common stock. After the Merger, HY (HK) Financial Investments Co., Ltd. owns 5,001,000 shares of common stock of the Company.

 

The Merger was effective on March 13, 2019.

 

On December 11, 2019, the Board of Directors approved a change to its fiscal year-end from September 30 to December 31. As a result of this change, the fiscal year is a 3 months transition period beginning October 1, 2019 through December 31, 2020. In these statements, including the notes thereto, financial results for fiscal 2019 are for a 3-month period. Corresponding results for the years ended September 30, 2019 and 2018 are both for 12-month periods.

 

On July 9, 2020, the Company consummated the Share Exchange Agreement (“the “Share Exchange Agreement”) with Elite Creation Group Limited, a private limited company organized under the laws of British Virgin Islands (“ECGL”). As a result of the acquisition of ECGL, the Company entered into the healthcare product distributing and marketing industry, pursuing a new strategy of developing and distributing health related products, including supplements, across the globe with a focus on mainland China, Europe and Australia.

 

4

 

 

ECGL will comprise the ongoing operations of the combined entity and its senior management will serve as the senior management of the combined entity, ECGL is deemed to be the accounting acquirer for accounting purposes. The transaction will be treated as a recapitalization of the Company. Accordingly, the consolidated assets, liabilities and results of operations of the Company will become the historical financial statements of ECGL, and the Company’s assets, liabilities and results of operations will be consolidated with ECGL beginning on the acquisition date. ECGL was the legal acquiree but deemed to be the accounting acquirer. The Company was the legal acquirer but deemed to be the accounting acquiree in the reverse merger. The historical financial statements prior to the acquisition are those of the accounting acquirer (ECGL). After completion of the Share Exchange Transaction, the Company’s consolidated financial statements include the assets and liabilities, the operations and cash flow of the accounting acquirer.

 

Effective July 9, 2020, we consummated the acquisition of ECGL, and its wholly owned subsidiary GXXHIC, a limited liability company organized under the laws of China on March 8, 2017. Alpha Wellness (HK) Limited, a limited liability company organized under the laws of Hong Kong on April 24, 2019, is a holding company without operations.

 

Corporate Org Chart

 

 

Our Products

 

Our health products are designed to help enhance immunity and improve general wellbeing. We provide the following categories of healthcare products and customized healthcare consultation services in China: (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare. The products target all age groups with different needs.

 

Our products are taken as healthcare supplements in accordance with the principles of traditional Chinese medicine including the principle complementary medicine and ideal ratios and combinations of ingredients. 

 

Due to the impact of the COVID-19 pandemic in the healthcare industry, we have also offered a new line of high-end wine products in our online and offline sales platform, to diversify the market demand and customer needs.

 

Our services

 

We also extend our service scope to provide the personalized health consulting services to our clients, as well as consultancy services such as tailor-made natural food supplement solutions.

 

5

 

 

Markets and Regions

 

The Great Health Industry refers to production, operation, service and information dissemination, maintenance, restoration, and promotions linked to health. It covers medical products, health supplements, nutritional foods, medical devices, health appliances, fitness, health management, health consulting and many other production and service areas closely related to human health. The Great Health Industry is an emerging industry with huge market potential, especially in China.

 

According to the “China Great Health Industry Strategic Planning and Enterprise Strategy Consulting Report” published by Qianzhan Industry Institute (前瞻產業研究院), the scale of the Great Health Industry in 2017 was USD 947.42 billion, which increased to over USD 1,069.66 billion in 2018. The report predicted USD 1,341.66 billion volume for 2019 and forecast over USD 1,528.09 billion for 2020. In the years till 2023, the average annual compound growth rate will be approximately 12.55%, and with the Great Health Industry reaching approximately USD 2,153.08 billion in 2023.

 

Our Strategies

 

We are focused on achieving long-term growth in revenues, cash flow and profit. We believe that we can achieve this by developing multiple distribution channels and strengthening our marketing and promotions, leading to better product turnover and revenue. We also expect to broaden our product range as well as product differentiation in the future. Based on the business experience accumulated over the years, we believe we can improve the efficiency of our supply chain with time-saving and cost-saving supply chain management and marketing planning for the target customer base with our one-stop service.

 

Our primary aims are (i) to strengthen our product salability; (ii) to cut logistics cost and time spent and (iii) to further expand the market share in China. Toward this end, we plan to pursue the following business strategies:

 

  ● Collaborate with third-party e-commerce platforms to boost product exposure, e.g. Tmall, Jingdong mall
  ● Deliver healthcare knowledge and consultation service via social media and We-media
  ● Build brand image and reputation through customer experience and word of mouth
  ● Increase the number of downstream distributors and wholesalers
  ● Strengthen the relationship with manufacturers, suppliers, drug agents and distributors
  ● Pursue strategic acquisitions and partnerships

 

We intend to develop both online and offline distribution channels to increase sales volume and revenue. We expect to partner with third party e-commerce platforms, social media and We-media such as Wechat, TikTok and Xiaohongshu to build our online presence. We believe that online channels will allow us to provide real-time nutrition and healthcare consultation services as well as increase customer engagement and retention. Starting from the second half of 2020, we have launched our “nutrition consulting” support services using a major social media software to allow customer groups to receive pre-purchase consultation and after-sales service for products anytime and anywhere.

 

Our current offline sales channel relies on distributors and sales agents. To enhance the visibility and marketability of our products and services and to improve brand recognition and awareness, we hope to develop store-in-shop and counter experiences. We also intend to partner with high-end gyms to form nutrition clubs and hold weight-loss training camps, health assessment and fitness training camps and other activities.

 

We intend to create a ‘one-stop’ solution for our customers by creating a multi-channel health product supply and retail system. We not only provide personalized consultation service to our customers, but also summarize and analyze our customer feedback and experiences through our consultation service and after-sales service. We intend to share this data with our manufacturers and supply chain partners to develop products and services that better meet the demands of our customers. By pooling and addressing the needs of downstream businesses and combining it with the Consumer to Manufacturer model for upstream transformation, we anticipate establishing a close relationship between manufacturers and suppliers. We believe this model can also reduce circulation costs and improve the efficiency of our supply chain.

 

6

 

 

We are a Delaware corporation and we conduct our primary operations in China through our subsidiary GXXHIC. We face various risks and uncertainties related to doing business in China， Our subsidiary GXXHIC is subject to complex and evolving PRC laws and regulations. Recently, the PRC enacted rules and regulations governing offshore offerings, anti-monopoly actions, and additional oversight on cybersecurity and data privacy.

 

We do not believe there GXXHIC is in violation of any laws, rules or regulations but since these newly enacted rules are still evolving, we cannot assure you that our business operations comply with such regulations and authorities’ requirements in all respects during the development of these new rules. However, in terms of business operation, GXXHIC expects to adapt to the newly issued rules and take dependent measures to comply with the laws and regulations of the Chinese authorities

 

The PRC government’s authority in regulating our operations and its oversight and control over offerings and listings conducted overseas by, and foreign investment in, China-based issuers could significantly limit or completely hinder our ability to offer or continue to offer securities to investors. Implementation of industry-wide regulations in this nature may cause the value of such securities to significantly decline or be worthless. Risks and uncertainties arising from the legal system in China, including risks and uncertainties regarding the enforcement of laws and quickly evolving rules and regulations in China, could result in a material adverse change in our operations and the value of our securities. But so far, the current operation and securities value of the CFO are stable, and we believe that its risks are to the Company are manageable.

 

For example, the recently promulgated PRC Data Security Law and the PRC Personal Information Protection Law in 2021 posed additional challenges to our cybersecurity and data privacy compliance. The Cybersecurity Review Measures issued by the Cyberspace Administration of China, or the CAC and several other PRC governmental authorities in December 2021, as well as the Administration Regulations on Cyber Data Security (Draft for Comments) published by the CAC for public comments in November 2021, exposes uncertainties and potential additional restrictions on China-based overseas-listed companies like us. If the detailed rules, implementations, or the enacted version of the draft measures mandate clearance of cybersecurity review and other specific actions to be completed by us, we face uncertainties as to whether such clearance can be timely obtained, the failure of which may subject us to penalties, which could materially and adversely affect our business and results of operations and the price of our securities. However, as the Company operates in a traditional food industry, we believe the promulgation of the above laws will have a low impact on the Company and CFOO believes it is in compliance with the above laws.

 

In addition, on December 24, 2021, the China Securities Regulatory Commission, or the CSRC, published the draft Regulations of the State Council on the Administration of Overseas Securities Offering and Listing by Domestic Companies (Draft for Comments), or the Administrative Provisions, and the draft Administrative Measures for the Filing of Overseas Securities Offering and Listing by Domestic Companies (Draft for Comments) for public comments. Pursuant to these drafts, PRC domestic companies that directly or indirectly seek to offer or list their securities on an overseas stock exchange, including a PRC company limited by shares and an offshore company whose main business operations are in China and intends to offer securities or be listed on an overseas stock exchange based on its onshore equities, assets, incomes or similar interests, are required to file with the CSRC within three business days after submitting their application documents to the regulator in the place of intended listing or offering. Particularly, as for the PRC domestic companies that have directly or indirectly listed securities in overseas markets intend to conduct follow-on offerings in overseas markets, such companies are required to submit the filing with respect to the follow-on offering within three business days after completion of the follow-on offering.

 

Furthermore, the PRC anti-monopoly regulators have promulgated new anti-monopoly and competition laws and regulations and strengthened the enforcement under these laws and regulations. There remain uncertainties as to how the laws, regulations and guidelines recently promulgated will be implemented and whether these laws, regulations and guidelines will have a material impact on our business, financial condition, results of operations and prospects. We do not believe there GXXHIC is in violation of any laws, rules or regulations related to monopolies or competition but we cannot assure you that our business operations comply with such regulations and authorities’ requirements in all respects. If any non-compliance is raised by relevant authorities and determined against us, we may be subject to fines and other penalties. These risks could result in a material adverse change in our operations and the value of our securities, significantly limit or completely hinder our ability to continue to offer securities to investors, or cause the value of such securities to significantly decline or be worthless.

 

7

 

 

Permissions Required from the PRC Authorities for Our Operations

 

GXXHIC has received a Business License from the relevant department of the State Administration for Market Regulation. Apart from the Business License, GXXHIC may be subject to additional licensing requirements for our business operation due to the uncertainties of interpretation and implementation of relevant laws and regulations and the enforcement practice by relevant government authorities.

 

Furthermore, in connection with the operations of GXXHIC, as of the date of this report, neither GXXHIC nor the Company are required to obtain any approval or permission from the CSRC, CAC or any other PRC governmental authorities, nor has the Company or GXXHIC received any formal inquiry, notice, warning or sanction from any PRC governmental authorities in connection with requirements of obtaining such approval or permission, under any currently effective PRC laws, regulations and regulatory rules.

 

However, the PRC government has recently indicated an intent to exert more oversight over offerings that are conducted overseas and/or foreign investment in China-based issuers like us, and published a series of proposed rules for public comments in this regard, the enaction timetable, final content, interpretation and implementation of which remains uncertain. Therefore, there are substantial uncertainties as to how PRC governmental authorities will regulate overseas listing in general and whether we are required to complete filing or obtain any specific regulatory approvals from the CSRC, CAC or any other PRC governmental authorities for our future offshore offerings. If we had inadvertently concluded that such approvals were not required, or if applicable laws, regulations or interpretations change in a way that requires us to obtain such approval in the future, we may be unable to obtain such necessary approvals in a timely manner, or at all, and such approvals may be rescinded even if obtained. Any such circumstance could subject us to penalties, including fines, suspension of business and revocation of required licenses, significantly limit or completely hinder our ability to continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless.

 

Our Subsidiary, GXXHIC, is Subject to Chinese Laws, Rules, And Regulations

 

Our subsidiary, GXXHIC, is subject to Chinese laws, rules, and regulations. Uncertainties with respect to the interpretation and enforcement of Chinese laws, rules and regulations could have a material adverse effect on us. We believe that GXXHIC will continue to manage any adverse effects on the premise of complying with Chinese laws, rules, and regulations. Risks and uncertainties arising from the legal system in China, including risks and uncertainties regarding that the rules and regulations in China can change quickly with little advance notice and that the Chinese government may intervene or influence our operations at any time, could result in a material adverse change in our operations and the value of our securities.

 

Substantially all of our operations are conducted in China, and are governed by Chinese laws, rules and regulations. The Chinese legal system is a civil law system based on written statutes. Unlike common law systems, it is a system in which legal cases may be cited for reference but have limited value as precedents. In the late 1970s, the Chinese government began to promulgate a comprehensive system of laws and regulations governing economic matters in general. The overall effect of legislation over the past four decades has significantly increased the protections afforded to various forms of foreign or private-sector investment in China. However, since these laws and regulations are relatively new and the Chinese legal system continues to rapidly evolve, the interpretations of many laws, regulations and rules are not always uniform and enforcement of these laws, regulations and rules involve uncertainties.

 

From time to time, we may have to resort to administrative and court proceedings to interpret and/or enforce our legal rights. However, since Chinese administrative and court authorities have significant discretion in interpreting and implementing statutory and contractual terms, it may be more difficult to evaluate the outcome of administrative and court proceedings, and the level of legal protection we enjoy, than in more developed legal systems. Any administrative and court proceedings in China may be protracted, resulting in substantial costs and diversion of resources and management attention. Furthermore, the Chinese legal system is based in part on government policies and internal rules (some of which are not published in a timely manner or at all) that may have retroactive effect.

 

As a result, we may not be aware of our violation of these policies and rules until sometime after the violation. Such uncertainties, including uncertainty over the scope and effect of our contractual, property (including intellectual property) and procedural rights, and any failure to respond to changes in the regulatory environment in China could affect our business and our ability to continue our operations.

 

8

 

 

Changes in Chinese political policies and economic and social policies or conditions may affect and fluctuate our business, results of operations and financial condition and may affect our growth and expansion strategies.

 

Substantially all of our assets and business operations are located in China. Accordingly, our business, results of operations, financial condition and prospects may be influenced to a significant degree by political, economic and social conditions in China generally, by continued economic growth in China as a whole, and by geopolitical stability in the region.

 

The Chinese economy, markets and levels of consumer spending are influenced by many factors beyond our control, including current and future economic conditions, political uncertainty, unemployment rates, inflation, fluctuations in the level of disposable income, taxation, foreign exchange control, and changes in interest and currency exchange rates. The Chinese economy differs from the economies of most developed countries in many respects, including the level of government involvement, level of development, growth rate, foreign exchange control and fiscal measures and allocation of resources. Although the Chinese government has implemented measures since the late 1970s emphasizing the utilization of market forces for economic reform, the restructuring of state assets and state-owned enterprises, and the establishment of improved corporate governance in business enterprises, a significant portion of productive assets in China is still owned or controlled by the Chinese government. The Chinese government also exercises significant control or influence over Chinese economic growth through allocating resources, controlling payment of foreign currency-denominated obligations, setting monetary and fiscal policies, regulating financial services and institutions and providing preferential treatment to particular industries or companies.

 

While the Chinese economy has experienced significant growth in recent decades, growth has been uneven, both geographically and among various sectors of the economy. The Chinese government has implemented various measures to encourage economic growth and guide the allocation of resources. Some of these measures benefit the overall Chinese economy but may also have an effect on us. Our results of operations and financial condition could be affected by government control over capital investments or changes in tax regulations that are applicable to us. In addition, the Chinese government has implemented certain measures, including interest rate increases, to control the pace of economic growth. These measures may cause decreased economic activity in China.

 

The Holding Foreign Companies Accountable Act

 

The Holding Foreign Companies Accountable Act (the “HFCAA”), was enacted on December 18, 2020. The HFCAA requires that the Public Company Accounting Oversight Board (the “PCAOB”) determine whether it is unable to inspect or investigate completely registered public accounting firms located in a non-U.S. jurisdiction because of a position taken by one or more authorities in that jurisdiction. Our auditor, HKCM & CPA Co., is based in Hong Kong and is subject to the determinations announced by the PCOAB on December 16, 2021 and the HFCAA. On December 16, 2021, the PCAOB reported its determination that it was unable to inspect or investigate completely registered public accounting firms headquartered in the PRC and Hong Kong, because of positions taken by PRC authorities in those jurisdictions. On March 30, 2022, based on this determination, the Company was transferred to the SEC’s “Conclusive list of issuers identified under the HFCA.” Since our auditor is located in Hong Kong, a jurisdiction where the PCAOB has been unable to conduct inspections without the approval of the Chinese authorities, our auditor is not currently inspected by the PCAOB. The HFCAA states that if the SEC determines that we have filed audit reports issued by a registered public accounting firm that has not been subject to inspection by the PCAOB for two consecutive years beginning in 2021, the SEC shall prohibit our shares from being traded on a national securities exchange or in the over-the-counter trading market in the United States. The related risks and uncertainties could cause the value of our shares to significantly decline or be worthless.

 

9

 

 

ITEM 2. PROPERTIES

 

The Company’s operating office is located at No. 11, Qingbo Road, Ersha Island, Yuexiu District, Guangzhuou, China, and is comprised of 250 square meters. The Company entered a new lease. According to the new lease, we are obligated to pay a quarterly rent of RMB118,026 (approximately US$18,100) during the term, to be expired on March 31, 2026.

 

The Company also entered a lease of corporate office located at Room 2301A, China Resources Building, 26 Harbour Raod, Wanchai, Hong Kong with a monthly rent of HK$36,603 (approximately US$4,700). The lease will be expired on March 16, 2023.

 

ITEM 3. LEGAL PROCEEDINGS

 

We may be subject to litigation from time to time as a result of our normal business operations. Presently, there are no material pending legal proceedings to which we are a party or as to which any of our property is subject, and no such proceedings are known to be threatened or contemplated against us.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable

 

10

 

 

PART II

 

ITEM 5. MARKET FOR COMPANY’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

The Company’s common stock is quoted on the OTC Markets under the symbol “CFOO” (former symbol “TFLG”). Set forth below are the high and low bid prices for the Company’s Common Stock for the respective quarters. Although the Company’s common stock is quoted on the OTC Markets it has traded sporadically with no real volume and there is currently no ask price. Consequently, the information provided below may not be indicative of the Company’s common stock price under different conditions.

 

All prices listed herein reflect inter-dealer prices, without retail mark-up, mark-down or commissions and may not represent actual transactions. There is no established public trading market for our securities and a regular trading market may not develop, or if developed, may not be sustained.

 

The following table sets forth, for the fiscal quarters indicated, the high and low bid information for our common stock, as reported on the OTC Markets “Pink”. The following quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

 

Quarter Ended  High Bid  Low Bid
December 2021  $2.50   $2.50 
September 2021  $2.50   $2.50 
June 2021  $2.00   $1.35 
March 2021  $1.50   $1.50 
           
December 2020  $1.25   $1.25 
September 2020  $1.25   $1.25 
June 2020  $1.25   $1.25 
March 2020  $1.25   $1.25 

 

Holders

 

At March 30, 2022, the Company had approximately 227 shareholders of record of our common stock. Such number does not include any shareholders holding shares in nominee or “street name”.

 

Dividends

 

Holders of our common stock are entitled to receive such dividends as may be declared by our board of directors. We paid no dividends during the periods reported herein, nor do we anticipate paying any dividends in the foreseeable future.

 

11

 

 

Recent Sales of Unregistered Securities

 

The Company had no sales of securities in 2021 and 2020.

 

Securities authorized for issuance under equity compensation plans

 

The Company does not have securities authorized for issuance under any equity compensation plans.

 

Performance graph

 

Not applicable to smaller reporting companies.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

The Company did not repurchase any shares of the Company’s common stock during 2021.

 

ITEM 6. SELECTED FINANCIAL DATA

 

Not applicable to a smaller reporting company.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Special Note Regarding Forward-Looking Statements

 

This Form 10-K contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this Form 10-K that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may”, “will”, “expect”, “believe”, “anticipate”, “estimate” or “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, and actual results may differ materially depending on a variety of factors, many of which are not within our control. These factors include by are not limited to economic conditions generally and in the industries in which we may participate; competition within our chosen industry, including competition from much larger competitors; technological advances and failure to successfully develop business relationships.

 

Plan of Operation

 

We are a health company that develops, markets, promotes and distributes a variety of customized health care products and services, including supplements, healthy snacks, meal replacements, and nutritional consultation services to consumers in China. We work with certain licensed healthcare food factories to develop and manufacture products and services that are distributed conventionally through sales agents and also through a network of e-commerce and social media platforms.

 

In addition to products, we are committed to providing customized science based wellness consultation and service programs to customers. Our diverse products and services target health conscious customers and differentiate based upon age and gender and seek to manage different conditions. We reach out to customers fitting certain health and lifestyle profiles through our offline and online consultation services, and track eating habits and health indicators to provide customized products such as supplements. We believe this will facilitate the ability of customers to monitor, understand and adjust their health practices and lifestyle anytime and anywhere for increased customer engagement and retention.

 

We conduct our business through our wholly owned subsidiary Guangzhou Xiao Xiang Health Industry Company Limited, a limited liability company organized under the laws of China on March 8, 2017. Alpha Wellness (HK) Limited, a limited liability company organized under the laws of Hong Kong on April 24, 2019, and Elite Creation Group, a limited liability company formed under the laws of the British Virgin Islands formed on September 5, 2018, are holding companies without operations.

 

12

 

 

Our Products and Services

 

Our health products are designed to help enhance immunity and improve general wellbeing. We provide the following categories of healthcare products and customized healthcare consultation services in China: (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare. The products target all age groups with different needs.

 

Product category   Representative Products   Description
Nutrition Catering Series   Jasmine Beauty   Meal replacement and healthy snacks
Special Health Food Series   Power Centinent   Products that support a healthy active lifestyle and enhance Immunity
Health Supplement Series   Fuli Fruit Juice   Functional fruit beverages and dietary and nutritional supplements containing resveratrol, anthocyanin, superoxide enzyme
Skincare Series   Tightness   Facial skin care and recovery
Wine   Ame de Purete   Bordeaux wine from France

 

Jasmine Beauty Power Centinent
   
Fuli Fruit Juice Tightness

 

Our products are taken as healthcare supplements in accordance with the principles of traditional Chinese medicine including the principle complementary medicine and ideal ratios and combinations of ingredients.

 

13

 

 

Our wine business is customized production and procurement through establishing cooperative relationships with wine suppliers. Among them, high-quality wine is directly packaged and labeled in the country of origin and then imported through supply chain agents. At present, the main product of Alpha Wellness’s high-end wine business is a Puerto Rican red wine from France. The deep, strong and full-bodied Puerto Rico is a wine with rich tannins and fruit. We source this wine through a distribution agreement with Shenzhen Guisheng Supply Chain Co., Ltd.

 

 

Markets and Regions

 

The Great Health Industry refers to production, operation, service and information dissemination, maintenance, restoration, and promotions linked to health. It covers medical products, health supplements, nutritional foods, medical devices, health appliances, fitness, health management, health consulting and many other production and service areas closely related to human health. The Great Health Industry is an emerging industry with huge market potential, especially in China. The marketing and competitive strategy of our alcohol business is consistent with our health care product business. The market and customers of our liquor business are mainly mainland China and Hong Kong.

 

According to the “China Great Health Industry Strategic Planning and Enterprise Strategy Consulting Report” published by Qianzhan Industry Institute (前瞻產業研究院), the scale of the Great Health Industry in 2017 was USD 947.42 billion, which increased to over USD 1,069.66 billion in 2018. The report predicted USD 1,341.66 billion volume for 2019 and forecast over USD 1,528.09 billion for 2020. In the years till 2023, the average annual compound growth rate will be approximately 12.55%, and with the Great Health Industry reaching approximately USD 2,153.08 billion in 2023.

 

Our Strategies

 

We are focused on achieving long-term growth in revenues, cash flow and profit. We believe that we can achieve this by developing multiple distribution channels and strengthening our marketing and promotions, leading to better product turnover and revenue. We also expect to broaden our product range as well as product differentiation in the future. Based on the business experience accumulated over the years, we believe we can improve the efficiency of our supply chain with time-saving and cost-saving supply chain management and marketing planning for the target customer base with our one-stop service.

 

14

 

 

Our primary aims are (i) to strengthen our product saleability; (ii) to cut logistics cost and time spent and (iii) to further expand the market share in China. Toward this end, we plan to pursue the following business strategies:

 

  ● Collaborate with third-party e-commerce platforms to boost product exposure, e.g. Tmall, Jingdong mall
  ● Deliver healthcare knowledge and consultation service via social media and We-media
  ● Build brand image and reputation through customer experience and word of mouth
  ● Increase the number of downstream distributors and wholesalers
  ● Strengthen the relationship with manufacturers, suppliers, drug agents and distributors
  ● Pursue strategic acquisitions and partnerships

 

We intend to develop both online and offline distribution channels to increase sales volume and revenue. We expect to partner with third party e-commerce platforms, social media and We-media such as Wechat, TikTok and Xiaohongshu to build our online presence. We believe that online channels will allow us to provide real-time nutrition and healthcare consultation services as well as increase customer engagement and retention. Starting from the second half of 2020, we have launched our “nutrition consulting” support services using a major social media software to allow customer groups to receive pre-purchase consultation and after-sales service for products anytime and anywhere.

 

Our current offline sales channel relies on distributors and sales agents. To enhance the visibility and marketability of our products and services and to improve brand recognition and awareness, we hope to develop store-in-shop and counter experiences. We also intend to partner with high-end gyms to form nutrition clubs and hold weight-loss training camps, health assessment and fitness training camps and other activities.

 

We intend to create a ‘one-stop’ solution for our customers by creating a multi-channel health product supply and retail system. We not only provide personalized consultation service to our customers, but also summarize and analyze our customer feedback and experiences through our consultation service and after-sales service. We intend to share this data with our manufacturers and supply chain partners to develop products and services that better meet the demands of our customers. By pooling and addressing the needs of downstream businesses and combining it with the Consumer to Manufacturer model for upstream transformation, we anticipate establishing a close relationship between manufacturers and suppliers. We believe this model can also reduce circulation costs and improve the efficiency of our supply chain.

 

The main sales model of wine business is to develop online and offline distribution channels to increase sales and revenue. In terms of online sales, we hope to cooperate with third-party e-commerce platforms, social media, WeChat, Tiktok, Xiaohongshu and other We Media to build our online image. For example, we have built the official flagship store of Xiao Xiang Health on the Tmall e-commerce platform. The offline sales channel mainly cooperates with dealers for sales, mainly relying on distributors and sales agents.

 

15

 

 

Competition

 

We operate in a highly competitive and fragmented industry that is sensitive to price and service. We compete with leading e-commerce companies such as Alibaba (China) which may offer substantially the same or similar product offerings as us. We also compete with businesses that focus on particular merchant categories or markets such as UNI HEALTH (HK stock code: 02211) and ALI HEALTH (HK stock code:0241). We also compete with traditional cash payments and other popular online shopping websites and apps, and other traditional media companies that provide discounts on products and services. We believe the principal competitive factors in our market include the following:

 

  ● Breadth of member base and the products and services featured.
  ● Close and fast pre-sales and after-sales service response.
  ● Ability to reduce the product turnover time and inventory cost.
  ● Relationship and bargaining power with supplier and manufacturer.
  ● Healthcare product effectiveness and acceptance from customer.
  ● Local presence and understanding of local business trends.
  ● Ability to deliver a high volume of relevant services and information to consumers.
  ● Ability to produce high purchase rates for products and services among members.
  ● Strength and recognition of our brand.

 

Although we believe we compete favorably on the factors described above, many of our current and potential competitors have longer operating histories, significantly greater financial, technical, marketing and other resources, larger product and services offerings, larger customer base and greater brand recognition. These factors may allow our competitors to benefit from their existing customer base with lower development costs or to respond more quickly than we can to new or emerging technologies and changes in customer requirements. These competitors may engage in more extensive research and development efforts, undertake more far-reaching marketing campaigns and adopt more aggressive pricing policies, which may allow them to build a larger customer base more effectively than us. Our competitors may develop products or services that are similar to our products and services or that achieve greater market acceptance than our products and services. In addition, although we do not believe that customer payment terms are a principal competitive factor in our market, they may become such a factor, and we may be unable to compete on such terms.

 

Government and Industry Regulations

 

We are subject to the general laws in China governing businesses including labor, occupational safety and health, general corporations, intellectual property and other similar laws.

 

Product Liability and Consumers Protection

 

Product liability claims may arise if any of our healthcare products have a harmful effect on a consumer, who may make a claim for damages or compensation as an injured party. The General Principles of the Civil Law of the PRC, which became effective in January 1987, state that manufacturers and sellers of defective products causing property damage or injury shall incur civil liabilities for such damage or injuries.

 

The Product Quality Law of the PRC was enacted in 1993 and amended in 2000 to strengthen the quality control of products and protect consumers’ rights and interests. Under this law, manufacturers and distributors who produce or sell defective products may be subject to confiscation of earnings from such sales, revocation of business licenses and imposition of fines, and in severe circumstances, may be subject to criminal liability.

 

The Law of the PRC on the Protection of the Rights and Interests of Consumers was promulgated on October 31, 1993 and became effective on January 1, 1994 to protect consumers when they purchase or use goods or services. All business operators must comply with this law when they manufacture or sell goods and/or provide services to customers. In extreme situations, product manufacturers and distributors may be subject to criminal liability if their goods or services lead to the death or injuries of customers or other third parties.

 

16

 

 

Summary of Financial Information

 

We have been significantly impacted by COVID-19 global pandemic. In addition to the devastating effects on human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets. China and many other countries have issued policies intended to stop or slow the further spread of the disease.

 

COVID-19 and China’s response to the pandemic are significantly affecting the economy. There are no comparable events that provide guidance as to the effect the COVID-19 pandemic may have, and, as a result, the ultimate effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent of the effects on the economy, the markets we serve, our business or our operations.

 

The following table sets forth certain operational data for the years ended December 31, 2021 and 2020:

 

STATEMENT OF OPERATIONS DATA:

 

   For the Year Ended December 31, 2021   For the Year Ended December 31, 2020 
Revenues  $361,116   $1,013,141 
Cost of revenue   (121,690)   (596,530)
Gross profit   239,426    416,611 
Total operating expenses   (695,856)   (887,426)
Total other income   7,692    9,554 
Loss before income taxes   (448,738)   (461,261)
Income tax expense   (6,671)   (8,215)
Net loss   (455,409)   (469,476)

 

Revenue. We generated revenues of $361,116 and $1,013,141 for the fiscal years ended December 31, 2021 and 2020. All the major customers are located in the PRC and Hong Kong. The significant decreases in the revenue due to the outbreak of COVID-19, we expected the revenue would be increased in the future once an efficacious COVID-19 vaccine emerges.

 

During the years ended December 31, 2021, and 2020, the nature of businesses and segment was shown as below:

 

Currently, the Company has two reportable business segments:

 

(i) Healthcare Segment, mainly provides health consulting advisory services and healthcare and wellness products to the customers; and
(ii) Wine Segment, mainly provides wine products to the customers.

 

17

 

 

In the following table, revenue is disaggregated by primary major product line, and timing of revenue recognition. The table also includes a reconciliation of the disaggregated revenue with the reportable segments.

 

   Year Ended December 31, 2021 
  

Healthcare

Segment

   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $216,850   $–   $216,850 
Sale of healthcare products   39,996    –    39,996 
Sale of wine products   –    104,270    104,270 
Total revenue   256,846    104,270    361,116 
                
Cost of sales:               
Consulting service income   (31,315)   -    (31,315)
Sale of healthcare products   (32,064)   -    (32,064)
Sale of wine products   -    (58,311)   (58,311)
Total cost of revenue   (63,379)   (58,311)   (121,690)
                
Gross profit   193,467    45,959    239,426 
                
Operating Expenses               
Selling and distribution   -    (5,076)   (5,076)
General and administrative   (690,780)   -    (690,780)
Total operating expenses   (690,780)   (5,076)   (695,856)
                
Segment (loss) income  $(497,313)  $40,883   $(456,430)

 

   Year Ended December 31, 2020 
  

Healthcare

Segment

   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $221,041   $–   $221,041 
Sale of healthcare products   564,814    –    564,814 
Sale of wine products   -    227,286    227,286 
Total revenue   785,855    227,286    1,013,141 
                
Cost of sales:               
Consulting service income   –    –    – 
Sale of healthcare products   (395,392)   –    (395,392)
Sale of wine products   –    (201,138)   (201,138)
Total cost of revenue   (395,392)   (201,138)   (596,530)
                
Gross profit   390,463    26,148    416,611 
                
Operating Expenses               
Selling and distribution   –    (158,432)   (158,432)
General and administrative   (728,994)   –    (728,994)
Total operating expenses   (728,994)   (158,432)   (887,426)
                
Segment (loss) income  $(338,531)  $(132,284)  $(470,815)

 

18

 

 

The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables:

 

   Years ended December 31, 
   2021   2020 
         
Hong Kong  $216,851   $221,041 
China   144,265    792,100 
           
   $361,116   $1,013,141 

 

During the years ended December 31, 2021, and 2020, the following customers accounted for 10% or more of our total net revenues:

 

  

Year ended

December 31, 2021

       December 31, 2021 
   Revenues   Percentage of revenues       Accounts receivable 
Simmax Supply Chian Limited  $165,391    46%       $- 
Guangzhou Dexin Huamao Trading Co., Ltd.   103,072    29%        - 
Tang Fung Limited   51,460    14%        　- 
TOTAL  $319,923    89%   Total   $- 

 

  

Year ended

December 31, 2020

        December 31, 2020 
   Revenues   Percentage of revenues        Accounts receivable 
Guangdong Hualian Health Industry Co., Ltd.  $394,158    　39%        $- 
Huaye Little Elephant Health Industry Co., Ltd.   　234,547    　23 %         　- 
TOTAL  $628,705    　62%     Total   $- 

 

Cost of Revenue. Cost of revenue as a percentage of net revenue was approximately 33.70% for the fiscal year ended December 31, 2021. Cost of revenue as a percentage of net revenue was approximately 58.88% for the fiscal year ended December 31, 2020. The decrease of cost of revenue as a percentage of net revenue is attributable to a decrease in import of product from supplier and manufacturer due to the COVID-19 global pandemic.

 

During the years ended December 31, 2021 and 2020, the following vendors accounted for 10% or more of our purchases:

 

19

 

 

  

Year ended

December 31, 2021

        December 31, 2021 
Vendor  Purchases   Percentage of purchases        Accounts payable 
Guangzhou Jingdong Trading Co., Ltd.  $195,152    99%    Total:   $- 
                      

 

  

Year ended

December 31, 2020

       December 31, 2020 
Vendor  Purchases   Percentage of purchases       Accounts payable 
                 
Zhejiang Hongshiliang Group Tiantai Mountain Wuyao Co., Ltd.  $219,007    37%       $- 
Tengfeng (China) Trading Co., Ltd.   71,616    12%        - 
Guangzhou Zeli Pharmaceutical Technology Co., Ltd.   61,222    10%        - 
                     
Total:  $351,845    59%   Total:   $- 

 

Gross Profit. We achieved a gross profit of $239,426 and $416,611 for the fiscal years ended December 31, 2021, and 2020, respectively. The decrease in gross profit is primarily attributable to the decrease in revenue.

 

General and Administrative Expenses (“G&A”). We incurred G&A expenses of $690,780 and $728,994 for the fiscal years ended December 31, 2021, and 2020, respectively.

 

Other Income, net. We incurred net other income of $7,692 for the fiscal year ended December 31, 2021, as compared to a net other income of $9,554 for the fiscal year ended December 31, 2020. Our net other income for the year ended December 31, 2020 consisted of the subsidy funds from Government.

 

Income Tax Expense. We recorded income tax expense of $6,671 and $8,215 for the fiscal years ended December 31, 2021 and 2020.

 

Net Loss. During the year ended December 31, 2021, we incurred a net loss of $445,409, as compared to a net income $469,476 for the year ended December 31, 2020. The significant decreases due to a decrease in the revenue, cost of revenue and selling and distribution expenses due to the outbreak of COVID-19.

 

20

 

 

Liquidity And Capital Resources

 

As of December 31, 2021, we had cash and cash equivalents of $609,434, inventories of $327,551 operating right of use assets of $350,563, tax recoverable of $8,910 and prepayments and other receivables of $139,254.

 

As of December 31, 2020, we had cash and cash equivalents of $1,006,394, inventories of $206,272, and prepayments and other receivables of $121,501.

 

We believe that our current cash and other sources of liquidity discussed below are adequate to support general operations for at least the next 12 months.

 

   Years Ended December 31, 
   2021   2020 
Net cash (used in) provided by operating activities  $(438,620)  $343,657 
Net cash used in investing activities   (27,358)   (67,862)
Net cash provided by financing activities   50,319    45,862 

 

Net Cash (Used In) Generated from Operating Activities.

 

For the year ended December 31, 2021, net cash used in operating activities was $438,620 which consisted primarily of the increase in accrued liabilities and other payables of $48,884, increase in prepayment and other receivables of $17,753, decrease in accounts payables of $7,827, decrease in tax payables of $17,229, increase in inventories of $121,279, and decrease in customer deposit of $69,141.

 

For the year ended December 31, 2020, net cash provided by operating activities was $343,657, which consisted primarily of the decrease in prepayment and other receivables of $199,317, decrease in accounts receivables of $530,196, increase in accrued liabilities and other payables of $2,316, increase in accounts payables of $7,827, increase in tax payables of $8,219, increase in inventories of $94,655, increase in lease liabilities of $47, and increase in customer deposit of $13,044.

 

We expect to continue to rely on cash generated through financing from our existing shareholders and private placements of our securities, however, to finance our operations and future acquisitions.

 

Net Cash Used In Investing Activities.

 

For the year ended December 31, 2021, net cash used in investing activities was $27,358, consisted primarily of leasehold improvement.

 

For the year ended December 31, 2020, net cash used in investing activities was $67,862, consisted primarily of purchase of plant and equipment of $75,060, and cash from acquisition of legal acquirer of $7,198.

 

Net Cash Generated From Financing Activities.

 

For the year ended December 31, 2021, net cash provided by financing activities was $50,319, consisting primarily of advance from a related company of $150,508 and repayment of lease liabilities of $100,189.

 

For the year ended December 31, 2020, net cash provided by financing activities was $45,862, consisting primarily of repayment to a related company of $3,038, advance from a director 128,295 and repayment of lease liabilities of $79,395.

 

Material Commitments

 

As of the date of this Annual Report, we do not have any material commitments.

 

21

 

 

Material Cash Requirements

 

We have not achieved profitability since our inception and we expect to continue to incur net losses for the foreseeable future. We expect net cash expended in 2022 to be significantly higher than 2021. As of December 31, 2021, we had an accumulated deficit of $918,195. Our material cash requirements are highly dependent upon the additional financial support from our major shareholders in the next 12 - 18 months.

 

We had the following contractual obligations and commercial commitments as of December 31, 2021:

 

Contractual Obligations  Total   Less
than
1 year		   1-3 Years   3-5
Years		   More
than 5
Years		 
   $   $   $   $   $ 
Amounts due to a related company   199,964    199,964    –    –    – 
Amount due to a director    219,461    219,461    –    –    – 
Operating lease obligations    360,154    114,132    246,022           
Accrued liabilities and other payables    51,200    51,200    –    –    – 
Customer deposits   340,783    340,783                
              –    –    – 
Total obligations    1,171,562    925,540    246,022    –    – 

 

Off-Balance Sheet Arrangements.

 

The Company does not have any off-balance sheet arrangements and it is not anticipated that the Company will enter into any off-balance sheet arrangements.

 

Summary of Significant Accounting Policies

 

The Company’s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (GAAP). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Update (ASU) of the Financial Accounting Standards Board (FASB). All adjustments considered necessary for a fair presentation have been included. These adjustments consist of normal and recurring accruals, as well as non-recurring charges.

 

The consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. The results of subsidiaries acquired or disposed of during the periods are included in the consolidated statements of operations from the effective date of acquisition or up to the effective date of disposal.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

 

Significant areas for which management uses estimates include:

 

● revenue recognition,
● asset impairments, including goodwill and other indefinite-lived intangible assets;
● sales returns and allowances;
● inventory;
● estimated lives for tangible and intangible assets;
● income tax valuation allowances; and

 

22

 

 

These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.

 

Segment Reporting

 

Accounting Standards Codification (“ASC”) Topic 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in one reportable operating segment in Hong Kong and China.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of December 31, 2021 and 2020, there was no allowance for doubtful accounts.

 

Inventories

 

Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of December 31, 2021 and 2020, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.

 

23

 

 

Plant and equipment

 

Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:

 

   Expected useful lives  Residual value 
Furniture, fixture and equipment  3 years   5%
Motor vehicle  3.33 to 4 years   5%
Leasehold improvement  2 years   5%

 

Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.

 

Intangible assets

 

Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is 10 years and will expire in 2028.

 

Impairment of long-lived assets

 

In accordance with the provisions of ASC Topic 360, “Impairment or Disposal of Long-Lived Assets”, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets.

 

Revenue recognition

 

The Company adopted Accounting Standards Codification (“ASC”) 606 – Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:

 

  ● identify the contract with a customer;
  ● identify the performance obligations in the contract;
  ● determine the transaction price;
  ● allocate the transaction price to performance obligations in the contract; and
  ● recognize revenue as the performance obligation is satisfied.

 

24

 

 

Currently, the Company operates two business segments.

 

Healthcare Business mainly provides health consulting advisory services and healthcare and wellness products to the customers.

 

Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.

 

The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Wine Business mainly provides the wine products to the customers. Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The Company recorded product sales returns $148,208 and $0 for the years ended December 31, 2021 and 2020, respectively. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

25

 

 

Transfers of Cash to and from Our Subsidiaries

 

China Foods Holdings Ltd is a Delaware holding company with no operations of its own. We conduct our operations in Hong Kong through our subsidiary in Hong Kong, while our operations in PRC through our subsidiary in PRC. We may rely on dividends to be paid by our Hong Kong subsidiary to fund our cash and financing requirements, including the funds necessary to pay dividends and other cash distributions to our shareholders, to service any debt we may incur and to pay our operating expenses. There is a possibility that the PRC could prevent our cash maintained in Hong Kong from leaving or the PRC could restrict the deployment of the cash into our business or for the payment of dividends. Any such controls or restrictions may adversely affect our ability to finance our cash requirements, service debt or make dividend or other distributions to our shareholders. If our Hong Kong subsidiary incurs debt on its own behalf in the future, the instruments governing the debt may restrict its ability to pay dividends or make other distributions to us. To date, our subsidiaries have not made any transfers, dividends or distributions to China Foods Holdings Ltd. and China Foods Holdings Ltd. has not made any transfers, dividends or distributions to our subsidiaries.

 

China Foods Holdings Ltd. is permitted under the Delaware laws to provide funding to our subsidiaries in Hong Kong through loans or capital contributions without restrictions on the amount of the funds, subject to satisfaction of applicable government registration, approval and filing requirements. Our Hong Kong is also permitted under the laws of Hong Kong to provide funding China Foods Holdings Ltd. through dividend distribution without restrictions on the amount of the funds. As of the date of this prospectus, there has been no dividends or distributions among the holding company or the subsidiaries nor do we expect such dividends or distributions to occur in the foreseeable future among the holding company and its subsidiaries.

 

We currently intend to retain all available funds and future earnings, if any, for the operation and expansion of our business and do not anticipate declaring or paying any dividends in the foreseeable future. Any future determination related to our dividend policy will be made at the discretion of our board of directors after considering our financial condition, results of operations, capital requirements, contractual requirements, business prospects and other factors the board of directors deems relevant, and subject to the restrictions contained in any future financing instruments.

 

Subject to the Delaware Statutes and our bylaws, our board of directors may authorize and declare a dividend to shareholders at such time and of such an amount as they think fit if they are satisfied, on reasonable grounds, that immediately following the dividend the value of our assets will exceed our liabilities and we will be able to pay our debts as they become due. There is no further Delaware statutory restriction on the amount of funds which may be distributed by us by dividend.

 

Under the current practice of the Inland Revenue Department of Hong Kong, no tax is payable in Hong Kong in respect of dividends paid by us. The laws and regulations of the PRC do not currently have any material impact on transfer of cash from China Foods Holdings Ltd. to our Hong Kong subsidiaries or from our Hong Kong subsidiaries to China Foods Holdings Ltd. There are no restrictions or limitation under the laws of Hong Kong imposed on the conversion of HK dollar into foreign currencies and the remittance of currencies out of Hong Kong or across borders and to U.S investors.

 

Current PRC regulations permit PRC subsidiaries to pay dividends to Hong Kong subsidiaries only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, each of our subsidiaries in China is required to set aside at least 10% of its after-tax profits each year, if any, to fund a statutory reserve until such reserve reaches 50% of its registered capital. Each of such entity in China is also required to further set aside a portion of its after-tax profits to fund the employee welfare fund, although the amount to be set aside, if any, is determined at the discretion of its board of directors. Although the statutory reserves can be used, among other ways, to increase the registered capital and eliminate future losses in excess of retained earnings of the respective companies, the reserve funds are not distributable as cash dividends except in the event of liquidation. As of the date of this prospectus, we do not have any PRC subsidiaries.

 

26

 

 

The PRC government also imposes controls on the conversion of RMB into foreign currencies and the remittance of currencies out of the PRC. Therefore, we may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currency for the payment of dividends from our profits, if any. Furthermore, if our subsidiaries in the PRC incur debt on their own in the future, the instruments governing the debt may restrict their ability to pay dividends or make other payments. If we or our subsidiaries are unable to receive all of the revenues from our operations, we may be unable to pay dividends on our common stock.

 

Cash dividends, if any, on our common stock will be paid in U.S. dollars. If we are considered a PRC tax resident enterprise for tax purposes, any dividends we pay to our overseas shareholders may be regarded as China-sourced income and as a result may be subject to PRC withholding tax at a rate of up to 10.0%.

 

In order for us to pay dividends to our shareholders, we will rely on payments made from our Hong Kong subsidiary to China Foods. Certain payments from PRC subsidiaries to Hong Kong subsidiaries will be subject to PRC taxes, including business taxes and VAT. As of the date of this report, our Hong Kong subsidiary has not made any transfers or distributions.

 

Pursuant to the Arrangement between Mainland China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and Tax Evasion on Income, or the Double Tax Avoidance Arrangement, the 10% withholding tax rate may be lowered to 5% if a Hong Kong resident enterprise owns no less than 25% of a PRC entity. However, the 5% withholding tax rate does not automatically apply and certain requirements must be satisfied, including, without limitation, that (a) the Hong Kong entity must be the beneficial owner of the relevant dividends; and (b) the Hong Kong entity must directly hold no less than 25% share ownership in the PRC entity during the 12 consecutive months preceding its receipt of the dividends. In current practice, a Hong Kong entity must obtain a tax resident certificate from the Hong Kong tax authority to apply for the 5% lower PRC withholding tax rate. As the Hong Kong tax authority will issue such a tax resident certificate on a case-by-case basis, we cannot assure you that we will be able to obtain the tax resident certificate from the relevant Hong Kong tax authority and enjoy the preferential withholding tax rate of 5% under the Double Taxation Arrangement with respect to dividends to be paid by a PRC subsidiary to its immediate holding company. As of the date of this prospectus, we do not have a PRC subsidiary. In the event that we acquire or form a PRC subsidiary in the future and such PRC subsidiary desires to declare and pay dividends to our Hong Kong subsidiary, our Hong Kong subsidiary will be required to apply for the tax resident certificate from the relevant Hong Kong tax authority. In such event, we plan to inform the investors through SEC filings, such as a current report on Form 8-K, prior to such actions.

 

27

 

 

Income taxes

 

The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statement of operations.

 

28

 

 

The reporting currency of the Company is United States Dollar (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the People’s Republic of China and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholder’s equity.

 

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share.” Basic income per share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Comprehensive income

 

ASC Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying consolidated statements of changes in shareholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.

 

Retirement plan costs

 

Contributions to retirement plans (which are defined contribution plans) are charged to general and administrative expenses in the accompanying statements of operation as the related employee service are provided.

 

29

 

 

Leases

 

The Company adopts the FASB Accounting Standards Update (“ASU”) 2016-02 “Leases (Topic 842).” for all periods presented.  This standard requires lessees to recognize lease assets (“right of use”) and related lease obligations (“lease liabilities”) on the balance sheet for leases with terms in excess of 12 months.

 

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities in the consolidated balance sheets. Finance leases are included in finance lease ROU assets and finance lease liabilities in the consolidated balance sheets.

 

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease and finance lease ROU assets and liabilities are recognized at January 1, 2019 based on the present value of lease payments over the lease term discounted using the rate implicit in the lease. In cases where the implicit rate is not readily determinable, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 

Related parties

 

The Company follows the ASC 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

30

 

 

Commitments and contingencies

 

The Company follows the ASC 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Fair value of financial instruments

 

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and has adopted paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by paragraph 820-10-35-37 of the FASB Accounting Standards Codification are described below:

 

  Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
     
  Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
     
  Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

 

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

 

31

 

 

Recent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

 

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), (“ASU 2021-04”). This ASU reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. This ASU provides guidance for a modification or an exchange of a freestanding equity-classified written call option that is not within the scope of another Topic. It specifically addresses: (1) how an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; (2) how an entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; and (3) how an entity should recognize the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange. This ASU will be effective for all entities for fiscal years beginning after December 15, 2021. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The adoption of ASU 2021-04 on January 1, 2022 did not have a material impact on the Company’s financial statements or disclosures.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

32

 

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

China Foods Holdings Ltd

Index to

Consolidated Financial Statements

 

  Pages
   
Report of Independent Registered Public Accounting Firm 34
   
Consolidated Balance Sheets 35
   
Consolidated Statements of Operations and Comprehensive (Loss) Income 36
   
Consolidated Statements of Changes in Shareholders’ Equity 37
   
Consolidated Statements of Cash Flows 38
   
Notes to Consolidated Financial Statements 39

 

33

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the stockholders and the board of directors of

China Foods Holdings Limited

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of China Foods Holdings Limited (the “Company”) as of December, 31 2021 and 2020 and the related consolidated statements of operations and comprehensive (loss) income, shareholders’ equity, and cash flows for the years ended December 31, 2021 and 2020, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years ended December 31, 2021 and 2020, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial report. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinions.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (i) relate to accounts or disclosures that are material to the financial statements; and (ii) involved our especially challenging, subjective, or complex judgements.

 

/s/ HKCM CPA& Co.  
Certified Public Accountants  

 

We have served as the Company’s auditor since 2020.

 

Hong Kong, China

April 15, 2022

 

PCAOB ID : 3299

 

34

 

 

China Foods Holdings Ltd.

Consolidated Balance Sheets

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

   December 31, 2021   December 31, 2020 
         
ASSETS          
           
Current Assets          
Cash and cash equivalents   609,434    1,006,394 
Prepayments and other receivables   139,254    121,501 
Inventories   327,551    206,272 
Tax recoverable   8,910    - 
Right-of-use assets   350,563    - 
Total Current Assets   1,435,712    1,334,167 
           
Non-Current Assets          
Plant and equipment   132,604    193,621 
Intangible assets   3,947    4,353 
Total Non-Current Assets   136,551    197,974 
           
TOTAL ASSETS   1,572,263    1,532,141 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
           
Current Liabilities          
Accounts payable   -    7,827 
Accrued liabilities and other payables   51,200    2,316 
Customer deposits   340,783    409,924 
Lease liabilities   114,132    - 
Amount due to a director   219,461    68,953 
Amount due to a related company   199,964    199,964 
Tax payable   -    8,319 
Total Current-Liabilities   925,540    697,303 
           
Non-Current Liabilities          
Lease liabilities – non-current portion   246,022    - 
           
Commitment and contingents   -    - 
           
Shareholders’ Equity          
Common stock $0.0001 par value, 100,000,000 shares authorized, 20,252,309 and 20,252,309 shares issued and outstanding as of December 31, 2021 and 2020 respectively   2,025    2,025 
Additional paid-in capital   1,290,355    1,290,355 
Accumulated other comprehensive income   26,516    5,244 
Accumulated deficit   (918,195)   (462,786)
Total Shareholders’ Equity   400,701    834,838 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   1,572,263    1,532,141 

 

The accompanying notes are an integral part of these consolidated financial statements

 

35

 

 

China Foods Holdings Ltd.

Consolidated Statements of Operations and Comprehensive (Loss) Income

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Revenue, net  $361,116   $1,013,141 
           
Cost of revenue   (121,690)   (596,530)
           
Gross profit   239,426    416,611 
           
Operating expenses          
Selling and distribution expenses   5,076    158,432 
General and administrative expenses   690,780    728,994 
Total operating expenses   695,856    887,426 
           
Loss from operation   (456,430)   (470,815)
           
Other income:          
Interest income   1,277    2,602 
Sundry income   6,415    6,952 
Total other income   7,692    9,554 
           
Loss before income tax   (448,738)   (461,261)
           
Income tax expenses   (6,671)   (8,215)
           
NET LOSS  $(455,409)  $(469,476)
           
Other comprehensive loss          
Foreign currency adjustment gain   21,272    59,245 
           
Comprehensive loss  $(434,137)  $(410,231)
           
Net loss per common share          
Basic and diluted  $(0.02)  $(0.03)
           
Weighted average number of common share          
Basic and diluted   20,252,309    17,525,701 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

36

 

 

CHINA FOODS HOLDINGS LTD.

Consolidated Statements of Changes in Shareholders’ Equity

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

                               
   Common Stock   Additional paid-in   Retained earnings (accumulated   Accumulated other comprehensive  

Total

shareholders’

 
   Share   Amount   capital   deficit)   (loss) income   equity 
Balances at January 1, 2020   15,000,000    1,500    1,290,355    159,441    (54,001)   1,397,295 
                               
Foreign currency translation adjustment   -    -    -    -    59,245    59,245
                               
Shares issued for acquisition of legal acquirer   5,252,309    525    -    (152,751)   -    (152,226

)

                               
Net loss for the year   -    -    -    (469,476)   -    (469,476

)

                               
Balances at December 31, 2020  20,252,309     　2,025    1,290,355    (462,786)   5,244    834,838 
                               
Foreign currency translation adjustment   -    -    -    -    21,272    21,272 
                               
Net loss for the year   -    -    -    (455,409)   -    (455,409)
                               
Balances at December 31, 2021    20,252,309     　2,025    1,290,355    (918,195)   26,516    400,701 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

37

 

 

China Foods Holdings Ltd

Consolidated Statements of Cash Flows

(Currency expressed in United States Dollars (“US$”))

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Cash flow from operating activities:          
Net loss  $(455,409)  $(469,476)
Adjustments to reconcile net loss to net cash (used in) generated from operating activities          
Depreciation   90,961    71,472 
Amortization   521    487 
Non-cash lease expense   109,652    74,863 
Total adjustments to reconcile net income to net cash (used in) generated from operating activities   (254,275)   (322,654)
Change in operating assets and liabilities:          
Accounts receivable   -    530,196 
Prepayments and other receivables   (17,753)   199,317 
Inventories   (121,279)   (94,655)
Accounts payable   (7,827)   7,827 
Accrued liabilities and other payables   48,884    2,316
Customer deposits   (69,141)   13,044
Tax payable   (17,229)   8,219 
Lease liabilities   -    47
Net cash (used in) generated from operating activities   (438,620)   343,657 
           
Cash flow from investing activities          
Purchase of plant and equipment   (27,358)   (75,060)
Cash from acquisition of legal acquirer   -    7,198 
           
Net cash used in investing activities   (27,358)   (67,862)
           
Cash flow from financing activities:          
Payment of lease liabilities   (100,189)   (79,395)
Advance from (repayment to) a related company   150,508    (3,038)
Advance from a director   -    128,295 
Net cash generated from financing activities   50,319    45,862 
           
Foreign currency translation adjustment   18,699    50,245 
           
Net change in cash and cash equivalents   (396,960)   371,902 
           
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR   1,006,394    634,492 
           
CASH AND CASH EQUIVALENTS, END OF YEAR  $609,434   $1,006,394 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid for interest  $-   $- 
Cash paid for income taxes  $-   $- 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

38

 

 

China Foods Holdings Ltd

Notes to Consolidated Financial Statements

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

NOTE 1 – ORGANIZATION AND BUSINESS BACKGROUND

 

China Foods Holdings Ltd. (the “Company” or “CFOO”) was incorporated in Delaware on January 10, 2019. The Company currently engages in the sale of healthcare product and rendering of consulting service in Hong Kong and China. 

 

On July 9, 2020, the Company consummated the Share Exchange Agreement (“the “Share Exchange Agreement”) with Elite Creation Group Limited, a private limited company organized under the laws of British Virgin Islands (“ECGL”). As a result of the acquisition of ECGL, the Company entered into the healthcare product distributing and marketing industry, and then pursue a new strategy of developing and distributing health related products, including supplements, across the globe with a focus on mainland China, Europe and Australia.

 

ECGL will comprise the ongoing operations of the combined entity and its senior management will serve as the senior management of the combined entity, ECGL is deemed to be the accounting acquirer for accounting purposes. The transaction will be treated as a recapitalization of the Company. Accordingly, the consolidated assets, liabilities and results of operations of the Company will become the historical financial statements of ECGL, and the Company’s assets, liabilities and results of operations will be consolidated with ECGL beginning on the acquisition date. ECGL was the legal acquiree but deemed to be the accounting acquirer. The Company was the legal acquirer but deemed to be the accounting acquiree in the reverse merger. The historical financial statements prior to the acquisition are those of the accounting acquirer (ECGL). After completion of the Share Exchange Transaction, the Company’s consolidated financial statements include the assets and liabilities, the operations and cash flow of the accounting acquirer.

 

The following table depicts the description of the Company’s subsidiaries :

 

Name  Place of incorporation
and kind of
legal entity		  Principal activities  Particulars of registered/
paid up share capital		  Effective interest
held		 
              
Elite Creation Group Limited  BVI, a limited liability company  Investment holding  50,000 issued shares of US$1each   100%
               
Alpha Wellness (HK) Limited  Hong Kong, a limited liability company  Investment holding  300,000 issued shares of HK$300,000   100%
               
Guangzhou Xiao Xiang Health Industry Company Limited  The PRC, a limited liability company  Sales of healthcare products  RMB8,300,000   100%

 

The Company and its subsidiaries are hereinafter referred to as (the “Company”).

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation and consolidation

 

The Company’s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”). All adjustments considered necessary for a fair presentation have been included. These adjustments consist of normal and recurring accruals, as well as non-recurring charges.

 

The consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. The results of subsidiaries acquired or disposed of during the periods are included in the consolidated statements of operations from the effective date of acquisition or up to the effective date of disposal.

 

39

 

 

Use of estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

 

Significant areas for which management uses estimates include:

 

● revenue recognition,
● asset impairments, including goodwill and other indefinite-lived intangible assets;
● sales returns and allowances;
● inventory;
● estimated lives for tangible and intangible assets;
● income tax valuation allowances; and

 

These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.

 

Segment reporting

 

Accounting Standards Codification (“ASC”) Topic 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in one reportable operating segment in Hong Kong and China.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectibility. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of December 31, 2021 and 2020, there was no allowance for doubtful accounts.

 

Inventories

 

Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of December 31, 2021 and 2020, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.

 

40

 

 

Plant and equipment

 

Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:

 

   Expected useful lives  Residual value 
Furniture, fixture and equipment  3 years   5% 
Motor vehicle  3.33 to 4 years   5% 
Leasehold improvement  2 years   5% 

 

Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.

 

Intangible assets

 

Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is 10 years and will expire in 2028.

 

Amortization expense for the years ended December 31, 2021 and 2020 was $521 and $487, respectively.

 

Impairment of long-lived assets

 

In accordance with the provisions of ASC Topic 360, “Impairment or Disposal of Long-Lived Assets”, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment charge for the years presented.

 

Revenue recognition

 

The Company adopted Accounting Standards Codification (“ASC”) 606 – Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:

 

  ● identify the contract with a customer;
  ● identify the performance obligations in the contract;
  ● determine the transaction price;
  ● allocate the transaction price to performance obligations in the contract; and
  ● recognize revenue as the performance obligation is satisfied.

 

41

 

 

Currently, the Company operates two business segments.

 

Healthcare Business mainly provides health consulting advisory services and healthcare and wellness products to the customers.

 

Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.

 

The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Wine Business mainly provides the wine products to the customers. Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The Company recorded product sales returns $148,208 and $0 for the years ended December 31, 2021 and 2020, respectively. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Disaggregation of Revenue

 

The following table provides information about disaggregated revenue from customers into the nature of the products and services and includes a reconciliation of the disaggregated revenue with reportable segments.

 

  

For the Year Ended December 31,

2021

  

For the Year Ended December 31,

2020

 
         
Consultancy service fee income  $216,851   $221,041 
Sale of healthcare products   31,874    481,049 
Sale of wine products   112,392    311,051 
           
TOTAL  $361,116   $1,013,141 

 

Income taxes

 

The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

 

42

 

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statement of operations.

 

The reporting currency of the Company is United States Dollar (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the People’s Republic of China and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholder’s equity.

 

Translation of amounts from HK$ and RMB into US$ have been made at the following exchange rates for the years ended December 31, 2021 and 2020.

 

Years ended December 31, 2021 and 2020

 

   2021   2020 
Year-end HK$:US$ exchange rate   0.12822    0.12899 
Annual average HK$:US$ exchange rate   0.12865    0.12893 
Year-end RMB:US$ exchange rate   0.15742    0.15307 
Annual average RMB:US$ exchange rate   0.15507    0.14503 

 

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share.” Basic income per share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Comprehensive income

 

ASC Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying consolidated statements of changes in shareholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.

 

Retirement plan costs

 

Contributions to retirement plans (which are defined contribution plans) are charged to general and administrative expenses in the accompanying statements of operation as the related employee service are provided.

 

43

 

 

Leases

 

The Company adopts the FASB Accounting Standards Update (“ASU”) 2016-02 “Leases (Topic 842).” for all periods presented.  This standard requires lessees to recognize lease assets (“right of use”) and related lease obligations (“lease liabilities”) on the balance sheet for leases with terms in excess of 12 months.

 

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities in the consolidated balance sheets. Finance leases are included in finance lease ROU assets and finance lease liabilities in the consolidated balance sheets.

 

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease and finance lease ROU assets and liabilities are recognized at January 1, 2019 based on the present value of lease payments over the lease term discounted using the rate implicit in the lease. In cases where the implicit rate is not readily determinable, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 

Related parties

 

The Company follows the ASC 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

44

 

 

Commitments and contingencies

 

The Company follows the ASC 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Fair value of financial instruments

 

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and has adopted paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by paragraph 820-10-35-37 of the FASB Accounting Standards Codification are described below:

 

  Level 1

Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
  Level 2

Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
  Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

 

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

 

45

 

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, approximate their fair values because of the short maturity of these instruments.

 

Recent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

 

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), (“ASU 2021-04”). This ASU reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. This ASU provides guidance for a modification or an exchange of a freestanding equity-classified written call option that is not within the scope of another Topic. It specifically addresses: (1) how an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; (2) how an entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; and (3) how an entity should recognize the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange. This ASU will be effective for all entities for fiscal years beginning after December 15, 2021. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The adoption of ASU 2021-04 on January 1, 2022 did not have a material impact on the Company’s financial statements or disclosures.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

NOTE 3: LIQUIDITY AND CAPITAL RESOURCES

 

Our cash balance on December 31, 2021, was $609,434, as compared to $1,006,394 on December 31, 2021, it was decreased by $396,960. We had an accumulated deficit of $918,195. We believe that our cash and investments will be sufficient to fund our planned operations for at least one year past the issuance date of the consolidated financial statements.

 

The Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial support from its major shareholders. Management believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due.

 

Despite the amount of funds that the Company has raised, no assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its shareholders, in the case of equity financing.

 

46

 

 

NOTE 4: SEGMENT REPORTING

 

Currently, the Company has two reportable business segments:

 

(i) Healthcare Segment, mainly provides health consulting advisory services and healthcare and wellness products to the customers; and
(ii) Wine Segment, mainly provides the wine products to the customers.

 

In the following table, revenue is disaggregated by primary major product line, and timing of revenue recognition. The table also includes a reconciliation of the disaggregated revenue with the reportable segments.

 

  

Healthcare

Segment

   Wine Segment   Total 
   Year Ended December 31, 2021 
  

Healthcare

Segment

   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $216,850   $–   $216,850 
Sale of healthcare products   39,996    –    39,996 
Sale of wine products   –    104,270    104,270 
Total revenue   256,846    104,270    361,116 
                
Cost of sales:               
Consulting service income   (31,315)   –    (31,315)
Sale of healthcare products   (32,064)    –   (32,064)
Sale of wine products   –    (58,311)   (58,311)
Total cost of revenue   (63,379)   (58,311)   (121,690)
                
Gross profit   193,467    45,959    239,426 
                
Operating Expenses               
Selling and distribution   –    (5,076)   (5,076)
General and administrative   (690,780)   –   (690,780)
Total operating expenses   (690,780)   (5,076)   (695,856)
                
Segment (loss) income  $(497,313)   $40,883  $(456,430)

 

  

Healthcare

Segment

   Wine Segment   Total 
   Year Ended December 31, 2020 
  

Healthcare Segment

   Wine
Segment		   Total 
Revenue from external customers:               
Consulting service income  $221,041   $–   $221,041 
Sale of healthcare products   564,814    –    564,814 
Sale of wine products   –    227,286     227,286 
Total revenue   785,855    227,286    1,013,141 
                
Cost of sales:               
Consulting service income   –    –    
Sale of healthcare products   (395,392)    –   (395,392)
Sale of wine products   –    (201,138)    (201,138)
Total cost of revenue   (395,392)    (201,138)   (596,530)
                
Gross profit   390,463    26,148    416,611 
                
Operating Expenses               
Selling and distribution   –    (158,432)   (158,432)
General and administrative   (728,994)   –   (728,994)
Total operating expenses   (728,994)   (158,432)   (887,426)
                
Segment loss  $(338,531)   $(132,284)  $(470,815)

 

47

 

 

The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Hong Kong  $216,851   $221,041 
China   144,265    792,100 
           
Total revenue  $361,116   $1,013,141 

 

NOTE 5: PREPAYMENTS AND OTHER RECEIVABLES

 

Prepayments and other receivable consisted of the following:

 

   December 31, 2021   December 31, 2020 
         
Prepayments  $3,077   $7,712 
Other deposits   -    119 
Rental deposits   33,961    - 
Other receivables   102,216    113,670 
Prepayments and other receivable  $139,254   $121,501 

 

Purchase deposits represented deposit payments made to vendors for procurement, which are interest-free, unsecured and relieved against accounts payable when goods are received by the Company.

 

NOTE 6: INVENTORIES

 

Inventories consisted of the following:

 

   December 31, 2021   December 31, 2020 
         
Packing materials  $-   $21,527 
Finished goods   327,551    184,745 
Inventories  $327,551   $206,272 

 

For the years ended December 31, 2021 and 2020, no allowance for obsolete inventories was recorded by the Company.

 

48

 

 

NOTE 7: PLANT AND EQUIPMENT

 

   December 31, 2021   December 31, 2020 
         
Motor vehicle  $311,343   $311,343 
Furniture, fixture and equipment   15,465    15,465 
Leasehold improvement   27,358    - 
Foreign translation difference, net   17,603    10,471 
Plant and equipment, gross   371,769    337,279 
           
Less: accumulated depreciation   (228,507)   (137,546)
Foreign translation difference, net   (10,658)   (6,112)
Plant and equipment. net  $132,604   $193,621 

 

Depreciation expense for the years ended December 31, 2021 and 2020 were $90,961 and $71,472, respectively.

 

NOTE 8: CUSTOMER DEPOSITS

 

Customer deposits represented cash paid to the Company from the customers, for which the Company has an obligation to deliver the orders to satisfy with the customers, or to return the funds, within twelve months.

 

As of December 31, 2021 and 2020, the deposit received from customers was $340,783 and $409,924, respectively.

 

NOTE 9: AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY

 

The amounts represented temporary advances to the Company by its director and its related company which were unsecured, interest-free and have no fixed terms of repayments.

 

NOTE 10: LEASE

 

The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of 2 to 4 year, through December 31, 2025.

 

Right of use assets and lease liability – right of use are as follows:

 

  

December 31,

2021

  

December 31,

2020

 
         
Right-of-use assets  $350,563   $- 

 

The lease liability – right of use is as follows:

 

  

December 31,

2021

  

December 31,

2020

 
         
Current portion  $114,132   $- 
Non-current portion   246,022    - 
           
Total  $360,154   $- 

 

NOTE 11: SHAREHOLDERS’ EQUITY

 

Common Stock

 

The Company is authorized, subject to limitations prescribed by Delaware law, to issue up to 100,000,000 shares of common stock with a nominal par value of $0.0001.

 

Dividend Rights

 

Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and only then at the times and in the amounts that our board of directors may determine.

 

49

 

 

Voting Rights

 

Each holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Under our Certificate of Incorporation, stockholders do not have the right to cumulate votes for the election of directors.

 

No Preemptive or Similar Rights

 

Our common stock is not entitled to preemptive rights and is not subject to conversion, redemption or sinking fund provisions.

 

Right to Receive Liquidation Distributions

 

Upon our dissolution, liquidation or winding-up, the assets legally available for distribution to our stockholders are distributable ratably among the holders of our common stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding shares of preferred stock.

 

On July 9, 2020, the Company consummated the Share Exchange Agreement (“the “Share Exchange Agreement”) with Elite Creation Group Limited, a private limited company organized under the laws of British Virgin Islands (“ECGL”), and the shareholders of ECGL. Pursuant to the Share Exchange Agreement, we purchased Fifty Thousand (50,000) shares of ECGL (the “ECGL Shares”), representing all of the issued and outstanding shares of common stock of ECGL. As consideration, the Company agreed to issue to the shareholders of ECGL Fifteen Million (15,000,000) shares of its common stock, at a value of $0.32 per share, for an aggregate value of $4,800,000.

 

As of December 31, 2021 and 2020, a total of 20,252,309 outstanding shares of common stock were issued.

 

Preferred Stock

 

The Company is not currently authorized to issue shares of preferred stock. The Certificate of Incorporation however, allows the board of directors to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the common stock in the event that shares of preferred stock are authorized in the future. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and may adversely affect the market price of our common stock and the voting and other rights of the holders of common stock. The Company has no current plans to issue any shares of preferred stock.

 

NOTE 12: NET LOSS PER SHARE

 

Basic net loss per share is computed using the weighted average number of common shares outstanding during the year. The dilutive effect of potential common shares outstanding is included in diluted net loss per share. The following table sets forth the computation of basic and diluted net loss per share for the years ended December 31, 2021 and 2020:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
Net loss attributable to common shareholders  $(455,409)  $(469,476)
           
Weighted average common shares outstanding – Basic and diluted   20,252,309    17,525,701 
           
Net loss per share – Basic and diluted  $(0.02)  $(0.03)

 

For the years ended December 31, 2021 and 2020, diluted weighted-average common shares outstanding is equal to basic weighted-average common shares, due to the Company’s net loss position. Hence, no common stock equivalents were included in the computation of diluted net loss per share since such inclusion would have been antidilutive.

 

50

 

 

NOTE 13: INCOME TAXES

 

The provision for income taxes consisted of the following:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Current tax  $6,671   $8,215 
Deferred tax   -    - 
Income tax expense  $6,671   $8,215 

 

The effective tax rate in the years presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rate. The Company operates in various countries: United States of America, Hong Kong and the PRC that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

CFOO is registered in the State of Delaware and is subject to US federal corporate income tax. The U.S. Tax Cuts and Jobs Act (the “Tax Reform Act”) was signed into law. The Tax Reform Act significantly revised the U.S. corporate income tax regime by, among other things, lowering the U.S. corporate tax rate from 35% to 21% effective January 1, 2018. The Company’s policy is to recognize accrued interest and penalties related to unrecognized tax benefits in its income tax provision. The Company has not accrued or paid interest or penalties which were not material to its results of operations for the years presented.

 

For the years ended December 31, 2021 and 2020, the Company did not have any interest and penalties associated with tax positions. As of December 31, 2021 and 2020, the Company has not accrued any penalties on uncertain tax positions.

 

As of December 31, 2021, the operation in the United States incurred $173,076 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carryforwards begin to expire in 2041, if unutilized.

 

BVI

 

Under the current BVI law, the Company is not subject to tax on income.

 

Hong Kong

 

The Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25% to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax year. The reconciliation of income tax rate to the effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Income before income taxes  $80,157   $170,555 
Statutory income tax rate   8.25%   8.25%
Income tax expense at statutory rate   6,613    14,070 
Tax adjustments   1,345   (3,277)
Tax holiday   

(1,287

)   (2,578)
Income tax expense  $6,671   $8,215 

 

51

 

 

The PRC

 

The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the People’s Republic of China at a unified income tax rate of 25%. The reconciliation of income tax rate to the effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Loss before income taxes  $(505,601)  $(482,014)
Statutory income tax rate   25%   25%
Income tax expense at statutory rate   (126,400)   (120,503)
Net operating loss   126,400    120,503 
Income tax expense  $-   $- 

 

The following table sets forth the significant components of the deferred tax assets of the Company as of December 31, 2021 and 2020:

 

   2021   2020 
   As of December 31, 
   2021   2020 
Deferred tax assets:          
Net operating loss carryforwards          
- United States  $54,747   $31,454 
- PRC   246,903    120,503 
Net operating loss carryforwards   301,650    151,957 
Less: valuation allowance   (301,650)   (151,957)
Deferred tax assets, net  $-   $- 

 

NOTE 14: PENSION COSTS

 

The Company is required to make contributions to their employees under a government-mandated defined contribution pension scheme for its eligible full-times employees in the People’s Republic of China. The Company is required to contribute a specified percentage of the participants’ relevant income based on their ages and wages level. During the years ended December 31, 2021 and 2020, $23,617 and $12,284 contributions were made accordingly.

 

NOTE 15: RELATED PARTY TRANSACTIONS

 

From time to time, the Company’s director and related company advanced funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand. As of December 31, 2021 and 2020, the Company owed the balance of $219,461 and $68,953 to its director, and owed the balance of $199,964 and $199,964 to a related company.

 

The Company purchased a motor vehicle from a related company at the carrying value of $42,966 for the year ended December 31, 2020.

 

Apart from the transactions and balances detailed elsewhere in these accompanying consolidated financial statements, the Company has no other significant or material related party transactions during the years presented.

 

52

 

 

NOTE 16: CONCENTRATIONS OF RISK

 

The Company is exposed to the following concentrations of risk:

 

(a) Major customers

 

For the years ended December 31, 2021 and 2020, the customers who accounts for 10% or more of the Company’s revenues and its outstanding receivable balances as at year-end dates, are presented as follows:

 

  

Year ended

December 31, 2021

       December 31, 2021 
   Revenues   Percentage of revenues       Accounts receivable 
Customer C  $165,391    46%       $- 
Customer D   103,072    29%         
Customer E   51,460    14%        - 
TOTAL  $319,923    89%    Total   $- 

 

  

Year ended

December 31, 2020

       December 31, 2020  
Customer  Revenues   Percentage of revenues       Accounts receivable  
   　               　  
Customer A  $394,158    　39%         $ -  
Customer B   234,547    　23%           -  
　   　　　    　　　            　　　　  
Total:  $628,705    　62%    Total:    $ -  

 

All of the Company’s customers are located in the People’s Republic of China and Hong Kong.

 

(b) Major vendors

 

For the years ended December 31, 2021 and 2020, the vendor who accounts for 10% or more of the Company’s purchases and its outstanding payable balances as at year-end dates, are presented as follows:

 

  

Year ended

December 31, 2021

        December 31, 2021 
Vendor  Purchases   Percentage of purchases        Accounts payable 
Vendor D  $195,152    99%    Total:   $- 

 

 

  

Year ended

December 31, 2020

       December 31, 2020 
Vendor  Purchases   Percentage of purchases       Accounts payable 
   　   　       　 
Vendor A  $219,007    37%       $- 
Vendor B   71,616    12%        - 
Vendor C   61,222    10%        - 
　   　              　 
Total:  $351,845    59%   Total:   $- 

 

53

 

 

All of the Company’s vendors are located in the People’s Republic of China.

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of trade receivables. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Economic and political risk

 

The Company’s major operations are conducted in the People’s Republic of China. Accordingly, the political, economic, and legal environments in PRC, as well as the general state of PRC’s economy may influence the Company’s business, financial condition, and results of operations.

 

(e) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of HKD and RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

(f) Risk from COVID

 

As a result of COVID-19, the Company has been unable to satisfy certain customer orders for the products. As a result, the customers have experienced delays in receiving the products . There is uncertainty around the duration and breadth of the COVID-19 pandemic, and other actions taken to contain or treat the impact of COVID-19, and the extent of such impact will depend on future developments, which are highly uncertain and cannot be predicted.

 

NOTE 17: COMMITMENTS AND CONTINGENCIES

 

As of December 31, 2021 and 2020, the Company has no material commitments or contingencies.

 

NOTE 18: SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2021, up through the date the Company issued the audited consolidated financial statements. During the period, the Company did not have any material recognizable subsequent events.

 

54

 

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

The Company has had no disagreements with its principal independent accountants with respect to accounting practices or procedures or financial disclosure.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, including our CEO and Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our CEO and CFO concluded that due to the small size of the Company and lack of segregation of duties, our disclosure controls and procedures as of the end of the period covered by this report were not effective such that the information required to be disclosed by us in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding disclosure. A controls system cannot provide absolute assurance, however, that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. However, management believes the controls and procedures provide a reasonable basis for the conclusions.

 

Management’s Annual Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

 

Our management evaluated the effectiveness of our internal control over financial reporting as of December 31, 2021. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO - 2013”) in Internal Control - Integrated Framework. Further, our management considered the lack of segregation of duties could result in inadequate implementation and review financial reporting control procedures. Based on this evaluation, our management concluded that, as of December 31, 2021, our internal control over financial reporting was not effective.

 

Management believes that the material weakness set forth above did not have an effect on our financial results.

 

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm since the Company is not an accelerated or larger accelerated filer.

 

Evaluation of Changes in Internal Control over Financial Reporting

 

There have been no changes in internal control over financial reporting that occurred during the last fiscal quarter ended December 31, 2021, that has materially affected, or is reasonably likely to materially affect, the internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

None

 

55

 

 

PART III

 

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The following table sets forth as of December 31, 2021, the name, age, and position of each executive officer and director and the term of office of each director of the Company.

 

 

Name   Age   Position
         
Kong Xiao Jun   47   Chief Executive Officer, Chief Financial Officer and Director
         
Liu Yang   34   Director
         
Cheng Ni Hu   31   Director
         
Yunsi Liu   32   Director

 

Set forth below is a brief description of the background and business experience of our sole executive officer and director:

 

Xiao Jun Kong, age 47, has served as our Chief Executive Officer, Chief Financial Officer and Director since July 13, 2019. He currently serves as the Chief Executive Officer of Guangdong HY Capital Management CO., LTD and has served in that role since 2011. From 2007 to 2011, Mr. Kong was the Executive Director of the Asia Aluminum Group. Mr. Kong has experience in leading large-scale M&A and investment projects in different industries such as agriculture, film and media, and cultural tourism. Mr. Kong holds a bachelor degree in accounting from Southwestern University of Finance and Economics in Chengdu, Sichuan, China. He is also qualified as Chinese Certified Public Accountant, Certified Tax Agent, US Chartered Financial Analyst, and Fellow of the Institute of Financial Accountants UK. Mr. Kong brings to our board his experience in business development, strategic planning, and management.

 

Liu Yang, age 34, has been a director to hold office since May 13, 2019. She currently serves as the Investment Director of Guangdong HY Capital Management Co., Ltd and has served in that role since 2015. Ms. Liu has experience in M&A and investment projects in different industries such as consumer goods, agriculture, cultural tourism, and education. Ms. Liu holds a bachelor degree in Economics from Southern China University of Technology in Guangzhou, Guangdong, China.

 

Cheng Ni Hu, age 31, was appointed to serve as our director in July 9, 2020. She currently serves as the Marketing director of KangHuaGuoYao (GuangDong) Tech Pty. Ltd. for formulating the company’s strategy in marketing, branding and producing, and has served in that role since December 2018. From 2016 to 2018, she served as restore and relocate project manager in North Sydney Railway. Ms. Hu graduated from the University of Sydney with a Bachelor degree in Commerce and Combined Commerce (Marketing) and Public Affair from Southern California University. Ms. Hu brings to the Board her experience in marketing and operations.

 

Yunsi Liu, age 32, has been a President and director of China Foods, prior to the Merger, since January 15, 2019. She currently serves as the General Manager of Dray Alliance (a venture-backed, technology startup in the trucking industry) and has served in that role since 2019. Concurrently, she is the Managing Partner of Craft and Swan, LLC. From 2015 to 2020, Ms. Yunsi Liu served in executive capacities for various startups in the Southern California region. Ms. Liu graduated from the University of Pennsylvania with a Bachelor of Science in Economics degree from the Wharton School, and a Bachelor of Arts in Philosophy degree from the College of Arts and Sciences. Ms. Liu brings to the Board her experience in finance, management and operation.

 

56

 

 

Except as indicated below, to the knowledge of management, during the past five years, no present or former director, or executive officer of the Company:

 

  (1) filed a petition under the federal bankruptcy laws or any state insolvency law, nor had a receiver, fiscal agent or similar officer appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing;
     
  (2) was convicted in a criminal proceeding or named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses);
     
  (3) was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from or otherwise limiting, the following activities:

 

  (i) acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, associated person of any of the foregoing, or as an investment advisor, underwriter, broker or dealer in securities, or as an affiliate person, director or employee of any investment company, or engaging in or continuing any conduct or practice in connection with such activity;
     
  (ii) engaging in any type of business practice; or
     
  (iii) engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of federal or state securities laws or federal commodities laws;

 

  (4) was the subject of any order, judgment, or decree, not subsequently reversed, suspended, or vacated, of any federal or state authority barring, suspending, or otherwise limiting for more than 60 days the right of such person to engage in any activity described above under this Item, or to be associated with persons engaged in any such activity;
     
  (5) was found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission to have violated any federal or state securities law, and the judgment in such civil action or finding by the Securities and Exchange Commission has not been subsequently reversed, suspended, or vacated.
     
  (6) was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated.

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Exchange Act requires our directors, executive officers, and the persons who beneficially own more than 10% of the Common Stock and securities convertible into shares of Common Stock (together with the Common Stock, “Subject Shares”), to file with the SEC initial reports of ownership and reports of changes in ownership of Subject Shares. Directors, officers and greater than 10% beneficial owners of the Subject Shares are required by the SEC’s regulations to furnish us with copies of all forms they file with the SEC pursuant to Section 16(a) of the Exchange Act. Based solely on the reports received by us and on the representations of the reporting persons, we believe that these persons have complied with all applicable filing requirements during the fiscal year ended December 31, 2021.

 

Code of Ethics

 

We have not yet adopted a code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions. We intend to adopt a code of ethics in the immediate future.

 

Corporate Governance

 

There have been no changes in any state law or other procedures by which security holders may recommend nominees to our board of directors. We do not have a nominating committee, however we intend to appoint one in the immediate future.

 

57

 

 

Audit Committee

 

Our board of directors has an Audit Committee consisting of Mr. Kong. The Audit Committee does not at the present time have an audit committee financial expert serving on its Audit Committee; however, our board intends to appoint an audit committee financial expert in the immediate future.

 

Family Relationships

 

There are no family relationships between any of our directors or executive officers.

 

Involvement in Certain Legal Proceedings

 

None of our directors, executive officers and control persons has been involved in any of the following events during the past ten years:

 

● Any bankruptcy petition filed by or against any business or property of such person, or of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
   
● Any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
   
● Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities;
   
● Being found by a court of competent jurisdiction (in a civil action), the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;
   
● Being the subject of or a party to any judicial or administrative order, judgment, decree or finding, not subsequently reversed, suspended or vacated relating to an alleged violation of any federal or state securities or commodities law or regulation, or any law or regulation respecting financial institutions or insurance companies, including but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail, fraud, wire fraud or fraud in connection with any business entity; or
   
● Being the subject of or a party to any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act, any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

Conflicts of Interest

 

Except as provided for in Article XI of the Company’s By-Laws: Board Director Compensation, no officer, director or security holder of the company may be involved in pecuniary interest in any investment acquired or disposed of by the registrant or in any transaction to which the registrant or any of its subsidiaries is party or has an interest.

 

None of the directors, officers, security holders or affiliates of the registrant may engage, for their own account, business activities of the types conducted by the registrant and its subsidiaries.

 

58

 

 

ITEM 11. EXECUTIVE COMPENSATION

 

Summary Compensation Table

 

The following tables set forth, for each of the last two completed fiscal years of the Company, the total compensation awarded to, earned by or paid to any person who was a principal executive officer during the preceding fiscal year and every other highest compensated executive officers earning more than $100,000 during the last fiscal year (together, the “Named Executive Officers”). The tables set forth below reflect the compensation of the Named Executive Officers.

 

Summary Compensation Table

 

Name and Principal
Position		  Year   Salary   Bonus   Stock Awards   Option Awards   Non- Equity Incentive Plan Compensation   All
Other Compensation		   Total 
Kong Xiao Jun, CEO   2021    -0-    -0-    -0-    -0-    -0-    -0-    -0- 
    2020    -0-    -0-    -0-    -0-    -0-    -0-    -0- 

 

(1) Xiao Jun Kong has served as our Chief Executive Officer, Chief Financial Officer, and director since July 13, 2018.

 

Cash Compensation – No cash compensation was paid to any director or executive officer of the Company during the fiscal years ended December 31, 2021, and 2020. Mr. Kong was paid no compensation for his roles as CEO, CFO and director for the years 2018, 2019, 2020 and 2021. Mr. Kong agreed to take no compensation during this time frame to voluntarily reduce the financial obligation of the Company. He currently serves as the Chief Executive Officer of Guangdong HY Capital Management CO. LTD (“GHCMC”), which is not a competitor of the Company or GXXHIC. The CEO of GHCMC is a part-time position, requiring Mr. Kong to attend management meetings and Board of Director meetings, It is estimated that Mr. Kong’s service as CEO of GHCMC is very insignificant compared to his service to the Company, and these roles do not pose any conflict of interest.. Mr. Kong does not hold any other positions in any other entities.

 

Bonuses and Deferred Compensation – None

 

Compensation Pursuant to Plans – None

 

Pension Table – None

 

Other Compensation – None

 

Compensation of Directors

 

During our fiscal year ended December 31, 2021, we did not provide compensation to any of our employee directors for serving as our director. We currently have no formal plan for compensating our employee directors for their services in their capacity as directors, although we may elect to issue stock options to such persons from time to time. Directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses incurred in connection with attendance at meetings of our board of directors. Our board of directors may award special remuneration to any director undertaking any special services on our behalf other than services ordinarily required of a director.

 

Non-Employee Director Fees

 

Our Board determines the form and amount of compensation for our non-employee directors based on informal surveys of similar companies and the amount necessary to attract and retain such directors. For the fiscal year ended December 31, 2021, we paid each of our non-employee directors as follows:

 

Name  

Fees earned or paid in cash*

($)

    

Stock awards

($)

     Option awards
($)		     Non-equity incentive plan compensation
($)		     Change in pension value and nonqualified deferred compensation earnings     All other compensation
($)		    

Total

($)

  
(a)     (b)       (c)       (d)       (e)       (f)       (g)       (h)  
Yunsi Liu (1)     –       –       –       –       –       –       -  

 

(1) Ms. Liu was appointed to her position on our Board of Directors effective January 15, 2019.

 

* All fees were paid in United States Dollars.

 

Directors who are residents of China do not receive compensation. Ms. Liu, our director who is a U.S. resident, receives a quarterly retainer in the amount of $2,000 in accordance with the terms of a Director Retainer Agreement effective from January 1, 2020. All directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses incurred in connection with attendance at meetings of our Board of Directors. Our Board may award special remuneration to any director undertaking any special services on our behalf other than services ordinarily required of a director.

 

Termination of Employment and Change of Control Arrangement

 

There are no compensatory plans or arrangements, including payments to be received from the Company, with respect to any person named in Cash Compensation set out above which would in any way result in payments to any such person because of his resignation, retirement, or other termination of such person’s employment with the Company or its subsidiaries, or any change in control of the Company, or a change in the person’s responsibilities following a changing in control of the Company.

 

59

 

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDERS MATTERS

 

The following table sets forth certain information concerning the number of shares of our common stock owned beneficially as of April 9, 2021 by: (i) each person (including any group) known to us to own more than five percent (5%) of any class of our voting securities, (ii) each of our directors and each of our named executive officers (as defined under Item 402(m)(2) of Regulation S-K), and (iii) officers and directors as a group. Unless otherwise indicated, the shareholders listed possess sole voting and investment power with respect to the shares shown.

 

Name of Beneficial Owner (2)  Amount and Nature of Beneficial Ownership (1)   Percent of Class 
Officers and Directors          
Xiao Jun Kong (3)   18,951,000    93.57%
Cheng Ni Hu (4)   675,000    3.33%
           
All executive officers and directors as a group (2 persons)   19,626,000    96.90%
           
Shareholders Holding In Excess of 5%          
HY (HK) Financial Investments Co., Ltd. (3)   5,001,000    24.69%

 

(1) Beneficial ownership is determined in accordance with SEC rules and generally includes voting or investment power with respect to securities. For purposes of this table, a person or group of persons is deemed to have “beneficial ownership” of any shares of common stock that such person has the right to acquire within 60 days of July 9, 2020. Applicable percentage ownership is based on 20,252,309 shares of common stock outstanding as of July 9, 2020, and any shares that such person or persons has the right to acquire within 60 days of July 9, 2020, is deemed to be outstanding for such person, but is not deemed to be outstanding for the purpose of computing the percentage ownership of any other person. The inclusion herein of any shares listed as beneficially owned does not constitute an admission of beneficial ownership.
(2) Unless otherwise noted, the business address of each beneficial owner listed is 17/F, 80 Gloucester Road, Wanchai, Hong Kong. Except as otherwise indicated, the persons listed below have sole voting and investment power with respect to all shares of our common stock owned by them, except to the extent that power may be shared with a spouse.
(3) Mr. Kong is deemed to be the beneficial owner of these 5,001,000 shares held by HY (HK) Financial Investments Co., Ltd. Mr. Kong is the Chief Executive Officer and majority shareholder of HY (HK) Financial Investments Co., Ltd.
(4) Ms. Hu was appointed to serve on our board of directors effective July 9, 2020.

 

60

 

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

 

Transactions with management and others

 

During the year ended December 31, 2021, there were transactions, or series of similar transactions, since the beginning of the Company’s last fiscal year, or any currently proposed transactions, or series of similar transactions, to which the Company was or is to be party, in which the amount involved exceeds $60,000, and in which any director or executive officer, or any security holder who is known by the Company to own of record or beneficially more than 5% of any class of the Company’s common stock, or any member of the immediate family of any of the foregoing persons, has an interest. Please see Note 15 above.

 

   As of December 31 
   2021   2020 
Amount due to a director   (219,461)   (68,953)

 

Indebtedness of Management

 

During the year ended December 31, 2021, there were transactions, or series of similar transactions, since the beginning of the Company’s last fiscal year, or any currently proposed transactions, or series of similar transactions, to which the Company was or is to be a party, in which the amount involved exceeds $60,000 and in which any director or executive officer, or any security holder who is known to the Company to own of record or beneficially more than 5% of any class of the Company’s common stock, or any member of the immediate family of any of the foregoing persons, has an interest. Please see Note 15 above.

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

(1) Audit Fees - The aggregate fees billed in each of the last two fiscal years for professional services rendered by the Company’s auditor for the audit of the annual financial statements and review of financial statements included in the Form 10-Q or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years are: $36,000 for 2021 and $35,900 for 2020.

 

(2) Audit-Related Fees - The aggregate fees billed in each of the last two fiscal years for assurance and related services by the Company’s principal accountant that are reasonably related to the performance of the audit or review of the financial statements and are not reported in (1) Audit-related Fees: $0 for 2021 and $0 for 2020.

 

(3) Tax Fees - The aggregate fees billed in each of the last two fiscal years for professional services rendered by the Company’s principal accountant for tax compliance, tax advice, and tax planning: $0 for 2021 and $0 for 2020.

 

(4) All Other Fees - The aggregate fees billed in each of the last two fiscal years for products and services provided by the Company’s principal accountant, other than the services reported in (1) Audit Fees; (2) Audit-Related Fees; and (3) Tax Fees: $0 for 2021 and $0 for 2020.

 

(5) The Company does not have an audit committee.

 

(6) Not Applicable.

 

61

 

 

PART IV

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

(a)(1)   List of Financial statements included in Part II hereof
     
    Report of Independent Registered Public Accounting Firm
    Consolidated Balance Sheet:
    December 31, 2021 and 2020
    Consolidated Statements of Operations and Comprehensive (Loss) Income:
    For the years ended December 31, 2021 and 2020
    Consolidated Statements of Changes in Shareholders’ (Deficit) Equity:
    For the years ended December 31, 2021 and 2020
    Consolidated Statements of Cash Flows:
    For the years ended December 31, 2021 and 2020
    Notes to Consolidated Financial Statements:
    For the years ended December 31, 2021 and 2020
     
(a)(2)   List of Financial Statement schedules included in Part IV hereof: None
     
(a)(3)   Exhibits
     
    The following exhibits are included herewith:

 

  Exhibit No.   Description
  4.2   Description of Securities
  31.1   Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  32.1   Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  101.INS*   XBRL Instance Document
  101.SCH*   XBRL Taxonomy Extension Schema Document
  101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
  101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
  101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
  101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document

 

  * XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

Following are a list of exhibits which we previously filed in other reports which we filed with the SEC, including the Exhibit No., description of the exhibit and the identity of the Report where the exhibit was filed.

 

Exhibit Number   Description
3.1   Certificate of Incorporation (1)
3.2   Bylaws (1)
4.1   Form of common stock certificate (4)
10.1   Share Exchange Agreement, dated June 8, 2020, by and among the Company, Elite Creation Group Limited (ECGL), and the shareholders of ECGL (2)
10.2   Lease Agreement, dated June 28, 2018, by and between Guangzhou New Litchi Bay Exhibition Co. Ltd. and Guangzhou Xiao Xiang Health Industry Co., Ltd. (3)
10.3   Warehouse Lease Contract, effective April 1, 2018, by and between Guangzhou JinPengLai Property Management Co., Ltd. and Guangzhou Xiao Xiang Health Industry Co., Ltd. (3)
10.4   Supplementary Contract, by and between Guangzhou Xiao Xiang Health Industry Co., Ltd. and Heilongjiang Hengyuan Food Co., Ltd. (3)
10.5   Supplementary Contract, by and between Guangzhou Xiao Xiang Health Industry Co., Ltd. and Guangzhou JinTong Special Medical Food Co. Ltd. (3)
10.6   Director Retainer Agreement, dated July 7, 2020, by and between the Company and Yunsi Liu (3)
21.1   List of Subsidiaries.(3)

 

(1) Incorporated by reference to the Exhibits to the Definitive Information Statement on Schedule 14C filed with the Securities and Exchange Commission on February 20, 2019.

(2) Incorporated by reference to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 8, 2020.

(3) Incorporated by reference to the Current Report on Form 8-K/A filed with the Securities and Exchange Commission previously filed on September 2, 2020

(4) Incorporated by Reference to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 9, 2020

 

62

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Report to be signed on its behalf by the undersigned duly authorized person.

 

In accordance with the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed by the following persons in the capacities and on the dates stated.

 

China Foods Holdings Limited

(Registrant)

 

Dated: February 7, 2023

 

By: /s/ Kong Xiao Jun  
  Kong Xiao Jun  
  Chief Executive Officer, Chief Financial Officer, President and Director  

 

63

 

 GRAPHIC 2 form10-ka_001.jpg begin 644 form10-ka_001.jpg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form10-ka_002.jpg begin 644 form10-ka_002.jpg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end GRAPHIC 4 form10-ka_003.jpg begin 644 form10-ka_003.jpg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end GRAPHIC 5 form10-ka_004.jpg begin 644 form10-ka_004.jpg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end GRAPHIC 6 form10-ka_005.jpg begin 644 form10-ka_005.jpg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end GRAPHIC 7 form10-ka_006.jpg begin 644 form10-ka_006.jpg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end EX-4.2 8 ex4-2.htm

 

Exhibit 4.2

 

Description of Securities Registered Pursuant to

Section 12 of the Securities Exchange Act of 1934, as amended

 

General

 

Our authorized capital stock consists of 100,000,000 shares of common stock, $0.0001 par value per share, 20,252,309 of which were issued and outstanding as of March 22, 2022.

 

The following description of our common stock summarizes the material terms and provisions of the common stock that we may offer under this prospectus but is not complete. For the complete terms of our common stock, please refer to our certificate of incorporation, as amended, (the “Certificate of Incorporation”) which may be further amended from time to time, and our by-laws, as further amended from time to time (the “By-laws”). The Delaware General Corporation Law (“DGCL”) may also affect the terms of these securities.

 

Common Stock

 

Holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders, and do not have cumulative voting rights. Subject to preferences that may be applicable to any outstanding shares of preferred stock, holders of common stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by our Board of Directors out of funds legally available for dividend payments. All outstanding shares of common stock are fully paid and nonassessable. The holders of common stock have no preferences or rights of cumulative voting, conversion, or pre-emptive or other subscription rights. There are no redemption or sinking fund provisions applicable to the common stock. In the event of any liquidation, dissolution or winding-up of our affairs, holders of common stock will be entitled to share ratably in any of our assets remaining after payment or provision for payment of all of our debts and obligations and after liquidation payments to holders of outstanding shares of preferred stock, if any.

 

Preferred Stock

 

Under our articles of incorporation and subject to the limitations prescribed by law, our Board of Directors may have such classes and preference of shares of preferred stock as the Board of Directors may determine from time to time.

 

When and if we issue additional shares of preferred stock, we will establish the applicable preemptive rights, dividend rights, voting rights, conversion privileges, redemption rights, sinking fund rights, rights upon voluntary or involuntary liquidation, dissolution or winding up and any other relative rights, preferences and limitations for the particular preferred stock series.

 

Delaware Anti-Takeover Statute

 

We are also subject to certain anti-takeover provisions under the General Corporation Law of the State of Delaware, or the DGCL. Under Section 203 of the DGCL, a corporation may not, in general, engage in a business combination with any holder of 15% or more of its capital stock unless the holder has held the stock for three years or (i) our board of directors approves the transaction prior to the stockholder acquiring the 15% ownership position, (ii) upon consummation of the transaction that resulted in the stockholder acquiring the 15% ownership position, the stockholder owns at least 85% of the outstanding voting stock (excluding shares owned by directors or officers and shares owned by certain employee stock plans) or (iii) the transaction is approved by the board of directors and by the stockholders at an annual or special meeting by a vote of 66 2/3% of the outstanding voting stock (excluding shares held or controlled by the interested stockholder). These provisions in our certificate of incorporation and by-laws and under Delaware law could discourage potential takeover attempts.

 

 

 

 

In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by any such entity or person.

 

A Delaware corporation may opt out of this provision by express provision in its original certificate of incorporation or by amendment to its certificate of incorporation or by-laws approved by its stockholders. We have not opted out of Section 203. The statute could prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us.

 

Options and Warrants

 

As of the date provided on the cover page of the Annual Report, the Company had 0 options outstanding and 0 warrants outstanding.

 

Listing

 

Our common stock trades on the OTC:PK under the symbol “CFOO”.

 

Transfer Agent and Registrar

 

Colonial Stock Transfer is serving as our transfer agent and registrar. They are located at 66 Exchange Place, Salt Lake City, UT 84111.

 

 

 

 

 EX-31.1 9 ex31-1.htm

 

Exhibit 31.1

 

Rule 13a-14(a) Certification of the Chief Executive Officer

Pursuant to 18 U.S.C. 1350

(Section 302 of the Sarbanes-Oxley Act of 2002)

 

I, Kong Xiao Jun, certify that:

 

1. I have reviewed this amendment to the Report on Form 10-K of China Foods Holdings Limited;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The Registrant other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 7, 2023 By: /s/ Kong Xiao Jun
    Kong Xiao Jun
    Chief Executive Officer & Chief Financial Officer

 

 

 

EX-32.1 10 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

I, Kong Xiao Jun, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the this amendment to the Annual Report on Form 10-K of China Foods Holdings Limited for the period ended December 31, 2021, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such amendment to the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of China Foods Holdings Limited.

 

Date: February 7, 2023 By: /s/ Kong Xiao Jun
    Kong Xiao Jun
    Chief Executive Officer & Chief Financial Officer

 

 

 EX-101.SCH 11 cfoo-20211231.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - PREPAYMENTS AND OTHER RECEIVABLES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - PLANT AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - CUSTOMER DEPOSITS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - LEASE link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SHAREHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - NET LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - PENSION COSTS link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - CONCENTRATIONS OF RISK link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - PREPAYMENTS AND OTHER RECEIVABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - PLANT AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - LEASE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - NET LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - CONCENTRATIONS OF RISK (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - SCHEDULE OF SUBSIDIARIES INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SUMMARY OF GEOGRAPHIC SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - INVENTORIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - PLANT AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - CUSTOMER DEPOSITS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - LEASE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SHAREHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - PENSION COSTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - SCHEDULE OF CONCENTRATIONS OF RISK (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 12 cfoo-20211231_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 13 cfoo-20211231_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 14 cfoo-20211231_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Consolidated Entities [Axis] Elite Creation Group Limited [Member] Alpha Wellness (HK) Limited [Member] Guangzhou Xiao Xiang Health Industry Company Limited [Member] Long-Lived Tangible Asset [Axis] Furniture, Fixture and Equipment [Member] Motor Vehicles [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Leasehold Improvements [Member] Product and Service [Axis] Consultancy Service Fee Income [Member] Sales of Healthcare [Member] Sale Of Wine Products [Member] Derivative Instrument [Axis] Year-end HK$:US$ Exchange Rate [Member] Annual Average HK$:US$ Exchange Rate [Member] Year-end RMB:US$ Exchange Rate [Member] Annual Average RMB:US$ Exchange Rate [Member] Segments [Axis] Healthcare Segment [Member] Consulting Service Income [Member] Wine Segment [Member] Sale of Healthcare Products [Member] Consolidation Items [Axis] Segment Reconciling Items [Member] Geographical [Axis] HONG KONG CHINA Motor Vehicle [Member] Foreign Translation Difference [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Share Exchange Agreement [Member] Legal Entity [Axis] Business Acquisition [Axis] UNITED STATES Retirement Plan Sponsor Location [Axis] Foreign Plan [Member] Customer [Axis] Customer C [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Accounts Receivable [Member] Customer D [Member] Customer E [Member] Customer [Member] Customer A [Member] Customer B [Member] Vendor D[Member] Accounts Payable [Member] Vendor A [Member] Vendor B [Member] Vendor C [Member] Vendor [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Name Auditor Location Auditor Firm ID Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Prepayments and other receivables Inventories Tax recoverable Right-of-use assets Total Current Assets Non-Current Assets Plant and equipment Intangible assets Total Non-Current Assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities Accounts payable Accrued liabilities and other payables Customer deposits Lease liabilities Amount due to a director Amount due to a related company Tax payable Total Current-Liabilities Non-Current Liabilities Lease liabilities – non-current portion Commitment and contingents Shareholders’ Equity Common stock $0.0001 par value, 100,000,000 shares authorized, 20,252,309 and 20,252,309 shares issued and outstanding as of December 31, 2021 and 2020 respectively Additional paid-in capital Accumulated other comprehensive income Accumulated deficit Total Shareholders’ Equity TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue, net Cost of revenue Gross profit Operating expenses Selling and distribution expenses General and administrative expenses Total operating expenses Loss from operation Other income: Interest income Sundry income Total other income Loss before income tax Income tax expenses NET LOSS Other comprehensive loss Foreign currency adjustment gain Comprehensive loss Net loss per common share Basic and diluted Weighted average number of common share Basic and diluted Statement [Table] Statement [Line Items] Balance Balance, shares Foreign currency translation adjustment Shares issued for acquisition of legal acquirer Shares issued for acquisition of legal acquirer, shares Net loss for the year Balance Balance, shares Statement of Cash Flows [Abstract] Cash flow from operating activities: Net loss Adjustments to reconcile net loss to net cash (used in) generated from operating activities Depreciation Amortization Non-cash lease expense Total adjustments to reconcile net income to net cash (used in) generated from operating activities Change in operating assets and liabilities: Accounts receivable Prepayments and other receivables Inventories Accounts payable Accrued liabilities and other payables Customer deposits Tax payable Lease liabilities Net cash (used in) generated from operating activities Cash flow from investing activities Purchase of plant and equipment Cash from acquisition of legal acquirer Net cash used in investing activities Cash flow from financing activities: Payment of lease liabilities Advance from (repayment to) a related company Advance from a director Net cash generated from financing activities Foreign currency translation adjustment Net change in cash and cash equivalents CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR CASH AND CASH EQUIVALENTS, END OF YEAR SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid for interest Cash paid for income taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND BUSINESS BACKGROUND Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES LIQUIDITY AND CAPITAL RESOURCES Segment Reporting [Abstract] SEGMENT REPORTING Prepayments And Other Receivables PREPAYMENTS AND OTHER RECEIVABLES Inventory Disclosure [Abstract] INVENTORIES Property, Plant and Equipment [Abstract] PLANT AND EQUIPMENT Customer Deposits CUSTOMER DEPOSITS Amounts Due To Director And Related Company AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY Lease LEASE Equity [Abstract] SHAREHOLDERS’ EQUITY Earnings Per Share [Abstract] NET LOSS PER SHARE Income Tax Disclosure [Abstract] INCOME TAXES Retirement Benefits [Abstract] PENSION COSTS Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Risks and Uncertainties [Abstract] CONCENTRATIONS OF RISK Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of presentation and consolidation Use of estimates Segment reporting Cash and cash equivalents Accounts receivable Inventories Plant and equipment Intangible assets Impairment of long-lived assets Revenue recognition Disaggregation of Revenue Income taxes Foreign currencies translation Net loss per share Comprehensive income Retirement plan costs Leases Related parties Commitments and contingencies Fair value of financial instruments Recent accounting pronouncements SCHEDULE OF SUBSIDIARIES INFORMATION SCHEDULE OF ESTIMATED USEFUL LIVES SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES SUMMARY OF GEOGRAPHIC SEGMENTS SUMMARY OF GEOGRAPHIC SEGMENTS SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE SCHEDULE OF INVENTORIES SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE SCHEDULE OF DEFERRED TAX ASSETS SCHEDULE OF CONCENTRATIONS OF RISK Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Place of incorporation and kind of legal entity Principal activities Stock Issued During Period, Shares, New Issues Stock Issued During Period, Value, New Issues Effective interest held percentage Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Estimated useful lives Residual value Schedule of Product Information [Table] Product Information [Line Items] TOTAL Offsetting Assets [Table] Offsetting Assets [Line Items] Foreign currency translation exchange rates Number of operating segments Allowance for doubtful accounts Intangible assets amortization period Amortization expense Sales tax percentage Product sales returns Income tax likelihood, description Cash Net cash Accumulated Deficit Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Total revenue Total cost of revenue Gross profit Operating Expenses Selling and distribution General and administrative Total operating expenses Segment loss Schedule Of Prepayments And Other Receivable Prepayments Other deposits Rental deposits Other receivables Prepayments and other receivable Packing materials Finished goods Inventories Allowance for obsolete inventories Plant and equipment, gross Less: accumulated depreciation Foreign translation difference, net Plant and equipment. net Depreciation expense Deposit received from customers Schedule Of Right Of Use Assets And Liability Current portion Non-current portion Total Operaitng lease, description Lease term Lease expiration date Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of purchase of shares Number of shares issued Share price per share Aggregate fair value of shares issued Net loss attributable to common shareholders Weighted average common shares outstanding – Basic and diluted Net loss per share – Basic and diluted Current tax Deferred tax Income tax expense Loss before income taxes Statutory income tax rate Income tax expense at statutory rate Tax adjustments Tax holiday Income tax expense Net operating loss Net operating loss carryforwards Less: valuation allowance Deferred tax assets, net Income tax description Corporate tax rate umulative net operating losses Net operating loss carryforwards expiration Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Employee Contributions Due to related company Due from related company Concentration Risk [Table] Concentration Risk [Line Items] Revenues Concentration risk, percentage Accounts receivable Accounts payable Basis of presentation and consolidation [Policy Text Block] Schedule of subsidiaries information [Table Text Block] Prepayments and other receivables current. Operating lease right of use asset current. Due to director current. Place of incorporation and kind of legal entity. Elite Creation Group Limited [Member] Alpha Wellness (HK) Limited [Member] Guangzhou Xiao Xiang Health Industry Company Limited [Member] Principal activities. Effective interest held percentage. Non cash lease expenses. Increase decrease in lease liabilities. Increase decrease in prepayments and other receivables. Schedule of estimated useful lives [TableTextBlock] Proceeds from advances director. Furniture, Fixture and Equipment [Member] Motor Vehicles [Member] Sales tax percentage. Disaggregation of revenue [Policy Text Block] Retirement plan costs [Policy Text Block] Related parties [Policy Text Block] Prepayments and other receivable [Text Block]. Schedule of prepayments and other receivable [TableTextBlock] Other deposits, current. Rental deposits. Allowance for obsolete inventories. Schedule of right of use assets and liability [TableTextBlock] Foreign translation difference, net. Motor Vehicle [Member] Customer deposits [Text Block] Amounts due to director and related company [Text Block] Tax recoverable. Share Exchange Agreement [Member] Customer C [Member] Customer D [Member] Customer E [Member] Customer [Member] Customer A [Member] Customer B [Member] Vendor B [Member] Vendor D[Member] Vendor A [Member] Vendor C [Member] Vendor [Member] Net operating loss carry forwards expiration. Year-end HK$:US$ Exchange Rate [Member] Annual Average HK$:US$ Exchange Rate [Member] Year-end RMB:US$ Exchange Rate [Member] Annual Average RMB:US$ Exchange Rate [Member] Foreign Translation Difference [Member] Product sales returns. Consultancy Service Fee Income [Member] Sales of Healthcare [Member] Consulting Service Income [Member] Sale of Healthcare Products [Member] Healthcare Segment [Member] Sale Of Wine Products [Member] Wine Segment [Member] Assets, Current Assets, Noncurrent Assets Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Cost of Revenue Operating Expenses Nonoperating Income (Expense) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Shares, Outstanding Stock Issued During Period, Value, Acquisitions Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities Increase (Decrease) in Accounts Receivable Increase decrease in prepayments and other receivables Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability Increase (Decrease) in Income Taxes Payable Increase decrease in lease liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Finance Lease, Principal Payments Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Cash and Cash Equivalents, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Intangible Assets, Finite-Lived, Policy [Policy Text Block] Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Prepaid Expense and Other Assets Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Foreign translation difference, net Operating Lease, Liability Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Effective Income Tax Rate Reconciliation, Tax Holiday, Amount Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Accounts Receivable, after Allowance for Credit Loss Accounts Payable EX-101.PRE 15 cfoo-20211231_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 16 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover - USD ($)
 12 Months Ended
Dec. 31, 2021
Mar. 31, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description This amendment to our filing on Form 10-K for the annual period ended December 31, 2021 is filed primarily to update on our wine business and to address how the Holding Foreign Companies Accountable Act (“HFCAA”) and related regulations will affect our company.    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2021    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2021    
Current Fiscal Year End Date --12-31    
Entity File Number 001-32522    
Entity Registrant Name China Foods Holdings Ltd.    
Entity Central Index Key 0001310630    
Entity Tax Identification Number 84-1735478    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One Room 2301A    
Entity Address, Address Line Two China Resources Building,    
Entity Address, Address Line Three 26 Harbour Road,    
Entity Address, City or Town Wanchai    
Entity Address, Country HK    
Entity Address, Postal Zip Code 0000    
City Area Code (852)    
Local Phone Number 3618-8608    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers Yes    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 253,425
Entity Common Stock, Shares Outstanding   20,252,309  
Auditor Name HKCM CPA& Co    
Auditor Location Hong Kong, China    
Auditor Firm ID 3299    
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 609,434 $ 1,006,394
Prepayments and other receivables 139,254 121,501
Inventories 327,551 206,272
Tax recoverable 8,910
Right-of-use assets 350,563
Total Current Assets 1,435,712 1,334,167
Non-Current Assets    
Plant and equipment 132,604 193,621
Intangible assets 3,947 4,353
Total Non-Current Assets 136,551 197,974
TOTAL ASSETS 1,572,263 1,532,141
Current Liabilities    
Accounts payable 7,827
Accrued liabilities and other payables 51,200 2,316
Customer deposits 340,783 409,924
Lease liabilities 114,132
Amount due to a director 219,461 68,953
Amount due to a related company 199,964 199,964
Tax payable 8,319
Total Current-Liabilities 925,540 697,303
Non-Current Liabilities    
Lease liabilities – non-current portion 246,022
Commitment and contingents
Shareholders’ Equity    
Common stock $0.0001 par value, 100,000,000 shares authorized, 20,252,309 and 20,252,309 shares issued and outstanding as of December 31, 2021 and 2020 respectively 2,025 2,025
Additional paid-in capital 1,290,355 1,290,355
Accumulated other comprehensive income 26,516 5,244
Accumulated deficit (918,195) (462,786)
Total Shareholders’ Equity 400,701 834,838
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 1,572,263 $ 1,532,141
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 20,252,309 20,252,309
Common stock, shares outstanding 20,252,309 20,252,309
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenue, net $ 361,116 $ 1,013,141
Cost of revenue (121,690) (596,530)
Gross profit 239,426 416,611
Operating expenses    
Selling and distribution expenses 5,076 158,432
General and administrative expenses 690,780 728,994
Total operating expenses 695,856 887,426
Loss from operation (456,430) (470,815)
Other income:    
Interest income 1,277 2,602
Sundry income 6,415 6,952
Total other income 7,692 9,554
Loss before income tax (448,738) (461,261)
Income tax expenses (6,671) (8,215)
NET LOSS (455,409) (469,476)
Other comprehensive loss    
Foreign currency adjustment gain 21,272 59,245
Comprehensive loss $ (434,137) $ (410,231)
Net loss per common share    
Basic and diluted $ (0.02) $ (0.03)
Weighted average number of common share    
Basic and diluted 20,252,309 17,525,701
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance at Dec. 31, 2019 $ 1,500 $ 1,290,355 $ 159,441 $ (54,001) $ 1,397,295
Balance, shares at Dec. 31, 2019 15,000,000        
Foreign currency translation adjustment 59,245 59,245
Shares issued for acquisition of legal acquirer $ 525 (152,751) (152,226)
Shares issued for acquisition of legal acquirer, shares 5,252,309        
Net loss for the year (469,476) (469,476)
Balance at Dec. 31, 2020 $ 2,025 1,290,355 (462,786) 5,244 834,838
Balance, shares at Dec. 31, 2020 20,252,309        
Foreign currency translation adjustment 21,272 21,272
Net loss for the year (455,409) (455,409)
Balance at Dec. 31, 2021 $ 2,025 $ 1,290,355 $ (918,195) $ 26,516 $ 400,701
Balance, shares at Dec. 31, 2021 20,252,309        
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flow from operating activities:    
Net loss $ (455,409) $ (469,476)
Adjustments to reconcile net loss to net cash (used in) generated from operating activities    
Depreciation 90,961 71,472
Amortization 521 487
Non-cash lease expense 109,652 74,863
Total adjustments to reconcile net income to net cash (used in) generated from operating activities (254,275) (322,654)
Change in operating assets and liabilities:    
Accounts receivable 530,196
Prepayments and other receivables (17,753) 199,317
Inventories (121,279) (94,655)
Accounts payable (7,827) 7,827
Accrued liabilities and other payables 48,884 2,316
Customer deposits (69,141) 13,044
Tax payable (17,229) 8,219
Lease liabilities 47
Net cash (used in) generated from operating activities (438,620) 343,657
Cash flow from investing activities    
Purchase of plant and equipment (27,358) (75,060)
Cash from acquisition of legal acquirer 7,198
Net cash used in investing activities (27,358) (67,862)
Cash flow from financing activities:    
Payment of lease liabilities (100,189) (79,395)
Advance from (repayment to) a related company 150,508 (3,038)
Advance from a director 128,295
Net cash generated from financing activities 50,319 45,862
Foreign currency translation adjustment 18,699 50,245
Net change in cash and cash equivalents (396,960) 371,902
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 1,006,394 634,492
CASH AND CASH EQUIVALENTS, END OF YEAR 609,434 1,006,394
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid for interest
Cash paid for income taxes
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.4
ORGANIZATION AND BUSINESS BACKGROUND
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND BUSINESS BACKGROUND

NOTE 1 – ORGANIZATION AND BUSINESS BACKGROUND

 

China Foods Holdings Ltd. (the “Company” or “CFOO”) was incorporated in Delaware on January 10, 2019. The Company currently engages in the sale of healthcare product and rendering of consulting service in Hong Kong and China. 

 

On July 9, 2020, the Company consummated the Share Exchange Agreement (“the “Share Exchange Agreement”) with Elite Creation Group Limited, a private limited company organized under the laws of British Virgin Islands (“ECGL”). As a result of the acquisition of ECGL, the Company entered into the healthcare product distributing and marketing industry, and then pursue a new strategy of developing and distributing health related products, including supplements, across the globe with a focus on mainland China, Europe and Australia.

 

ECGL will comprise the ongoing operations of the combined entity and its senior management will serve as the senior management of the combined entity, ECGL is deemed to be the accounting acquirer for accounting purposes. The transaction will be treated as a recapitalization of the Company. Accordingly, the consolidated assets, liabilities and results of operations of the Company will become the historical financial statements of ECGL, and the Company’s assets, liabilities and results of operations will be consolidated with ECGL beginning on the acquisition date. ECGL was the legal acquiree but deemed to be the accounting acquirer. The Company was the legal acquirer but deemed to be the accounting acquiree in the reverse merger. The historical financial statements prior to the acquisition are those of the accounting acquirer (ECGL). After completion of the Share Exchange Transaction, the Company’s consolidated financial statements include the assets and liabilities, the operations and cash flow of the accounting acquirer.

 

The following table depicts the description of the Company’s subsidiaries :

 

Name  Place of incorporation
and kind of
legal entity		  Principal activities  Particulars of registered/
paid up share capital		  Effective interest
held		 
              
Elite Creation Group Limited  BVI, a limited liability company  Investment holding  50,000 issued shares of US$1each   100%
               
Alpha Wellness (HK) Limited  Hong Kong, a limited liability company  Investment holding  300,000 issued shares of HK$300,000   100%
               
Guangzhou Xiao Xiang Health Industry Company Limited  The PRC, a limited liability company  Sales of healthcare products  RMB8,300,000   100%

 

The Company and its subsidiaries are hereinafter referred to as (the “Company”).

 
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation and consolidation

 

The Company’s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”). All adjustments considered necessary for a fair presentation have been included. These adjustments consist of normal and recurring accruals, as well as non-recurring charges.

 

The consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. The results of subsidiaries acquired or disposed of during the periods are included in the consolidated statements of operations from the effective date of acquisition or up to the effective date of disposal.

 

 

Use of estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

 

Significant areas for which management uses estimates include:

 

● revenue recognition,
● asset impairments, including goodwill and other indefinite-lived intangible assets;
● sales returns and allowances;
● inventory;
● estimated lives for tangible and intangible assets;
● income tax valuation allowances; and

 

These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.

 

Segment reporting

 

Accounting Standards Codification (“ASC”) Topic 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in one reportable operating segment in Hong Kong and China.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectibility. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of December 31, 2021 and 2020, there was no allowance for doubtful accounts.

 

Inventories

 

Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of December 31, 2021 and 2020, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.

 

 

Plant and equipment

 

Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:

 

   Expected useful lives  Residual value 
Furniture, fixture and equipment  3 years   5% 
Motor vehicle  3.33 to 4 years   5% 
Leasehold improvement  2 years   5% 

 

Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.

 

Intangible assets

 

Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is 10 years and will expire in 2028.

 

Amortization expense for the years ended December 31, 2021 and 2020 was $521 and $487, respectively.

 

Impairment of long-lived assets

 

In accordance with the provisions of ASC Topic 360, “Impairment or Disposal of Long-Lived Assets”, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment charge for the years presented.

 

Revenue recognition

 

The Company adopted Accounting Standards Codification (“ASC”) 606 – Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:

 

  ● identify the contract with a customer;
  ● identify the performance obligations in the contract;
  ● determine the transaction price;
  ● allocate the transaction price to performance obligations in the contract; and
  ● recognize revenue as the performance obligation is satisfied.

 

 

Currently, the Company operates two business segments.

 

Healthcare Business mainly provides health consulting advisory services and healthcare and wellness products to the customers.

 

Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.

 

The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Wine Business mainly provides the wine products to the customers. Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The Company recorded product sales returns $148,208 and $0 for the years ended December 31, 2021 and 2020, respectively. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Disaggregation of Revenue

 

The following table provides information about disaggregated revenue from customers into the nature of the products and services and includes a reconciliation of the disaggregated revenue with reportable segments.

 

  

For the Year Ended December 31,

2021

  

For the Year Ended December 31,

2020

 
         
Consultancy service fee income  $216,851   $221,041 
Sale of healthcare products   31,874    481,049 
Sale of wine products   112,392    311,051 
           
TOTAL  $361,116   $1,013,141 

 

Income taxes

 

The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

 

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statement of operations.

 

The reporting currency of the Company is United States Dollar (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the People’s Republic of China and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholder’s equity.

 

Translation of amounts from HK$ and RMB into US$ have been made at the following exchange rates for the years ended December 31, 2021 and 2020.

 

Years ended December 31, 2021 and 2020

 

   2021   2020 
Year-end HK$:US$ exchange rate   0.12822    0.12899 
Annual average HK$:US$ exchange rate   0.12865    0.12893 
Year-end RMB:US$ exchange rate   0.15742    0.15307 
Annual average RMB:US$ exchange rate   0.15507    0.14503 

 

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share.” Basic income per share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Comprehensive income

 

ASC Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying consolidated statements of changes in shareholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.

 

Retirement plan costs

 

Contributions to retirement plans (which are defined contribution plans) are charged to general and administrative expenses in the accompanying statements of operation as the related employee service are provided.

 

 

Leases

 

The Company adopts the FASB Accounting Standards Update (“ASU”) 2016-02 “Leases (Topic 842).” for all periods presented.  This standard requires lessees to recognize lease assets (“right of use”) and related lease obligations (“lease liabilities”) on the balance sheet for leases with terms in excess of 12 months.

 

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities in the consolidated balance sheets. Finance leases are included in finance lease ROU assets and finance lease liabilities in the consolidated balance sheets.

 

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease and finance lease ROU assets and liabilities are recognized at January 1, 2019 based on the present value of lease payments over the lease term discounted using the rate implicit in the lease. In cases where the implicit rate is not readily determinable, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 

Related parties

 

The Company follows the ASC 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

 

Commitments and contingencies

 

The Company follows the ASC 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Fair value of financial instruments

 

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and has adopted paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by paragraph 820-10-35-37 of the FASB Accounting Standards Codification are described below:

 

  Level 1

Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
  Level 2

Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
  Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

 

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

 

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, approximate their fair values because of the short maturity of these instruments.

 

Recent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

 

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), (“ASU 2021-04”). This ASU reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. This ASU provides guidance for a modification or an exchange of a freestanding equity-classified written call option that is not within the scope of another Topic. It specifically addresses: (1) how an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; (2) how an entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; and (3) how an entity should recognize the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange. This ASU will be effective for all entities for fiscal years beginning after December 15, 2021. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The adoption of ASU 2021-04 on January 1, 2022 did not have a material impact on the Company’s financial statements or disclosures.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.22.4
LIQUIDITY AND CAPITAL RESOURCES
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
LIQUIDITY AND CAPITAL RESOURCES

NOTE 3: LIQUIDITY AND CAPITAL RESOURCES

 

Our cash balance on December 31, 2021, was $609,434, as compared to $1,006,394 on December 31, 2021, it was decreased by $396,960. We had an accumulated deficit of $918,195. We believe that our cash and investments will be sufficient to fund our planned operations for at least one year past the issuance date of the consolidated financial statements.

 

The Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial support from its major shareholders. Management believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due.

 

Despite the amount of funds that the Company has raised, no assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its shareholders, in the case of equity financing.

 

 
XML 25 R10.htm IDEA: XBRL DOCUMENT v3.22.4
SEGMENT REPORTING
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 4: SEGMENT REPORTING

 

Currently, the Company has two reportable business segments:

 

(i) Healthcare Segment, mainly provides health consulting advisory services and healthcare and wellness products to the customers; and
(ii) Wine Segment, mainly provides the wine products to the customers.

 

In the following table, revenue is disaggregated by primary major product line, and timing of revenue recognition. The table also includes a reconciliation of the disaggregated revenue with the reportable segments.

 

  

Healthcare

Segment

   Wine Segment   Total 
   Year Ended December 31, 2021 
  

Healthcare

Segment

   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $216,850   $–   $216,850 
Sale of healthcare products   39,996    –    39,996 
Sale of wine products   –    104,270    104,270 
Total revenue   256,846    104,270    361,116 
                
Cost of sales:               
Consulting service income   (31,315)   –    (31,315)
Sale of healthcare products   (32,064)    –   (32,064)
Sale of wine products   –    (58,311)   (58,311)
Total cost of revenue   (63,379)   (58,311)   (121,690)
                
Gross profit   193,467    45,959    239,426 
                
Operating Expenses               
Selling and distribution   –    (5,076)   (5,076)
General and administrative   (690,780)   –   (690,780)
Total operating expenses   (690,780)   (5,076)   (695,856)
                
Segment (loss) income  $(497,313)   $40,883  $(456,430)

 

  

Healthcare

Segment

   Wine Segment   Total 
   Year Ended December 31, 2020 
  

Healthcare Segment

   Wine
Segment		   Total 
Revenue from external customers:               
Consulting service income  $221,041   $–   $221,041 
Sale of healthcare products   564,814    –    564,814 
Sale of wine products   –    227,286     227,286 
Total revenue   785,855    227,286    1,013,141 
                
Cost of sales:               
Consulting service income   –    –    
Sale of healthcare products   (395,392)    –   (395,392)
Sale of wine products   –    (201,138)    (201,138)
Total cost of revenue   (395,392)    (201,138)   (596,530)
                
Gross profit   390,463    26,148    416,611 
                
Operating Expenses               
Selling and distribution   –    (158,432)   (158,432)
General and administrative   (728,994)   –   (728,994)
Total operating expenses   (728,994)   (158,432)   (887,426)
                
Segment loss  $(338,531)   $(132,284)  $(470,815)

 

 

The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Hong Kong  $216,851   $221,041 
China   144,265    792,100 
           
Total revenue  $361,116   $1,013,141 

 
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAYMENTS AND OTHER RECEIVABLES
 12 Months Ended
Dec. 31, 2021
Prepayments And Other Receivables  
PREPAYMENTS AND OTHER RECEIVABLES

NOTE 5: PREPAYMENTS AND OTHER RECEIVABLES

 

Prepayments and other receivable consisted of the following:

 

   December 31, 2021   December 31, 2020 
         
Prepayments  $3,077   $7,712 
Other deposits   -    119 
Rental deposits   33,961    - 
Other receivables   102,216    113,670 
Prepayments and other receivable  $139,254   $121,501 

 

Purchase deposits represented deposit payments made to vendors for procurement, which are interest-free, unsecured and relieved against accounts payable when goods are received by the Company.

 
XML 27 R12.htm IDEA: XBRL DOCUMENT v3.22.4
INVENTORIES
 12 Months Ended
Dec. 31, 2021
Inventory Disclosure [Abstract]  
INVENTORIES

NOTE 6: INVENTORIES

 

Inventories consisted of the following:

 

   December 31, 2021   December 31, 2020 
         
Packing materials  $-   $21,527 
Finished goods   327,551    184,745 
Inventories  $327,551   $206,272 

 

For the years ended December 31, 2021 and 2020, no allowance for obsolete inventories was recorded by the Company.

 

 
XML 28 R13.htm IDEA: XBRL DOCUMENT v3.22.4
PLANT AND EQUIPMENT
 12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
PLANT AND EQUIPMENT

NOTE 7: PLANT AND EQUIPMENT

 

   December 31, 2021   December 31, 2020 
         
Motor vehicle  $311,343   $311,343 
Furniture, fixture and equipment   15,465    15,465 
Leasehold improvement   27,358    - 
Foreign translation difference, net   17,603    10,471 
Plant and equipment, gross   371,769    337,279 
           
Less: accumulated depreciation   (228,507)   (137,546)
Foreign translation difference, net   (10,658)   (6,112)
Plant and equipment. net  $132,604   $193,621 

 

Depreciation expense for the years ended December 31, 2021 and 2020 were $90,961 and $71,472, respectively.

 
XML 29 R14.htm IDEA: XBRL DOCUMENT v3.22.4
CUSTOMER DEPOSITS
 12 Months Ended
Dec. 31, 2021
Customer Deposits  
CUSTOMER DEPOSITS

NOTE 8: CUSTOMER DEPOSITS

 

Customer deposits represented cash paid to the Company from the customers, for which the Company has an obligation to deliver the orders to satisfy with the customers, or to return the funds, within twelve months.

 

As of December 31, 2021 and 2020, the deposit received from customers was $340,783 and $409,924, respectively.

 
XML 30 R15.htm IDEA: XBRL DOCUMENT v3.22.4
AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY
 12 Months Ended
Dec. 31, 2021
Amounts Due To Director And Related Company  
AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY

NOTE 9: AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY

 

The amounts represented temporary advances to the Company by its director and its related company which were unsecured, interest-free and have no fixed terms of repayments.

 
XML 31 R16.htm IDEA: XBRL DOCUMENT v3.22.4
LEASE
 12 Months Ended
Dec. 31, 2021
Lease  
LEASE

NOTE 10: LEASE

 

The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of 2 to 4 year, through December 31, 2025.

 

Right of use assets and lease liability – right of use are as follows:

 

  

December 31,

2021

  

December 31,

2020

 
         
Right-of-use assets  $350,563   $- 

 

The lease liability – right of use is as follows:

 

  

December 31,

2021

  

December 31,

2020

 
         
Current portion  $114,132   $- 
Non-current portion   246,022    - 
           
Total  $360,154   $- 

 
XML 32 R17.htm IDEA: XBRL DOCUMENT v3.22.4
SHAREHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
SHAREHOLDERS’ EQUITY

NOTE 11: SHAREHOLDERS’ EQUITY

 

Common Stock

 

The Company is authorized, subject to limitations prescribed by Delaware law, to issue up to 100,000,000 shares of common stock with a nominal par value of $0.0001.

 

Dividend Rights

 

Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and only then at the times and in the amounts that our board of directors may determine.

 

 

Voting Rights

 

Each holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Under our Certificate of Incorporation, stockholders do not have the right to cumulate votes for the election of directors.

 

No Preemptive or Similar Rights

 

Our common stock is not entitled to preemptive rights and is not subject to conversion, redemption or sinking fund provisions.

 

Right to Receive Liquidation Distributions

 

Upon our dissolution, liquidation or winding-up, the assets legally available for distribution to our stockholders are distributable ratably among the holders of our common stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding shares of preferred stock.

 

On July 9, 2020, the Company consummated the Share Exchange Agreement (“the “Share Exchange Agreement”) with Elite Creation Group Limited, a private limited company organized under the laws of British Virgin Islands (“ECGL”), and the shareholders of ECGL. Pursuant to the Share Exchange Agreement, we purchased Fifty Thousand (50,000) shares of ECGL (the “ECGL Shares”), representing all of the issued and outstanding shares of common stock of ECGL. As consideration, the Company agreed to issue to the shareholders of ECGL Fifteen Million (15,000,000) shares of its common stock, at a value of $0.32 per share, for an aggregate value of $4,800,000.

 

As of December 31, 2021 and 2020, a total of 20,252,309 outstanding shares of common stock were issued.

 

Preferred Stock

 

The Company is not currently authorized to issue shares of preferred stock. The Certificate of Incorporation however, allows the board of directors to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the common stock in the event that shares of preferred stock are authorized in the future. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and may adversely affect the market price of our common stock and the voting and other rights of the holders of common stock. The Company has no current plans to issue any shares of preferred stock.

 
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.22.4
NET LOSS PER SHARE
 12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
NET LOSS PER SHARE

NOTE 12: NET LOSS PER SHARE

 

Basic net loss per share is computed using the weighted average number of common shares outstanding during the year. The dilutive effect of potential common shares outstanding is included in diluted net loss per share. The following table sets forth the computation of basic and diluted net loss per share for the years ended December 31, 2021 and 2020:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
Net loss attributable to common shareholders  $(455,409)  $(469,476)
           
Weighted average common shares outstanding – Basic and diluted   20,252,309    17,525,701 
           
Net loss per share – Basic and diluted  $(0.02)  $(0.03)

 

For the years ended December 31, 2021 and 2020, diluted weighted-average common shares outstanding is equal to basic weighted-average common shares, due to the Company’s net loss position. Hence, no common stock equivalents were included in the computation of diluted net loss per share since such inclusion would have been antidilutive.

 

 
XML 34 R19.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 13: INCOME TAXES

 

The provision for income taxes consisted of the following:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Current tax  $6,671   $8,215 
Deferred tax   -    - 
Income tax expense  $6,671   $8,215 

 

The effective tax rate in the years presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rate. The Company operates in various countries: United States of America, Hong Kong and the PRC that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

CFOO is registered in the State of Delaware and is subject to US federal corporate income tax. The U.S. Tax Cuts and Jobs Act (the “Tax Reform Act”) was signed into law. The Tax Reform Act significantly revised the U.S. corporate income tax regime by, among other things, lowering the U.S. corporate tax rate from 35% to 21% effective January 1, 2018. The Company’s policy is to recognize accrued interest and penalties related to unrecognized tax benefits in its income tax provision. The Company has not accrued or paid interest or penalties which were not material to its results of operations for the years presented.

 

For the years ended December 31, 2021 and 2020, the Company did not have any interest and penalties associated with tax positions. As of December 31, 2021 and 2020, the Company has not accrued any penalties on uncertain tax positions.

 

As of December 31, 2021, the operation in the United States incurred $173,076 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carryforwards begin to expire in 2041, if unutilized.

 

BVI

 

Under the current BVI law, the Company is not subject to tax on income.

 

Hong Kong

 

The Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25% to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax year. The reconciliation of income tax rate to the effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Income before income taxes  $80,157   $170,555 
Statutory income tax rate   8.25%   8.25%
Income tax expense at statutory rate   6,613    14,070 
Tax adjustments   1,345   (3,277)
Tax holiday   

(1,287

)   (2,578)
Income tax expense  $6,671   $8,215 

 

 

The PRC

 

The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the People’s Republic of China at a unified income tax rate of 25%. The reconciliation of income tax rate to the effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Loss before income taxes  $(505,601)  $(482,014)
Statutory income tax rate   25%   25%
Income tax expense at statutory rate   (126,400)   (120,503)
Net operating loss   126,400    120,503 
Income tax expense  $-   $- 

 

The following table sets forth the significant components of the deferred tax assets of the Company as of December 31, 2021 and 2020:

 

   2021   2020 
   As of December 31, 
   2021   2020 
Deferred tax assets:          
Net operating loss carryforwards          
- United States  $54,747   $31,454 
- PRC   246,903    120,503 
Net operating loss carryforwards   301,650    151,957 
Less: valuation allowance   (301,650)   (151,957)
Deferred tax assets, net  $-   $- 

 
XML 35 R20.htm IDEA: XBRL DOCUMENT v3.22.4
PENSION COSTS
 12 Months Ended
Dec. 31, 2021
Retirement Benefits [Abstract]  
PENSION COSTS

NOTE 14: PENSION COSTS

 

The Company is required to make contributions to their employees under a government-mandated defined contribution pension scheme for its eligible full-times employees in the People’s Republic of China. The Company is required to contribute a specified percentage of the participants’ relevant income based on their ages and wages level. During the years ended December 31, 2021 and 2020, $23,617 and $12,284 contributions were made accordingly.

 
XML 36 R21.htm IDEA: XBRL DOCUMENT v3.22.4
RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 15: RELATED PARTY TRANSACTIONS

 

From time to time, the Company’s director and related company advanced funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand. As of December 31, 2021 and 2020, the Company owed the balance of $219,461 and $68,953 to its director, and owed the balance of $199,964 and $199,964 to a related company.

 

The Company purchased a motor vehicle from a related company at the carrying value of $42,966 for the year ended December 31, 2020.

 

Apart from the transactions and balances detailed elsewhere in these accompanying consolidated financial statements, the Company has no other significant or material related party transactions during the years presented.

 

 
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.22.4
CONCENTRATIONS OF RISK
 12 Months Ended
Dec. 31, 2021
Risks and Uncertainties [Abstract]  
CONCENTRATIONS OF RISK

NOTE 16: CONCENTRATIONS OF RISK

 

The Company is exposed to the following concentrations of risk:

 

(a) Major customers

 

For the years ended December 31, 2021 and 2020, the customers who accounts for 10% or more of the Company’s revenues and its outstanding receivable balances as at year-end dates, are presented as follows:

 

  

Year ended

December 31, 2021

       December 31, 2021 
   Revenues   Percentage of revenues       Accounts receivable 
Customer C  $165,391    46%       $- 
Customer D   103,072    29%         
Customer E   51,460    14%        - 
TOTAL  $319,923    89%    Total   $- 

 

  

Year ended

December 31, 2020

       December 31, 2020  
Customer  Revenues   Percentage of revenues       Accounts receivable  
   　               　  
Customer A  $394,158    　39%         $ -  
Customer B   234,547    　23%           -  
　   　　　    　　　            　　　　  
Total:  $628,705    　62%    Total:    $ -  

 

All of the Company’s customers are located in the People’s Republic of China and Hong Kong.

 

(b) Major vendors

 

For the years ended December 31, 2021 and 2020, the vendor who accounts for 10% or more of the Company’s purchases and its outstanding payable balances as at year-end dates, are presented as follows:

 

  

Year ended

December 31, 2021

        December 31, 2021 
Vendor  Purchases   Percentage of purchases        Accounts payable 
Vendor D  $195,152    99%    Total:   $- 

 

 

  

Year ended

December 31, 2020

       December 31, 2020 
Vendor  Purchases   Percentage of purchases       Accounts payable 
   　   　       　 
Vendor A  $219,007    37%       $- 
Vendor B   71,616    12%        - 
Vendor C   61,222    10%        - 
　   　              　 
Total:  $351,845    59%   Total:   $- 

 

 

All of the Company’s vendors are located in the People’s Republic of China.

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of trade receivables. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Economic and political risk

 

The Company’s major operations are conducted in the People’s Republic of China. Accordingly, the political, economic, and legal environments in PRC, as well as the general state of PRC’s economy may influence the Company’s business, financial condition, and results of operations.

 

(e) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of HKD and RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

(f) Risk from COVID

 

As a result of COVID-19, the Company has been unable to satisfy certain customer orders for the products. As a result, the customers have experienced delays in receiving the products . There is uncertainty around the duration and breadth of the COVID-19 pandemic, and other actions taken to contain or treat the impact of COVID-19, and the extent of such impact will depend on future developments, which are highly uncertain and cannot be predicted.

 
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.22.4
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 17: COMMITMENTS AND CONTINGENCIES

 

As of December 31, 2021 and 2020, the Company has no material commitments or contingencies.

 
XML 39 R24.htm IDEA: XBRL DOCUMENT v3.22.4
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 18: SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2021, up through the date the Company issued the audited consolidated financial statements. During the period, the Company did not have any material recognizable subsequent events.
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Basis of presentation and consolidation

Basis of presentation and consolidation

 

The Company’s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”). All adjustments considered necessary for a fair presentation have been included. These adjustments consist of normal and recurring accruals, as well as non-recurring charges.

 

The consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. The results of subsidiaries acquired or disposed of during the periods are included in the consolidated statements of operations from the effective date of acquisition or up to the effective date of disposal.

 

 
Use of estimates

Use of estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

 

Significant areas for which management uses estimates include:

 

● revenue recognition,
● asset impairments, including goodwill and other indefinite-lived intangible assets;
● sales returns and allowances;
● inventory;
● estimated lives for tangible and intangible assets;
● income tax valuation allowances; and

 

These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.

 
Segment reporting

Segment reporting

 

Accounting Standards Codification (“ASC”) Topic 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in one reportable operating segment in Hong Kong and China.

 
Cash and cash equivalents

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 
Accounts receivable

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectibility. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of December 31, 2021 and 2020, there was no allowance for doubtful accounts.

 
Inventories

Inventories

 

Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of December 31, 2021 and 2020, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.

 

 
Plant and equipment

Plant and equipment

 

Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:

 

   Expected useful lives  Residual value 
Furniture, fixture and equipment  3 years   5% 
Motor vehicle  3.33 to 4 years   5% 
Leasehold improvement  2 years   5% 

 

Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.

 
Intangible assets

Intangible assets

 

Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is 10 years and will expire in 2028.

 

Amortization expense for the years ended December 31, 2021 and 2020 was $521 and $487, respectively.

 
Impairment of long-lived assets

Impairment of long-lived assets

 

In accordance with the provisions of ASC Topic 360, “Impairment or Disposal of Long-Lived Assets”, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment charge for the years presented.

 
Revenue recognition

Revenue recognition

 

The Company adopted Accounting Standards Codification (“ASC”) 606 – Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:

 

  ● identify the contract with a customer;
  ● identify the performance obligations in the contract;
  ● determine the transaction price;
  ● allocate the transaction price to performance obligations in the contract; and
  ● recognize revenue as the performance obligation is satisfied.

 

 

Currently, the Company operates two business segments.

 

Healthcare Business mainly provides health consulting advisory services and healthcare and wellness products to the customers.

 

Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.

 

The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Wine Business mainly provides the wine products to the customers. Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The Company recorded product sales returns $148,208 and $0 for the years ended December 31, 2021 and 2020, respectively. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 
Disaggregation of Revenue

Disaggregation of Revenue

 

The following table provides information about disaggregated revenue from customers into the nature of the products and services and includes a reconciliation of the disaggregated revenue with reportable segments.

 

  

For the Year Ended December 31,

2021

  

For the Year Ended December 31,

2020

 
         
Consultancy service fee income  $216,851   $221,041 
Sale of healthcare products   31,874    481,049 
Sale of wine products   112,392    311,051 
           
TOTAL  $361,116   $1,013,141 

 
Income taxes

Income taxes

 

The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

 

 
Foreign currencies translation

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statement of operations.

 

The reporting currency of the Company is United States Dollar (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the People’s Republic of China and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholder’s equity.

 

Translation of amounts from HK$ and RMB into US$ have been made at the following exchange rates for the years ended December 31, 2021 and 2020.

 

Years ended December 31, 2021 and 2020

 

   2021   2020 
Year-end HK$:US$ exchange rate   0.12822    0.12899 
Annual average HK$:US$ exchange rate   0.12865    0.12893 
Year-end RMB:US$ exchange rate   0.15742    0.15307 
Annual average RMB:US$ exchange rate   0.15507    0.14503 

 
Net loss per share

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share.” Basic income per share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 
Comprehensive income

Comprehensive income

 

ASC Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying consolidated statements of changes in shareholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.

 
Retirement plan costs

Retirement plan costs

 

Contributions to retirement plans (which are defined contribution plans) are charged to general and administrative expenses in the accompanying statements of operation as the related employee service are provided.

 

 
Leases

Leases

 

The Company adopts the FASB Accounting Standards Update (“ASU”) 2016-02 “Leases (Topic 842).” for all periods presented.  This standard requires lessees to recognize lease assets (“right of use”) and related lease obligations (“lease liabilities”) on the balance sheet for leases with terms in excess of 12 months.

 

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities in the consolidated balance sheets. Finance leases are included in finance lease ROU assets and finance lease liabilities in the consolidated balance sheets.

 

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease and finance lease ROU assets and liabilities are recognized at January 1, 2019 based on the present value of lease payments over the lease term discounted using the rate implicit in the lease. In cases where the implicit rate is not readily determinable, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 
Related parties

Related parties

 

The Company follows the ASC 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

 
Commitments and contingencies

Commitments and contingencies

 

The Company follows the ASC 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 
Fair value of financial instruments

Fair value of financial instruments

 

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and has adopted paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by paragraph 820-10-35-37 of the FASB Accounting Standards Codification are described below:

 

  Level 1

Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
  Level 2

Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
  Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

 

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

 

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, approximate their fair values because of the short maturity of these instruments.

 
Recent accounting pronouncements

Recent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

 

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), (“ASU 2021-04”). This ASU reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. This ASU provides guidance for a modification or an exchange of a freestanding equity-classified written call option that is not within the scope of another Topic. It specifically addresses: (1) how an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; (2) how an entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; and (3) how an entity should recognize the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange. This ASU will be effective for all entities for fiscal years beginning after December 15, 2021. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The adoption of ASU 2021-04 on January 1, 2022 did not have a material impact on the Company’s financial statements or disclosures.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 
XML 41 R26.htm IDEA: XBRL DOCUMENT v3.22.4
ORGANIZATION AND BUSINESS BACKGROUND (Tables)
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF SUBSIDIARIES INFORMATION

The following table depicts the description of the Company’s subsidiaries :

 

Name  Place of incorporation
and kind of
legal entity		  Principal activities  Particulars of registered/
paid up share capital		  Effective interest
held		 
              
Elite Creation Group Limited  BVI, a limited liability company  Investment holding  50,000 issued shares of US$1each   100%
               
Alpha Wellness (HK) Limited  Hong Kong, a limited liability company  Investment holding  300,000 issued shares of HK$300,000   100%
               
Guangzhou Xiao Xiang Health Industry Company Limited  The PRC, a limited liability company  Sales of healthcare products  RMB8,300,000   100%
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
SCHEDULE OF ESTIMATED USEFUL LIVES

 

   Expected useful lives  Residual value 
Furniture, fixture and equipment  3 years   5% 
Motor vehicle  3.33 to 4 years   5% 
Leasehold improvement  2 years   5% 
SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS

The following table provides information about disaggregated revenue from customers into the nature of the products and services and includes a reconciliation of the disaggregated revenue with reportable segments.

 

  

For the Year Ended December 31,

2021

  

For the Year Ended December 31,

2020

 
         
Consultancy service fee income  $216,851   $221,041 
Sale of healthcare products   31,874    481,049 
Sale of wine products   112,392    311,051 
           
TOTAL  $361,116   $1,013,141 
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES

Translation of amounts from HK$ and RMB into US$ have been made at the following exchange rates for the years ended December 31, 2021 and 2020.

 

Years ended December 31, 2021 and 2020

 

   2021   2020 
Year-end HK$:US$ exchange rate   0.12822    0.12899 
Annual average HK$:US$ exchange rate   0.12865    0.12893 
Year-end RMB:US$ exchange rate   0.15742    0.15307 
Annual average RMB:US$ exchange rate   0.15507    0.14503 
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.22.4
SEGMENT REPORTING (Tables)
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
SUMMARY OF GEOGRAPHIC SEGMENTS

In the following table, revenue is disaggregated by primary major product line, and timing of revenue recognition. The table also includes a reconciliation of the disaggregated revenue with the reportable segments.

 

  

Healthcare

Segment

   Wine Segment   Total 
   Year Ended December 31, 2021 
  

Healthcare

Segment

   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $216,850   $–   $216,850 
Sale of healthcare products   39,996    –    39,996 
Sale of wine products   –    104,270    104,270 
Total revenue   256,846    104,270    361,116 
                
Cost of sales:               
Consulting service income   (31,315)   –    (31,315)
Sale of healthcare products   (32,064)    –   (32,064)
Sale of wine products   –    (58,311)   (58,311)
Total cost of revenue   (63,379)   (58,311)   (121,690)
                
Gross profit   193,467    45,959    239,426 
                
Operating Expenses               
Selling and distribution   –    (5,076)   (5,076)
General and administrative   (690,780)   –   (690,780)
Total operating expenses   (690,780)   (5,076)   (695,856)
                
Segment (loss) income  $(497,313)   $40,883  $(456,430)

 

  

Healthcare

Segment

   Wine Segment   Total 
   Year Ended December 31, 2020 
  

Healthcare Segment

   Wine
Segment		   Total 
Revenue from external customers:               
Consulting service income  $221,041   $–   $221,041 
Sale of healthcare products   564,814    –    564,814 
Sale of wine products   –    227,286     227,286 
Total revenue   785,855    227,286    1,013,141 
                
Cost of sales:               
Consulting service income   –    –    
Sale of healthcare products   (395,392)    –   (395,392)
Sale of wine products   –    (201,138)    (201,138)
Total cost of revenue   (395,392)    (201,138)   (596,530)
                
Gross profit   390,463    26,148    416,611 
                
Operating Expenses               
Selling and distribution   –    (158,432)   (158,432)
General and administrative   (728,994)   –   (728,994)
Total operating expenses   (728,994)   (158,432)   (887,426)
                
Segment loss  $(338,531)   $(132,284)  $(470,815)

 

 

The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Hong Kong  $216,851   $221,041 
China   144,265    792,100 
           
Total revenue  $361,116   $1,013,141 
SUMMARY OF GEOGRAPHIC SEGMENTS

The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Hong Kong  $216,851   $221,041 
China   144,265    792,100 
           
Total revenue  $361,116   $1,013,141 
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAYMENTS AND OTHER RECEIVABLES (Tables)
 12 Months Ended
Dec. 31, 2021
Prepayments And Other Receivables  
SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE

Prepayments and other receivable consisted of the following:

 

   December 31, 2021   December 31, 2020 
         
Prepayments  $3,077   $7,712 
Other deposits   -    119 
Rental deposits   33,961    - 
Other receivables   102,216    113,670 
Prepayments and other receivable  $139,254   $121,501 
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.22.4
INVENTORIES (Tables)
 12 Months Ended
Dec. 31, 2021
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORIES

Inventories consisted of the following:

 

   December 31, 2021   December 31, 2020 
         
Packing materials  $-   $21,527 
Finished goods   327,551    184,745 
Inventories  $327,551   $206,272 
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.22.4
PLANT AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

 

   December 31, 2021   December 31, 2020 
         
Motor vehicle  $311,343   $311,343 
Furniture, fixture and equipment   15,465    15,465 
Leasehold improvement   27,358    - 
Foreign translation difference, net   17,603    10,471 
Plant and equipment, gross   371,769    337,279 
           
Less: accumulated depreciation   (228,507)   (137,546)
Foreign translation difference, net   (10,658)   (6,112)
Plant and equipment. net  $132,604   $193,621 
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.22.4
LEASE (Tables)
 12 Months Ended
Dec. 31, 2021
Lease  
SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY

Right of use assets and lease liability – right of use are as follows:

 

  

December 31,

2021

  

December 31,

2020

 
         
Right-of-use assets  $350,563   $- 

 

The lease liability – right of use is as follows:

 

  

December 31,

2021

  

December 31,

2020

 
         
Current portion  $114,132   $- 
Non-current portion   246,022    - 
           
Total  $360,154   $- 
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.22.4
NET LOSS PER SHARE (Tables)
 12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
Net loss attributable to common shareholders  $(455,409)  $(469,476)
           
Weighted average common shares outstanding – Basic and diluted   20,252,309    17,525,701 
           
Net loss per share – Basic and diluted  $(0.02)  $(0.03)
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2021
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE

The provision for income taxes consisted of the following:

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Current tax  $6,671   $8,215 
Deferred tax   -    - 
Income tax expense  $6,671   $8,215 
SCHEDULE OF DEFERRED TAX ASSETS

The following table sets forth the significant components of the deferred tax assets of the Company as of December 31, 2021 and 2020:

 

   2021   2020 
   As of December 31, 
   2021   2020 
Deferred tax assets:          
Net operating loss carryforwards          
- United States  $54,747   $31,454 
- PRC   246,903    120,503 
Net operating loss carryforwards   301,650    151,957 
Less: valuation allowance   (301,650)   (151,957)
Deferred tax assets, net  $-   $- 
HONG KONG  
SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Income before income taxes  $80,157   $170,555 
Statutory income tax rate   8.25%   8.25%
Income tax expense at statutory rate   6,613    14,070 
Tax adjustments   1,345   (3,277)
Tax holiday   

(1,287

)   (2,578)
Income tax expense  $6,671   $8,215 
CHINA  
SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE

 

   2021   2020 
   Years ended December 31, 
   2021   2020 
         
Loss before income taxes  $(505,601)  $(482,014)
Statutory income tax rate   25%   25%
Income tax expense at statutory rate   (126,400)   (120,503)
Net operating loss   126,400    120,503 
Income tax expense  $-   $- 
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.22.4
CONCENTRATIONS OF RISK (Tables)
 12 Months Ended
Dec. 31, 2021
Risks and Uncertainties [Abstract]  
SCHEDULE OF CONCENTRATIONS OF RISK

 

(a) Major customers

 

For the years ended December 31, 2021 and 2020, the customers who accounts for 10% or more of the Company’s revenues and its outstanding receivable balances as at year-end dates, are presented as follows:

 

  

Year ended

December 31, 2021

       December 31, 2021 
   Revenues   Percentage of revenues       Accounts receivable 
Customer C  $165,391    46%       $- 
Customer D   103,072    29%         
Customer E   51,460    14%        - 
TOTAL  $319,923    89%    Total   $- 

 

  

Year ended

December 31, 2020

       December 31, 2020  
Customer  Revenues   Percentage of revenues       Accounts receivable  
   　               　  
Customer A  $394,158    　39%         $ -  
Customer B   234,547    　23%           -  
　   　　　    　　　            　　　　  
Total:  $628,705    　62%    Total:    $ -  

 

All of the Company’s customers are located in the People’s Republic of China and Hong Kong.

 

(b) Major vendors

 

For the years ended December 31, 2021 and 2020, the vendor who accounts for 10% or more of the Company’s purchases and its outstanding payable balances as at year-end dates, are presented as follows:

 

  

Year ended

December 31, 2021

        December 31, 2021 
Vendor  Purchases   Percentage of purchases        Accounts payable 
Vendor D  $195,152    99%    Total:   $- 

 

 

  

Year ended

December 31, 2020

       December 31, 2020 
Vendor  Purchases   Percentage of purchases       Accounts payable 
   　   　       　 
Vendor A  $219,007    37%       $- 
Vendor B   71,616    12%        - 
Vendor C   61,222    10%        - 
　   　              　 
Total:  $351,845    59%   Total:   $- 
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF SUBSIDIARIES INFORMATION (Details) - 12 months ended Dec. 31, 2021
USD ($)
shares
HKD ($)
shares
CNY (¥)
shares
Elite Creation Group Limited [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Place of incorporation and kind of legal entity BVI, a limited liability company BVI, a limited liability company BVI, a limited liability company
Principal activities Investment holding Investment holding Investment holding
Stock Issued During Period, Shares, New Issues | shares 50,000 50,000 50,000
Stock Issued During Period, Value, New Issues | $ $ 1    
Effective interest held percentage 100.00% 100.00% 100.00%
Alpha Wellness (HK) Limited [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Place of incorporation and kind of legal entity Hong Kong, a limited liability company Hong Kong, a limited liability company Hong Kong, a limited liability company
Principal activities Investment holding Investment holding Investment holding
Stock Issued During Period, Shares, New Issues | shares 300,000 300,000 300,000
Stock Issued During Period, Value, New Issues | $   $ 300,000  
Effective interest held percentage 100.00% 100.00% 100.00%
Guangzhou Xiao Xiang Health Industry Company Limited [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Place of incorporation and kind of legal entity The PRC, a limited liability company The PRC, a limited liability company The PRC, a limited liability company
Principal activities Sales of healthcare products Sales of healthcare products Sales of healthcare products
Stock Issued During Period, Value, New Issues | ¥     ¥ 8,300,000
Effective interest held percentage 100.00% 100.00% 100.00%
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF ESTIMATED USEFUL LIVES (Details)
 12 Months Ended
Dec. 31, 2021
Furniture, Fixture and Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 3 years
Residual value 5.00%
Motor Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Residual value 5.00%
Motor Vehicles [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 3 years 3 months 29 days
Motor Vehicles [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 4 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 2 years
Residual value 5.00%
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Product Information [Line Items]    
TOTAL $ 361,116 $ 1,013,141
Consultancy Service Fee Income [Member]    
Product Information [Line Items]    
TOTAL 216,851 221,041
Sales of Healthcare [Member]    
Product Information [Line Items]    
TOTAL 31,874 481,049
Sale Of Wine Products [Member]    
Product Information [Line Items]    
TOTAL $ 112,392 $ 311,051
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)
Dec. 31, 2021
Dec. 31, 2020
Year-end HK$:US$ Exchange Rate [Member]    
Offsetting Assets [Line Items]    
Foreign currency translation exchange rates 0.12822 0.12899
Annual Average HK$:US$ Exchange Rate [Member]    
Offsetting Assets [Line Items]    
Foreign currency translation exchange rates 0.12865 0.12893
Year-end RMB:US$ Exchange Rate [Member]    
Offsetting Assets [Line Items]    
Foreign currency translation exchange rates 0.15742 0.15307
Annual Average RMB:US$ Exchange Rate [Member]    
Offsetting Assets [Line Items]    
Foreign currency translation exchange rates 0.15507 0.14503
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
 12 Months Ended
Dec. 31, 2021
USD ($)
Integer
Dec. 31, 2020
USD ($)
Accounting Policies [Abstract]    
Number of operating segments | Integer 1  
Allowance for doubtful accounts $ 0 $ 0
Intangible assets amortization period 10 years  
Amortization expense $ 521 487
Sales tax percentage 17.00%  
Product sales returns $ 148,208 $ 0
Income tax likelihood, description greater than fifty percent (50%) likelihood of being realized upon ultimate settlement  
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.22.4
LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Cash $ 609,434 $ 1,006,394
Net cash 396,960 (371,902)
Accumulated Deficit $ 918,195 $ 462,786
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF GEOGRAPHIC SEGMENTS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]    
Total revenue $ 361,116 $ 1,013,141
Total cost of revenue (121,690) (596,530)
Gross profit 239,426 416,611
Operating Expenses    
Selling and distribution (5,076) (158,432)
General and administrative (690,780) (728,994)
Total operating expenses (695,856) (887,426)
Segment loss (456,430) (470,815)
HONG KONG    
Segment Reporting Information [Line Items]    
Total revenue 216,851 221,041
CHINA    
Segment Reporting Information [Line Items]    
Total revenue 144,265 792,100
Consulting Service Income [Member]    
Segment Reporting Information [Line Items]    
Total revenue 216,850 221,041
Total cost of revenue (31,315)  
Sale of Healthcare Products [Member]    
Segment Reporting Information [Line Items]    
Total revenue 39,996 564,814
Total cost of revenue (32,064) (395,392)
Sale Of Wine Products [Member]    
Segment Reporting Information [Line Items]    
Total revenue 112,392 311,051
Total cost of revenue (58,311) (201,138)
Sale Of Wine Products [Member] | Segment Reconciling Items [Member]    
Segment Reporting Information [Line Items]    
Total revenue 104,270 227,286
Healthcare Segment [Member]    
Segment Reporting Information [Line Items]    
Total revenue 256,846 785,855
Total cost of revenue (63,379) (395,392)
Gross profit 193,467 390,463
Operating Expenses    
Selling and distribution
General and administrative (690,780) (728,994)
Total operating expenses (690,780) (728,994)
Segment loss (497,313) (338,531)
Healthcare Segment [Member] | Consulting Service Income [Member]    
Segment Reporting Information [Line Items]    
Total revenue 216,850 221,041
Total cost of revenue (31,315)
Healthcare Segment [Member] | Sale of Healthcare Products [Member]    
Segment Reporting Information [Line Items]    
Total revenue 39,996 564,814
Total cost of revenue (32,064) (395,392)
Healthcare Segment [Member] | Sale Of Wine Products [Member]    
Segment Reporting Information [Line Items]    
Total cost of revenue
Healthcare Segment [Member] | Sale Of Wine Products [Member] | Segment Reconciling Items [Member]    
Segment Reporting Information [Line Items]    
Total revenue
Wine Segment [Member]    
Segment Reporting Information [Line Items]    
Total revenue 104,270 227,286
Total cost of revenue (58,311) (201,138)
Gross profit 45,959 26,148
Operating Expenses    
Selling and distribution (5,076) (158,432)
General and administrative
Total operating expenses (5,076) (158,432)
Segment loss 40,883 (132,284)
Wine Segment [Member] | Consulting Service Income [Member]    
Segment Reporting Information [Line Items]    
Total revenue
Total cost of revenue
Wine Segment [Member] | Sale of Healthcare Products [Member]    
Segment Reporting Information [Line Items]    
Total revenue
Total cost of revenue
Wine Segment [Member] | Sale Of Wine Products [Member]    
Segment Reporting Information [Line Items]    
Total cost of revenue (58,311) (201,138)
Wine Segment [Member] | Sale Of Wine Products [Member] | Segment Reconciling Items [Member]    
Segment Reporting Information [Line Items]    
Total revenue $ 104,270 $ 227,286
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Prepayments And Other Receivables    
Prepayments $ 3,077 $ 7,712
Other deposits 119
Rental deposits 33,961
Other receivables 102,216 113,670
Prepayments and other receivable $ 139,254 $ 121,501
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF INVENTORIES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Inventory Disclosure [Abstract]    
Packing materials $ 21,527
Finished goods 327,551 184,745
Inventories $ 327,551 $ 206,272
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.22.4
INVENTORIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Inventory Disclosure [Abstract]    
Allowance for obsolete inventories $ 0 $ 0
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]    
Plant and equipment, gross $ 371,769 $ 337,279
Less: accumulated depreciation (228,507) (137,546)
Foreign translation difference, net (10,658) (6,112)
Plant and equipment. net 132,604 193,621
Motor Vehicle [Member]    
Property, Plant and Equipment [Line Items]    
Plant and equipment, gross 311,343 311,343
Furniture, Fixture and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Plant and equipment, gross 15,465 15,465
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Plant and equipment, gross 27,358
Foreign Translation Difference [Member]    
Property, Plant and Equipment [Line Items]    
Plant and equipment, gross $ 17,603 $ 10,471
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.22.4
PLANT AND EQUIPMENT (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 90,961 $ 71,472
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.22.4
CUSTOMER DEPOSITS (Details Narrative) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Customer Deposits    
Deposit received from customers $ 340,783 $ 409,924
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Lease    
Right-of-use assets $ 350,563
Current portion 114,132
Non-current portion 246,022
Total $ 360,154
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.22.4
LEASE (Details Narrative)
 12 Months Ended
Dec. 31, 2021
Operaitng lease, description The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of 2 to 4 year, through December 31, 2025.
Lease expiration date Dec. 31, 2025
Minimum [Member]  
Lease term 2 years
Maximum [Member]  
Lease term 4 years
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.22.4
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)
 12 Months Ended
Jul. 09, 2020
Dec. 31, 2020
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Common stock, shares authorized   100,000,000 100,000,000
Common stock, par value   $ 0.0001 $ 0.0001
Common stock, shares issued   20,252,309 20,252,309
Common Stock [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Number of purchase of shares   5,252,309  
Share Exchange Agreement [Member] | Common Stock [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Common stock, shares issued   20,252,309 20,252,309
Share Exchange Agreement [Member] | Common Stock [Member] | Elite Creation Group Limited [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Number of shares issued 15,000,000    
Share price per share $ 0.32    
Aggregate fair value of shares issued $ 4,800,000    
Share Exchange Agreement [Member] | Common Stock [Member] | Elite Creation Group Limited [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Number of purchase of shares 50,000    
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Earnings Per Share [Abstract]    
Net loss attributable to common shareholders $ (455,409) $ (469,476)
Weighted average common shares outstanding – Basic and diluted 20,252,309 17,525,701
Net loss per share – Basic and diluted $ (0.02) $ (0.03)
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
Current tax $ 6,671 $ 8,215
Deferred tax
Income tax expense $ 6,671 $ 8,215
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Loss before income taxes $ (448,738) $ (461,261)
Statutory income tax rate 21.00%  
Income tax expense $ 6,671 8,215
HONG KONG    
Loss before income taxes $ 80,157 $ 170,555
Statutory income tax rate 8.25% 8.25%
Income tax expense at statutory rate $ 6,613 $ 14,070
Tax adjustments 1,345 (3,277)
Tax holiday (1,287) (2,578)
Income tax expense 6,671 8,215
CHINA    
Loss before income taxes $ (505,601) $ (482,014)
Statutory income tax rate 25.00% 25.00%
Income tax expense at statutory rate $ (126,400) $ (120,503)
Income tax expense
Net operating loss $ 126,400 $ 120,503
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Net operating loss carryforwards $ 301,650 $ 151,957
Less: valuation allowance (301,650) (151,957)
Deferred tax assets, net
UNITED STATES    
Net operating loss carryforwards 54,747 31,454
CHINA    
Net operating loss carryforwards $ 246,903 $ 120,503
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income tax description The Tax Reform Act significantly revised the U.S. corporate income tax regime by, among other things, lowering the U.S. corporate tax rate from 35% to 21% effective January 1, 2018. The Company’s policy is to recognize accrued interest and penalties related to unrecognized tax benefits in its income tax provision. The Company has not accrued or paid interest or penalties which were not material to its results of operations for the years presented  
Corporate tax rate 21.00%  
umulative net operating losses $ 173,076  
Net operating loss carryforwards expiration The net operating loss carryforwards begin to expire in 2041, if unutilized.  
HONG KONG    
Income tax description The Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25% to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax year  
Corporate tax rate 8.25% 8.25%
CHINA    
Income tax description The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the People’s Republic of China at a unified income tax rate of 25%  
Corporate tax rate 25.00% 25.00%
XML 72 R57.htm IDEA: XBRL DOCUMENT v3.22.4
PENSION COSTS (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Foreign Plan [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Employee Contributions $ 23,617 $ 12,284
XML 73 R58.htm IDEA: XBRL DOCUMENT v3.22.4
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]    
Amount due to a director $ 219,461 $ 68,953
Due to related company 199,964 $ 199,964
Motor Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Due from related company $ 42,966  
XML 74 R59.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF CONCENTRATIONS OF RISK (Details) - Customer Concentration Risk [Member] - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Customer C [Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues $ 165,391  
Concentration risk, percentage 46.00%  
Customer C [Member] | Accounts Receivable [Member]    
Concentration Risk [Line Items]    
Accounts receivable  
Customer D [Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues $ 103,072  
Concentration risk, percentage 29.00%  
Customer E [Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues $ 51,460  
Concentration risk, percentage 14.00%  
Customer E [Member] | Accounts Receivable [Member]    
Concentration Risk [Line Items]    
Accounts receivable  
Customer [Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues $ 319,923 $ 628,705
Concentration risk, percentage 89.00% 62.00%
Customer [Member] | Accounts Receivable [Member]    
Concentration Risk [Line Items]    
Accounts receivable
Customer A [Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues   $ 394,158
Concentration risk, percentage   39.00%
Customer A [Member] | Accounts Receivable [Member]    
Concentration Risk [Line Items]    
Accounts receivable  
Customer B [Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues   $ 234,547
Concentration risk, percentage   23.00%
Customer B [Member] | Accounts Receivable [Member]    
Concentration Risk [Line Items]    
Accounts receivable  
Vendor D[Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues $ 195,152  
Concentration risk, percentage 99.00%  
Vendor D[Member] | Accounts Payable [Member]    
Concentration Risk [Line Items]    
Accounts payable  
Vendor A [Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues   $ 219,007
Concentration risk, percentage   37.00%
Vendor A [Member] | Accounts Payable [Member]    
Concentration Risk [Line Items]    
Accounts payable  
Vendor B [Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues   $ 71,616
Concentration risk, percentage   12.00%
Vendor B [Member] | Accounts Payable [Member]    
Concentration Risk [Line Items]    
Accounts payable  
Vendor C [Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues   $ 61,222
Concentration risk, percentage   10.00%
Vendor C [Member] | Accounts Payable [Member]    
Concentration Risk [Line Items]    
Accounts payable  
Vendor [Member] | Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Revenues   $ 351,845
Concentration risk, percentage   59.00%
Vendor [Member] | Accounts Payable [Member]    
Concentration Risk [Line Items]    
Accounts payable  
XML 75 form10-ka_htm.xml IDEA: XBRL DOCUMENT 0001310630 2021-01-01 2021-12-31 0001310630 2021-06-30 0001310630 2022-03-31 0001310630 2021-12-31 0001310630 2020-12-31 0001310630 2020-01-01 2020-12-31 0001310630 us-gaap:CommonStockMember 2019-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001310630 us-gaap:RetainedEarningsMember 2019-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001310630 2019-12-31 0001310630 us-gaap:CommonStockMember 2020-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001310630 us-gaap:RetainedEarningsMember 2020-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001310630 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001310630 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001310630 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001310630 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001310630 us-gaap:CommonStockMember 2021-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001310630 us-gaap:RetainedEarningsMember 2021-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001310630 CFOO:EliteCreationGroupLimitedMember 2021-01-01 2021-12-31 0001310630 CFOO:AlphaWellnessHKLimitedMember 2021-01-01 2021-12-31 0001310630 CFOO:GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember 2021-01-01 2021-12-31 0001310630 CFOO:FurnitureFixtureAndEquipmentMember 2021-01-01 2021-12-31 0001310630 CFOO:FurnitureFixtureAndEquipmentMember 2021-12-31 0001310630 srt:MinimumMember CFOO:MotorVehiclesMember 2021-01-01 2021-12-31 0001310630 srt:MaximumMember CFOO:MotorVehiclesMember 2021-01-01 2021-12-31 0001310630 CFOO:MotorVehiclesMember 2021-12-31 0001310630 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001310630 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2021-01-01 2021-12-31 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2020-01-01 2020-12-31 0001310630 CFOO:SalesofHealthcareMember 2021-01-01 2021-12-31 0001310630 CFOO:SalesofHealthcareMember 2020-01-01 2020-12-31 0001310630 CFOO:SaleOfWineProductsMember 2021-01-01 2021-12-31 0001310630 CFOO:SaleOfWineProductsMember 2020-01-01 2020-12-31 0001310630 CFOO:YearEndHKUSExchangeRateMember 2021-12-31 0001310630 CFOO:YearEndHKUSExchangeRateMember 2020-12-31 0001310630 CFOO:AnnualAverageHKUSExchangeRateMember 2021-12-31 0001310630 CFOO:AnnualAverageHKUSExchangeRateMember 2020-12-31 0001310630 CFOO:YearEndRMBUSExchangeRateMember 2021-12-31 0001310630 CFOO:YearEndRMBUSExchangeRateMember 2020-12-31 0001310630 CFOO:AnnualAverageRMBUSExchangeRateMember 2021-12-31 0001310630 CFOO:AnnualAverageRMBUSExchangeRateMember 2020-12-31 0001310630 CFOO:ConsultingServiceIncomeMember CFOO:HealthcareSegmentMember 2021-01-01 2021-12-31 0001310630 CFOO:ConsultingServiceIncomeMember CFOO:WineSegmentMember 2021-01-01 2021-12-31 0001310630 CFOO:ConsultingServiceIncomeMember 2021-01-01 2021-12-31 0001310630 CFOO:SaleofHealthcareProductsMember CFOO:HealthcareSegmentMember 2021-01-01 2021-12-31 0001310630 CFOO:SaleofHealthcareProductsMember CFOO:WineSegmentMember 2021-01-01 2021-12-31 0001310630 CFOO:SaleofHealthcareProductsMember 2021-01-01 2021-12-31 0001310630 us-gaap:MaterialReconcilingItemsMember CFOO:SaleOfWineProductsMember CFOO:HealthcareSegmentMember 2021-01-01 2021-12-31 0001310630 us-gaap:MaterialReconcilingItemsMember CFOO:SaleOfWineProductsMember CFOO:WineSegmentMember 2021-01-01 2021-12-31 0001310630 us-gaap:MaterialReconcilingItemsMember CFOO:SaleOfWineProductsMember 2021-01-01 2021-12-31 0001310630 CFOO:HealthcareSegmentMember 2021-01-01 2021-12-31 0001310630 CFOO:WineSegmentMember 2021-01-01 2021-12-31 0001310630 CFOO:SaleOfWineProductsMember CFOO:HealthcareSegmentMember 2021-01-01 2021-12-31 0001310630 CFOO:SaleOfWineProductsMember CFOO:WineSegmentMember 2021-01-01 2021-12-31 0001310630 CFOO:ConsultingServiceIncomeMember CFOO:HealthcareSegmentMember 2020-01-01 2020-12-31 0001310630 CFOO:ConsultingServiceIncomeMember CFOO:WineSegmentMember 2020-01-01 2020-12-31 0001310630 CFOO:ConsultingServiceIncomeMember 2020-01-01 2020-12-31 0001310630 CFOO:SaleofHealthcareProductsMember CFOO:HealthcareSegmentMember 2020-01-01 2020-12-31 0001310630 CFOO:SaleofHealthcareProductsMember CFOO:WineSegmentMember 2020-01-01 2020-12-31 0001310630 CFOO:SaleofHealthcareProductsMember 2020-01-01 2020-12-31 0001310630 us-gaap:MaterialReconcilingItemsMember CFOO:SaleOfWineProductsMember CFOO:HealthcareSegmentMember 2020-01-01 2020-12-31 0001310630 us-gaap:MaterialReconcilingItemsMember CFOO:SaleOfWineProductsMember CFOO:WineSegmentMember 2020-01-01 2020-12-31 0001310630 us-gaap:MaterialReconcilingItemsMember CFOO:SaleOfWineProductsMember 2020-01-01 2020-12-31 0001310630 CFOO:HealthcareSegmentMember 2020-01-01 2020-12-31 0001310630 CFOO:WineSegmentMember 2020-01-01 2020-12-31 0001310630 CFOO:SaleOfWineProductsMember CFOO:HealthcareSegmentMember 2020-01-01 2020-12-31 0001310630 CFOO:SaleOfWineProductsMember CFOO:WineSegmentMember 2020-01-01 2020-12-31 0001310630 country:HK 2021-01-01 2021-12-31 0001310630 country:HK 2020-01-01 2020-12-31 0001310630 country:CN 2021-01-01 2021-12-31 0001310630 country:CN 2020-01-01 2020-12-31 0001310630 CFOO:MotorVehicleMember 2021-12-31 0001310630 CFOO:MotorVehicleMember 2020-12-31 0001310630 CFOO:FurnitureFixtureAndEquipmentMember 2020-12-31 0001310630 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001310630 CFOO:ForeignTranslationDifferenceMember 2021-12-31 0001310630 CFOO:ForeignTranslationDifferenceMember 2020-12-31 0001310630 srt:MinimumMember 2021-12-31 0001310630 srt:MaximumMember 2021-12-31 0001310630 us-gaap:CommonStockMember CFOO:ShareExchangeAgreementMember CFOO:EliteCreationGroupLimitedMember 2020-07-08 2020-07-09 0001310630 CFOO:EliteCreationGroupLimitedMember us-gaap:CommonStockMember CFOO:ShareExchangeAgreementMember 2020-07-08 2020-07-09 0001310630 CFOO:EliteCreationGroupLimitedMember us-gaap:CommonStockMember CFOO:ShareExchangeAgreementMember 2020-07-09 0001310630 us-gaap:CommonStockMember CFOO:ShareExchangeAgreementMember 2021-12-31 0001310630 us-gaap:CommonStockMember CFOO:ShareExchangeAgreementMember 2020-12-31 0001310630 country:US 2021-12-31 0001310630 country:US 2020-12-31 0001310630 country:CN 2021-12-31 0001310630 country:CN 2020-12-31 0001310630 us-gaap:ForeignPlanMember 2021-01-01 2021-12-31 0001310630 us-gaap:ForeignPlanMember 2020-01-01 2020-12-31 0001310630 CFOO:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001310630 CFOO:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001310630 CFOO:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001310630 CFOO:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001310630 CFOO:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001310630 CFOO:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001310630 CFOO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001310630 CFOO:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:VendorDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001310630 CFOO:VendorDMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001310630 CFOO:VendorAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:VendorAMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:VendorBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:VendorBMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:VendorCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:VendorCMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001310630 CFOO:VendorMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001310630 CFOO:VendorMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 iso4217:USD shares iso4217:USD shares iso4217:HKD pure iso4217:CNY CFOO:Integer 0001310630 true FY 10-K/A true 2021-12-31 --12-31 2021 false 001-32522 China Foods Holdings Ltd. DE 84-1735478 Room 2301A China Resources Building, 26 Harbour Road, Wanchai HK 0000 (852) 3618-8608 No Yes Yes Yes Non-accelerated Filer true false false 253425 20252309 This amendment to our filing on Form 10-K for the annual period ended December 31, 2021 is filed primarily to update on our wine business and to address how the Holding Foreign Companies Accountable Act (“HFCAA”) and related regulations will affect our company. HKCM CPA& Co Hong Kong, China 3299 609434 1006394 139254 121501 327551 206272 8910 350563 1435712 1334167 132604 193621 3947 4353 136551 197974 1572263 1532141 7827 51200 2316 340783 409924 114132 219461 68953 199964 199964 8319 925540 697303 246022 0.0001 0.0001 100000000 100000000 20252309 20252309 20252309 20252309 2025 2025 1290355 1290355 26516 5244 -918195 -462786 400701 834838 1572263 1532141 361116 1013141 121690 596530 239426 416611 5076 158432 690780 728994 695856 887426 -456430 -470815 1277 2602 6415 6952 7692 9554 -448738 -461261 6671 8215 -455409 -469476 21272 59245 -434137 -410231 -0.02 -0.03 20252309 17525701 15000000 1500 1290355 159441 -54001 1397295 59245 59245 5252309 -525 152751 152226 -469476 -469476 20252309 2025 1290355 -462786 5244 834838 20252309 2025 1290355 -462786 5244 834838 21272 21272 -455409 -455409 20252309 2025 1290355 -918195 26516 400701 20252309 2025 1290355 -918195 26516 400701 455409 469476 90961 71472 521 487 109652 74863 -254275 -322654 -530196 17753 -199317 121279 94655 -7827 7827 48884 2316 -69141 13044 -17229 8219 -47 -438620 343657 27358 75060 7198 -27358 -67862 100189 79395 150508 -3038 128295 50319 45862 18699 50245 -396960 371902 1006394 634492 609434 1006394 <p id="xdx_807_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zfEADii9CkVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82C_zZfKaiVVUhel">ORGANIZATION AND BUSINESS BACKGROUND</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China Foods Holdings Ltd. (the “Company” or “CFOO”) was incorporated in Delaware on January 10, 2019. The Company currently engages in the sale of healthcare product and rendering of consulting service in Hong Kong and China.  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 9, 2020, the Company consummated the Share Exchange Agreement (“the “Share Exchange Agreement”) with Elite Creation Group Limited, a private limited company organized under the laws of British Virgin Islands (“ECGL”). As a result of the acquisition of ECGL, the Company entered into the healthcare product distributing and marketing industry, and then pursue a new strategy of developing and distributing health related products, including supplements, across the globe with a focus on mainland China, Europe and Australia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ECGL will comprise the ongoing operations of the combined entity and its senior management will serve as the senior management of the combined entity, ECGL is deemed to be the accounting acquirer for accounting purposes. The transaction will be treated as a recapitalization of the Company. Accordingly, the consolidated assets, liabilities and results of operations of the Company will become the historical financial statements of ECGL, and the Company’s assets, liabilities and results of operations will be consolidated with ECGL beginning on the acquisition date. ECGL was the legal acquiree but deemed to be the accounting acquirer. The Company was the legal acquirer but deemed to be the accounting acquiree in the reverse merger. The historical financial statements prior to the acquisition are those of the accounting acquirer (ECGL). After completion of the Share Exchange Transaction, the Company’s consolidated financial statements include the assets and liabilities, the operations and cash flow of the accounting acquirer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p id="xdx_897_ecustom--ScheduleOfSubsidiariesInformationTableTextBlock_zXr2NJdAIRW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table depicts the description of the Company’s subsidiaries :</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_z3A8JUeFaOa6" style="display: none">SCHEDULE OF SUBSIDIARIES INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Name</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Place of incorporation<br/> and kind of<br/> legal entity</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Principal activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Particulars of registered/ <br/> paid up share capital</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid">Effective interest<br/> held</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: left">Elite Creation Group Limited</td><td style="width: 2%"> </td> <td style="width: 18%; text-align: left"><span id="xdx_90B_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zg38ACgImPF6">BVI, a limited liability company</span></td><td style="width: 2%"> </td> <td style="width: 18%; text-align: left"><span id="xdx_902_ecustom--EntityPrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zQZljmd7KfNh">Investment holding</span></td><td style="width: 2%"> </td> <td style="width: 17%"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_znf4UUwjesjj">50,000 </span>issued shares of US$<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zcoRbVGl7Vv1">1</span>each</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"><span id="xdx_906_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zKpArd2JNUT8">100</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Alpha Wellness (HK) Limited</td><td> </td> <td style="text-align: left"><span id="xdx_90F_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_z6ownOOWS3fl">Hong Kong, a limited liability company</span></td><td> </td> <td style="text-align: left"><span id="xdx_90F_ecustom--EntityPrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zukAChbx3ej2">Investment holding</span></td><td> </td> <td><span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zOrHviahfkAd">300,000 </span>issued shares of HK$<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_uHKD_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_z6kjtnReCgw3">300,000</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_z4e78Kjdm9Qh">100</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Guangzhou Xiao Xiang Health Industry Company Limited</td><td> </td> <td style="text-align: left"><span id="xdx_909_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_zXsHl0yzlOLd">The PRC, a limited liability company</span></td><td> </td> <td style="text-align: left"><span id="xdx_90F_ecustom--EntityPrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_zBt6135hi6bj">Sales of healthcare products</span></td><td> </td> <td>RMB<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_uRMB_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_zwLXEQ1FMv97">8,300,000</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_z9JC7p8w9tE9">100</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A7_zJiQRiGD84rf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and its subsidiaries are hereinafter referred to as (the “Company”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_ecustom--ScheduleOfSubsidiariesInformationTableTextBlock_zXr2NJdAIRW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table depicts the description of the Company’s subsidiaries :</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_z3A8JUeFaOa6" style="display: none">SCHEDULE OF SUBSIDIARIES INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Name</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Place of incorporation<br/> and kind of<br/> legal entity</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Principal activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Particulars of registered/ <br/> paid up share capital</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid">Effective interest<br/> held</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: left">Elite Creation Group Limited</td><td style="width: 2%"> </td> <td style="width: 18%; text-align: left"><span id="xdx_90B_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zg38ACgImPF6">BVI, a limited liability company</span></td><td style="width: 2%"> </td> <td style="width: 18%; text-align: left"><span id="xdx_902_ecustom--EntityPrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zQZljmd7KfNh">Investment holding</span></td><td style="width: 2%"> </td> <td style="width: 17%"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_znf4UUwjesjj">50,000 </span>issued shares of US$<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zcoRbVGl7Vv1">1</span>each</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"><span id="xdx_906_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zKpArd2JNUT8">100</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Alpha Wellness (HK) Limited</td><td> </td> <td style="text-align: left"><span id="xdx_90F_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_z6ownOOWS3fl">Hong Kong, a limited liability company</span></td><td> </td> <td style="text-align: left"><span id="xdx_90F_ecustom--EntityPrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zukAChbx3ej2">Investment holding</span></td><td> </td> <td><span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zOrHviahfkAd">300,000 </span>issued shares of HK$<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_uHKD_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_z6kjtnReCgw3">300,000</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_z4e78Kjdm9Qh">100</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Guangzhou Xiao Xiang Health Industry Company Limited</td><td> </td> <td style="text-align: left"><span id="xdx_909_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_zXsHl0yzlOLd">The PRC, a limited liability company</span></td><td> </td> <td style="text-align: left"><span id="xdx_90F_ecustom--EntityPrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_zBt6135hi6bj">Sales of healthcare products</span></td><td> </td> <td>RMB<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_uRMB_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_zwLXEQ1FMv97">8,300,000</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_z9JC7p8w9tE9">100</span></td><td style="text-align: left">%</td></tr> </table> BVI, a limited liability company Investment holding 50000 1 1 Hong Kong, a limited liability company Investment holding 300000 300000 1 The PRC, a limited liability company Sales of healthcare products 8300000 1 <p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zSLHEWEN9XS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_822_zgcY28YmcD56">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--BasisOfPresentationAndConsolidationPolicyTextBlock_z8KAMnlgXqgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zt0pUuH7Hfp5">Basis of presentation and consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”). All adjustments considered necessary for a fair presentation have been included. These adjustments consist of normal and recurring accruals, as well as non-recurring charges.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. The results of subsidiaries acquired or disposed of during the periods are included in the consolidated statements of operations from the effective date of acquisition or up to the effective date of disposal.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_846_eus-gaap--UseOfEstimates_zJnKghfnrk8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_868_zzkzjTRLzDNf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant areas for which management uses estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revenue recognition,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">asset impairments, including goodwill and other indefinite-lived intangible assets;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales returns and allowances;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inventory;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">estimated lives for tangible and intangible assets;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">income tax valuation allowances; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zC30epJ2yCu" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zkdCJCJVq8te">Segment reporting</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Standards Codification (“ASC”) Topic 280, “<i>Segment Reporting</i>” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in <span id="xdx_907_eus-gaap--NumberOfOperatingSegments_dc_uInteger_c20210101__20211231_zQKAFg4DOct9" title="Number of operating segments">one</span> reportable operating segment in Hong Kong and China.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zz6KWi6EoYkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zW3ImTkfpvL1">Cash and cash equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zh3AW864XWP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zx7reZ0I1Iv1">Accounts receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectibility. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of December 31, 2021 and 2020, there was <span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20211231_z1Q1EdWqL4F" title="Allowance for doubtful accounts"><span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20201231_zpnuI6QKSDm4" title="Allowance for doubtful accounts">no</span></span> allowance for doubtful accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--InventoryPolicyTextBlock_zcCgPqkcNnyi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zD1GPnehp1Fa">Inventories</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of December 31, 2021 and 2020, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zVRhbxhXE87j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zIwlgYqoYEWh">Plant and equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:</span></p> <p id="xdx_895_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zLi1YCGZWWm6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zMNXMOiIrQPa" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Expected useful lives</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Residual value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: justify">Furniture, fixture and equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zxlYRjAstE38" title="Estimated useful lives">3</span> years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_z4U1QZkyZWnf" title="Residual value">5</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Motor vehicle</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MinimumMember_zadibzXqCEg6" title="Estimated useful lives">3.33</span> to <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MaximumMember_zVVHRKhd33vb" title="Estimated useful lives">4</span> years</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zuYhQZw7qPJh" title="Residual value">5</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Leasehold improvement</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z8ky7GNNBz0b" title="Estimated useful lives">2</span> years</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zqBNwmC0IkG1" title="Residual value">5</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zxz22ulNqOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zeDMHJutkdrb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zETFxWGDOGwg">Intangible assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is <span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20210101__20211231_z6MfflP1SgT7" title="Intangible assets amortization period">10</span> years and will expire in 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense for the years ended December 31, 2021 and 2020 was $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231_zVuhBAnKyoMg" title="Amortization expense">521</span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200101__20201231_zL4WVmk6Uiv6" title="Amortization expense">487</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zoumMLsy1ar2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zpT5YUfbvtrg">Impairment of long-lived assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the provisions of ASC Topic 360, “Impairment or Disposal of Long-Lived Assets”, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment charge for the years presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zMrsIA9iIFog" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zUeb1b8kalB">Revenue recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted Accounting Standards Codification (“ASC”) 606 – <i>Revenue from Contracts with Customers</i>” (“ASC 606”). Under ASC 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the contract with a customer;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine the transaction price;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Currently, the Company operates two business segments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Healthcare Business </i><span style="background-color: white">mainly provides health consulting advisory services and </span>healthcare and wellness products to the customers<span style="background-color: white">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of <span id="xdx_90A_ecustom--SalesTaxPercentage_pid_dp_c20210101__20211231_zlw3f4QnDc2k">17</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Wine Business</i> <span style="background-color: white">mainly provides </span>the wine products to the customers<span style="background-color: white">. </span>Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of <span id="xdx_90D_ecustom--SalesTaxPercentage_pid_dp_c20210101__20211231_zMPtPXXW78l3">17</span>% on the invoiced value of sales. The Company recorded product sales returns $<span id="xdx_909_ecustom--ProductSalesReturns_c20210101__20211231_zwssevc8cR6k" title="Product sales returns">148,208</span> and $<span id="xdx_90F_ecustom--ProductSalesReturns_c20200101__20201231_zu4ox9Plkk63">0</span> for the years ended December 31, 2021 and 2020, respectively. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_849_ecustom--DisaggregationOfRevenuePolicyTextBlock_zESHEwcwwcCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zoUBXeGCh59h">Disaggregation of Revenue</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_z0qhngo54Kv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides information about disaggregated revenue from customers into the nature of the products and services and includes a reconciliation of the disaggregated revenue with reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z5MaTwVplzI9" style="display: none">SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20210101__20211231_zVTLNtGlBsI3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Year Ended December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20200101__20201231_zWmRnHFc3gWa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Year Ended December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2020</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zmj99oDdGqBa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Consultancy service fee income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">216,851</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">221,041</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesofHealthcareMember_zr8nV8IdDku7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">31,874</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">481,049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zMxsvY8tqYgi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,392</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">311,051</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zbJhhYnPEhAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">361,116</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,013,141</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zDYoQ0NQtf28" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zPL2dSdZePAh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z4kZYoleZBW7">Income taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position should be measured based on the largest benefit that has a <span id="xdx_90F_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210101__20211231_z7bYYV3kl1B6" title="Income tax likelihood, description">greater than fifty percent (50%) likelihood of being realized upon ultimate settlement</span>. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zzBOGXFkWo81" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zjS28JDrmYNj">Foreign currencies translation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollar (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the People’s Republic of China and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement</i>”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholder’s equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zo6O6Ckt3oP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from HK$ and RMB into US$ have been made at the following exchange rates for the years ended December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Years ended December 31, 2021 and 2020</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zh3N9eDuwJD4" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Year-end HK$:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndHKUSExchangeRateMember_z6QHZuuCOMKe" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12822</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndHKUSExchangeRateMember_zCdlrE4wtTna" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12899</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Annual average HK$:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageHKUSExchangeRateMember_zeFWAwmpwi5c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.12865</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageHKUSExchangeRateMember_zDcl93c3VHwh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.12893</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Year-end RMB:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndRMBUSExchangeRateMember_zK4qOw8h8Gta" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.15742</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndRMBUSExchangeRateMember_zZ1S76A66Hka" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.15307</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Annual average RMB:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageRMBUSExchangeRateMember_z9y8GgMG7xP4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.15507</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageRMBUSExchangeRateMember_zZTgVLvuheNh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.14503</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zlv3LIDp9cf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zAey0v0lqiIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zShzzgRmKyF5">Net loss per share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates net loss per share in accordance with ASC Topic 260, “<i>Earnings per Share.” </i>Basic income per share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zt4BpsBVM4ek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zm8V674Dcbki">Comprehensive income</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying consolidated statements of changes in shareholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--RetirementPlanCostsPolicyTextBlock_zfuHdRswembc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zKq6Ym4g7hmh">Retirement plan costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contributions to retirement plans (which are defined contribution plans) are charged to general and administrative expenses in the accompanying statements of operation as the related employee service are provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_zDNK95Ozhg09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zRVkvMFC1o4d">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company adopts the FASB Accounting Standards Update (“ASU”) 2016-02 “Leases (Topic 842).” for all periods presented.  This standard requires lessees to recognize lease assets (“right of use”) and related lease obligations (“lease liabilities”) on the balance sheet for leases with terms in excess of 12 months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities in the consolidated balance sheets. Finance leases are included in finance lease ROU assets and finance lease liabilities in the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease and finance lease ROU assets and liabilities are recognized at January 1, 2019 based on the present value of lease payments over the lease term discounted using the rate implicit in the lease. In cases where the implicit rate is not readily determinable, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zfzvOHPv0XT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zsOtUL0LimG2">Related parties</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the ASC 850-10, <i>Related Party</i> for the identification of related parties and disclosure of related party transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_z18F5FaKcz6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_z88avKwcInF4">Commitments and contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the ASC 450-20, <i>Commitments</i> to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zPIPvZHuFgy" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zX9wG01xGhsf">Fair value of financial instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and has adopted paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by paragraph 820-10-35-37 of the FASB Accounting Standards Codification are described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</span></p></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</span></p></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing inputs that are generally observable inputs and not corroborated by market data.</span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, approximate their fair values because of the short maturity of these instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zsUzbeJtiLz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zZ5YZMlyzx2">Recent accounting pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the FASB issued ASU 2021-04, <i>Earnings Per Share</i> (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), (“ASU 2021-04”). This ASU reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. This ASU provides guidance for a modification or an exchange of a freestanding equity-classified written call option that is not within the scope of another Topic. It specifically addresses: (1) how an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; (2) how an entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; and (3) how an entity should recognize the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange. This ASU will be effective for all entities for fiscal years beginning after December 15, 2021. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The adoption of ASU 2021-04 on January 1, 2022 did not have a material impact on the Company’s financial statements or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84F_ecustom--BasisOfPresentationAndConsolidationPolicyTextBlock_z8KAMnlgXqgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zt0pUuH7Hfp5">Basis of presentation and consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”). All adjustments considered necessary for a fair presentation have been included. These adjustments consist of normal and recurring accruals, as well as non-recurring charges.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. The results of subsidiaries acquired or disposed of during the periods are included in the consolidated statements of operations from the effective date of acquisition or up to the effective date of disposal.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_846_eus-gaap--UseOfEstimates_zJnKghfnrk8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_868_zzkzjTRLzDNf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant areas for which management uses estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revenue recognition,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">asset impairments, including goodwill and other indefinite-lived intangible assets;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales returns and allowances;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inventory;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">estimated lives for tangible and intangible assets;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">income tax valuation allowances; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zC30epJ2yCu" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zkdCJCJVq8te">Segment reporting</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Standards Codification (“ASC”) Topic 280, “<i>Segment Reporting</i>” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in <span id="xdx_907_eus-gaap--NumberOfOperatingSegments_dc_uInteger_c20210101__20211231_zQKAFg4DOct9" title="Number of operating segments">one</span> reportable operating segment in Hong Kong and China.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zz6KWi6EoYkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zW3ImTkfpvL1">Cash and cash equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zh3AW864XWP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zx7reZ0I1Iv1">Accounts receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectibility. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of December 31, 2021 and 2020, there was <span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20211231_z1Q1EdWqL4F" title="Allowance for doubtful accounts"><span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20201231_zpnuI6QKSDm4" title="Allowance for doubtful accounts">no</span></span> allowance for doubtful accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_84A_eus-gaap--InventoryPolicyTextBlock_zcCgPqkcNnyi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zD1GPnehp1Fa">Inventories</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of December 31, 2021 and 2020, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zVRhbxhXE87j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zIwlgYqoYEWh">Plant and equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:</span></p> <p id="xdx_895_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zLi1YCGZWWm6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zMNXMOiIrQPa" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Expected useful lives</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Residual value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: justify">Furniture, fixture and equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zxlYRjAstE38" title="Estimated useful lives">3</span> years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_z4U1QZkyZWnf" title="Residual value">5</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Motor vehicle</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MinimumMember_zadibzXqCEg6" title="Estimated useful lives">3.33</span> to <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MaximumMember_zVVHRKhd33vb" title="Estimated useful lives">4</span> years</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zuYhQZw7qPJh" title="Residual value">5</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Leasehold improvement</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z8ky7GNNBz0b" title="Estimated useful lives">2</span> years</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zqBNwmC0IkG1" title="Residual value">5</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zxz22ulNqOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zLi1YCGZWWm6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zMNXMOiIrQPa" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Expected useful lives</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Residual value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: justify">Furniture, fixture and equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zxlYRjAstE38" title="Estimated useful lives">3</span> years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_z4U1QZkyZWnf" title="Residual value">5</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Motor vehicle</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MinimumMember_zadibzXqCEg6" title="Estimated useful lives">3.33</span> to <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MaximumMember_zVVHRKhd33vb" title="Estimated useful lives">4</span> years</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zuYhQZw7qPJh" title="Residual value">5</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Leasehold improvement</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z8ky7GNNBz0b" title="Estimated useful lives">2</span> years</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zqBNwmC0IkG1" title="Residual value">5</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> P3Y 0.05 P3Y3M29D P4Y 0.05 P2Y 0.05 <p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zeDMHJutkdrb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zETFxWGDOGwg">Intangible assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is <span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20210101__20211231_z6MfflP1SgT7" title="Intangible assets amortization period">10</span> years and will expire in 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense for the years ended December 31, 2021 and 2020 was $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231_zVuhBAnKyoMg" title="Amortization expense">521</span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200101__20201231_zL4WVmk6Uiv6" title="Amortization expense">487</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P10Y 521 487 <p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zoumMLsy1ar2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zpT5YUfbvtrg">Impairment of long-lived assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the provisions of ASC Topic 360, “Impairment or Disposal of Long-Lived Assets”, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment charge for the years presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zMrsIA9iIFog" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zUeb1b8kalB">Revenue recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted Accounting Standards Codification (“ASC”) 606 – <i>Revenue from Contracts with Customers</i>” (“ASC 606”). Under ASC 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the contract with a customer;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine the transaction price;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Currently, the Company operates two business segments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Healthcare Business </i><span style="background-color: white">mainly provides health consulting advisory services and </span>healthcare and wellness products to the customers<span style="background-color: white">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of <span id="xdx_90A_ecustom--SalesTaxPercentage_pid_dp_c20210101__20211231_zlw3f4QnDc2k">17</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Wine Business</i> <span style="background-color: white">mainly provides </span>the wine products to the customers<span style="background-color: white">. </span>Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of <span id="xdx_90D_ecustom--SalesTaxPercentage_pid_dp_c20210101__20211231_zMPtPXXW78l3">17</span>% on the invoiced value of sales. The Company recorded product sales returns $<span id="xdx_909_ecustom--ProductSalesReturns_c20210101__20211231_zwssevc8cR6k" title="Product sales returns">148,208</span> and $<span id="xdx_90F_ecustom--ProductSalesReturns_c20200101__20201231_zu4ox9Plkk63">0</span> for the years ended December 31, 2021 and 2020, respectively. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 0.17 0.17 148208 0 <p id="xdx_849_ecustom--DisaggregationOfRevenuePolicyTextBlock_zESHEwcwwcCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zoUBXeGCh59h">Disaggregation of Revenue</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_z0qhngo54Kv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides information about disaggregated revenue from customers into the nature of the products and services and includes a reconciliation of the disaggregated revenue with reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z5MaTwVplzI9" style="display: none">SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20210101__20211231_zVTLNtGlBsI3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Year Ended December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20200101__20201231_zWmRnHFc3gWa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Year Ended December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2020</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zmj99oDdGqBa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Consultancy service fee income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">216,851</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">221,041</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesofHealthcareMember_zr8nV8IdDku7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">31,874</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">481,049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zMxsvY8tqYgi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,392</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">311,051</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zbJhhYnPEhAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">361,116</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,013,141</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zDYoQ0NQtf28" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_z0qhngo54Kv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides information about disaggregated revenue from customers into the nature of the products and services and includes a reconciliation of the disaggregated revenue with reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z5MaTwVplzI9" style="display: none">SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20210101__20211231_zVTLNtGlBsI3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Year Ended December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20200101__20201231_zWmRnHFc3gWa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Year Ended December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2020</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zmj99oDdGqBa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Consultancy service fee income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">216,851</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">221,041</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesofHealthcareMember_zr8nV8IdDku7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">31,874</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">481,049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zMxsvY8tqYgi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,392</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">311,051</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zbJhhYnPEhAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">361,116</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,013,141</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 216851 221041 31874 481049 112392 311051 361116 1013141 <p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zPL2dSdZePAh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z4kZYoleZBW7">Income taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position should be measured based on the largest benefit that has a <span id="xdx_90F_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210101__20211231_z7bYYV3kl1B6" title="Income tax likelihood, description">greater than fifty percent (50%) likelihood of being realized upon ultimate settlement</span>. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> greater than fifty percent (50%) likelihood of being realized upon ultimate settlement <p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zzBOGXFkWo81" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zjS28JDrmYNj">Foreign currencies translation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollar (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the People’s Republic of China and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement</i>”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholder’s equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zo6O6Ckt3oP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from HK$ and RMB into US$ have been made at the following exchange rates for the years ended December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Years ended December 31, 2021 and 2020</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zh3N9eDuwJD4" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Year-end HK$:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndHKUSExchangeRateMember_z6QHZuuCOMKe" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12822</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndHKUSExchangeRateMember_zCdlrE4wtTna" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12899</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Annual average HK$:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageHKUSExchangeRateMember_zeFWAwmpwi5c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.12865</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageHKUSExchangeRateMember_zDcl93c3VHwh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.12893</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Year-end RMB:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndRMBUSExchangeRateMember_zK4qOw8h8Gta" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.15742</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndRMBUSExchangeRateMember_zZ1S76A66Hka" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.15307</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Annual average RMB:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageRMBUSExchangeRateMember_z9y8GgMG7xP4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.15507</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageRMBUSExchangeRateMember_zZTgVLvuheNh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.14503</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zlv3LIDp9cf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zo6O6Ckt3oP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from HK$ and RMB into US$ have been made at the following exchange rates for the years ended December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Years ended December 31, 2021 and 2020</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zh3N9eDuwJD4" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Year-end HK$:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndHKUSExchangeRateMember_z6QHZuuCOMKe" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12822</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndHKUSExchangeRateMember_zCdlrE4wtTna" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12899</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Annual average HK$:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageHKUSExchangeRateMember_zeFWAwmpwi5c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.12865</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageHKUSExchangeRateMember_zDcl93c3VHwh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.12893</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Year-end RMB:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndRMBUSExchangeRateMember_zK4qOw8h8Gta" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.15742</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--YearEndRMBUSExchangeRateMember_zZ1S76A66Hka" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.15307</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Annual average RMB:US$ exchange rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageRMBUSExchangeRateMember_z9y8GgMG7xP4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.15507</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--AnnualAverageRMBUSExchangeRateMember_zZTgVLvuheNh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation exchange rates">0.14503</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> 0.12822 0.12899 0.12865 0.12893 0.15742 0.15307 0.15507 0.14503 <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zAey0v0lqiIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zShzzgRmKyF5">Net loss per share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates net loss per share in accordance with ASC Topic 260, “<i>Earnings per Share.” </i>Basic income per share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zt4BpsBVM4ek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zm8V674Dcbki">Comprehensive income</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying consolidated statements of changes in shareholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--RetirementPlanCostsPolicyTextBlock_zfuHdRswembc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zKq6Ym4g7hmh">Retirement plan costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contributions to retirement plans (which are defined contribution plans) are charged to general and administrative expenses in the accompanying statements of operation as the related employee service are provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_zDNK95Ozhg09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zRVkvMFC1o4d">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company adopts the FASB Accounting Standards Update (“ASU”) 2016-02 “Leases (Topic 842).” for all periods presented.  This standard requires lessees to recognize lease assets (“right of use”) and related lease obligations (“lease liabilities”) on the balance sheet for leases with terms in excess of 12 months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities in the consolidated balance sheets. Finance leases are included in finance lease ROU assets and finance lease liabilities in the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease and finance lease ROU assets and liabilities are recognized at January 1, 2019 based on the present value of lease payments over the lease term discounted using the rate implicit in the lease. In cases where the implicit rate is not readily determinable, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zfzvOHPv0XT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zsOtUL0LimG2">Related parties</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the ASC 850-10, <i>Related Party</i> for the identification of related parties and disclosure of related party transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_z18F5FaKcz6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_z88avKwcInF4">Commitments and contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the ASC 450-20, <i>Commitments</i> to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zPIPvZHuFgy" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zX9wG01xGhsf">Fair value of financial instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and has adopted paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, paragraph 820-10-35-37 of the FASB Accounting Standards Codification establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by paragraph 820-10-35-37 of the FASB Accounting Standards Codification are described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</span></p></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</span></p></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing inputs that are generally observable inputs and not corroborated by market data.</span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, approximate their fair values because of the short maturity of these instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zsUzbeJtiLz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zZ5YZMlyzx2">Recent accounting pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the FASB issued ASU 2021-04, <i>Earnings Per Share</i> (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), (“ASU 2021-04”). This ASU reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. This ASU provides guidance for a modification or an exchange of a freestanding equity-classified written call option that is not within the scope of another Topic. It specifically addresses: (1) how an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; (2) how an entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange; and (3) how an entity should recognize the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange. This ASU will be effective for all entities for fiscal years beginning after December 15, 2021. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The adoption of ASU 2021-04 on January 1, 2022 did not have a material impact on the Company’s financial statements or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_80E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zcxnPvNOcuM4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3: <span id="xdx_82F_zQP3BwVLxsR9">LIQUIDITY AND CAPITAL RESOURCES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our cash balance on December 31, 2021, was $<span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_z5vrAkV4W5Rg" title="Cash">609,434</span>, as compared to $<span id="xdx_90D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20201231_zWAvwDsCr9o8" title="Cash">1,006,394</span> on December 31, 2021, it was decreased by $<span id="xdx_900_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iN_di_c20210101__20211231_zYTrLka0Edl3" title="Net cash">396,960</span>. We had an accumulated deficit of $<span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20211231_zCh3IK6vshP7" title="Accumulated Deficit">918,195</span>. We believe that our cash and investments will be sufficient to fund our planned operations for at least one year past the issuance date of the consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial support from its major shareholders. Management believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite the amount of funds that the Company has raised, no assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its shareholders, in the case of equity financing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 609434 1006394 -396960 -918195 <p id="xdx_80F_eus-gaap--SegmentReportingDisclosureTextBlock_z6M2MDVWgEu1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4: <span id="xdx_82C_zpZ0b5Koj8v">SEGMENT REPORTING</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Currently, the Company has two reportable business segments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Healthcare Segment, mainly provides health consulting advisory services and healthcare and wellness products to the customers; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Wine Segment, mainly provides the wine products to the customers.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zDZkW01jnGp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the following table, revenue is disaggregated by primary major product line, and timing of revenue recognition. The table also includes a reconciliation of the disaggregated revenue with the reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zl8inwHJNZ9j" style="display: none">SUMMARY OF RECONCILIATION OF DISAGGREGATED REVENUE WITH THE REPORTABLE SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zJxmvTXzVvLc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Healthcare</p> <p style="margin-top: 0; margin-bottom: 0">Segment</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_z3OYU91dvljj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20210101__20211231_zlcv8IQsEYS5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Healthcare</p> <p style="margin-top: 0; margin-bottom: 0">Segment</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultingServiceIncomeMember_zVInzuDcKZ08" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Consulting service income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">216,850</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0543">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">216,850</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleofHealthcareProductsMember_zRmsVImal5Sg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">39,996</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0547">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">39,996</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember__srt--ConsolidationItemsAxis__us-gaap--MaterialReconcilingItemsMember_zNg9rTA9Wva8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0550">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">104,270</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">104,270</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">256,846</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">104,270</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">361,116</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -8.1pt; padding-left: 8.1pt">Cost of sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--ConsultingServiceIncomeMember_zNGlL0gA90Na" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(31,315</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0559">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(31,315</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleofHealthcareProductsMember_zhnqPYrDeNJf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Sale of healthcare products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(32,064</td><td style="text-align: left">) </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0563">–</span></td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(32,064</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zRrPR6ISku59" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0566">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(58,311</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(58,311</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--CostOfRevenue_iN_pp0p0_di_zoIsOsSJIlXj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(63,379</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(58,311</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(121,690</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_pp0p0_znhzLTvNQkUg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193,467</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,959</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">239,426</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Operating Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--SellingAndMarketingExpense_i01N_pp0p0_di_zG8FlTJZZDN7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0582">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,076</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,076</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--GeneralAndAdministrativeExpense_i01N_pp0p0_di_zCPVsSfFlgg2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(690,780</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(690,780</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--OperatingExpenses_i01N_pp0p0_di_zuM7CGmmRfph" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(690,780</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,076</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(695,856</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -8.1pt; padding-left: 8.1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingIncomeLoss_iC_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Segment (loss) income</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(497,313</td><td style="padding-bottom: 2.5pt; text-align: left">) </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">40,883</td><td style="padding-bottom: 2.5pt; text-align: left"/><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(456,430</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zVZHGO4ElRMc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Healthcare</p> <p style="margin-top: 0; margin-bottom: 0">Segment</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_z2zCgK5u1hze" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20200101__20201231_zCvS487ZgCh3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Healthcare Segment</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine<br/> Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultingServiceIncomeMember_z6xvl8Xlr9ka" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Consulting service income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">221,041</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0599">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">221,041</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleofHealthcareProductsMember_zQWs8737Dog6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">564,814</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0603">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">564,814</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember__srt--ConsolidationItemsAxis__us-gaap--MaterialReconcilingItemsMember_zeq9nGHWJAm7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0606">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">227,286 </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">227,286</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zA2V30BG0nC4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">785,855</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">227,286</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,013,141</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cost of sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--ConsultingServiceIncomeMember_z9IvF1hTtAj7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0614">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0615">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"/><td style="text-align: left"/></tr> <tr id="xdx_40E_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleofHealthcareProductsMember_z6u5QiCBcuj5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of healthcare products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(395,392</td><td style="text-align: left">) </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0619">–</span></td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(395,392</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zHu0sOrleuki" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0622">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(201,138</td><td style="padding-bottom: 1.5pt; text-align: left">) </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(201,138</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--CostOfRevenue_iN_pp0p0_di_zMzbl7xLuzDc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(395,392</td><td style="padding-bottom: 1.5pt; text-align: left">) </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(201,138</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(596,530</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--GrossProfit_pp0p0_zuClddMByLR8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">390,463</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,148</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">416,611</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB_zd6Hg3HzOjX6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01N_pp0p0_di_z6itlEiQtlhf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0638">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(158,432</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(158,432</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--GeneralAndAdministrativeExpense_i01N_pp0p0_di_zKuRcsAqkMfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(728,994</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0643">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(728,994</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--OperatingExpenses_i01N_pp0p0_di_zKzNCrMCRddd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(728,994</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(158,432</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(887,426</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingIncomeLoss_pp0p0_zgjUMxmFGXFg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Segment loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(338,531</td><td style="padding-bottom: 2.5pt; text-align: left">) </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(132,284</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(470,815</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_zblhuq7C1HId" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zOgDBfuhQFWf" style="display: none">SUMMARY OF GEOGRAPHIC SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231_z8s5Qg9WnI83" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20200101__20201231_zHtiuCokmv0g" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Years ended December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_z6ITt6cGIIpa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Hong Kong</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">216,851</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">221,041</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zqlMbKPy5w56" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">China</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">144,265</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">792,100</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zj04SStbrPcj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">361,116</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,013,141</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_8A8_zwNonh36Yikd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zDZkW01jnGp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the following table, revenue is disaggregated by primary major product line, and timing of revenue recognition. The table also includes a reconciliation of the disaggregated revenue with the reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zl8inwHJNZ9j" style="display: none">SUMMARY OF RECONCILIATION OF DISAGGREGATED REVENUE WITH THE REPORTABLE SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zJxmvTXzVvLc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Healthcare</p> <p style="margin-top: 0; margin-bottom: 0">Segment</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_z3OYU91dvljj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20210101__20211231_zlcv8IQsEYS5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Healthcare</p> <p style="margin-top: 0; margin-bottom: 0">Segment</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultingServiceIncomeMember_zVInzuDcKZ08" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Consulting service income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">216,850</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0543">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">216,850</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleofHealthcareProductsMember_zRmsVImal5Sg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">39,996</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0547">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">39,996</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember__srt--ConsolidationItemsAxis__us-gaap--MaterialReconcilingItemsMember_zNg9rTA9Wva8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0550">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">104,270</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">104,270</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">256,846</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">104,270</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">361,116</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -8.1pt; padding-left: 8.1pt">Cost of sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--ConsultingServiceIncomeMember_zNGlL0gA90Na" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(31,315</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0559">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(31,315</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleofHealthcareProductsMember_zhnqPYrDeNJf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Sale of healthcare products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(32,064</td><td style="text-align: left">) </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0563">–</span></td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(32,064</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zRrPR6ISku59" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0566">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(58,311</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(58,311</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--CostOfRevenue_iN_pp0p0_di_zoIsOsSJIlXj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(63,379</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(58,311</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(121,690</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_pp0p0_znhzLTvNQkUg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193,467</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,959</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">239,426</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Operating Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--SellingAndMarketingExpense_i01N_pp0p0_di_zG8FlTJZZDN7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0582">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,076</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,076</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--GeneralAndAdministrativeExpense_i01N_pp0p0_di_zCPVsSfFlgg2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(690,780</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(690,780</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--OperatingExpenses_i01N_pp0p0_di_zuM7CGmmRfph" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(690,780</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,076</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(695,856</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -8.1pt; padding-left: 8.1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingIncomeLoss_iC_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Segment (loss) income</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(497,313</td><td style="padding-bottom: 2.5pt; text-align: left">) </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">40,883</td><td style="padding-bottom: 2.5pt; text-align: left"/><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(456,430</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zVZHGO4ElRMc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Healthcare</p> <p style="margin-top: 0; margin-bottom: 0">Segment</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_z2zCgK5u1hze" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20200101__20201231_zCvS487ZgCh3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Healthcare Segment</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine<br/> Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultingServiceIncomeMember_z6xvl8Xlr9ka" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Consulting service income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">221,041</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0599">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">221,041</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleofHealthcareProductsMember_zQWs8737Dog6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">564,814</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0603">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">564,814</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember__srt--ConsolidationItemsAxis__us-gaap--MaterialReconcilingItemsMember_zeq9nGHWJAm7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0606">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">227,286 </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">227,286</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zA2V30BG0nC4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">785,855</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">227,286</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,013,141</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cost of sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--ConsultingServiceIncomeMember_z9IvF1hTtAj7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0614">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0615">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"/><td style="text-align: left"/></tr> <tr id="xdx_40E_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleofHealthcareProductsMember_z6u5QiCBcuj5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of healthcare products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(395,392</td><td style="text-align: left">) </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0619">–</span></td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(395,392</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zHu0sOrleuki" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Sale of wine products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0622">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(201,138</td><td style="padding-bottom: 1.5pt; text-align: left">) </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(201,138</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--CostOfRevenue_iN_pp0p0_di_zMzbl7xLuzDc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(395,392</td><td style="padding-bottom: 1.5pt; text-align: left">) </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(201,138</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(596,530</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--GrossProfit_pp0p0_zuClddMByLR8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">390,463</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,148</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">416,611</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB_zd6Hg3HzOjX6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01N_pp0p0_di_z6itlEiQtlhf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0638">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(158,432</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(158,432</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--GeneralAndAdministrativeExpense_i01N_pp0p0_di_zKuRcsAqkMfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(728,994</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0643">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(728,994</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--OperatingExpenses_i01N_pp0p0_di_zKzNCrMCRddd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(728,994</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(158,432</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(887,426</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingIncomeLoss_pp0p0_zgjUMxmFGXFg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Segment loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(338,531</td><td style="padding-bottom: 2.5pt; text-align: left">) </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(132,284</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(470,815</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_zblhuq7C1HId" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zOgDBfuhQFWf" style="display: none">SUMMARY OF GEOGRAPHIC SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231_z8s5Qg9WnI83" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20200101__20201231_zHtiuCokmv0g" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Years ended December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_z6ITt6cGIIpa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Hong Kong</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">216,851</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">221,041</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zqlMbKPy5w56" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">China</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">144,265</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">792,100</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zj04SStbrPcj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">361,116</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,013,141</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 216850 216850 39996 39996 104270 104270 256846 104270 361116 31315 31315 32064 32064 58311 58311 63379 58311 121690 193467 45959 239426 5076 5076 690780 690780 690780 5076 695856 -497313 40883 -456430 221041 221041 564814 564814 227286 227286 785855 227286 1013141 395392 395392 201138 201138 395392 201138 596530 390463 26148 416611 158432 158432 728994 728994 728994 158432 887426 -338531 -132284 -470815 <p id="xdx_893_eus-gaap--ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_zblhuq7C1HId" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zOgDBfuhQFWf" style="display: none">SUMMARY OF GEOGRAPHIC SEGMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231_z8s5Qg9WnI83" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20200101__20201231_zHtiuCokmv0g" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Years ended December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_z6ITt6cGIIpa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Hong Kong</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">216,851</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">221,041</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zqlMbKPy5w56" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">China</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">144,265</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">792,100</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zj04SStbrPcj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">361,116</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,013,141</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 216851 221041 144265 792100 361116 1013141 <p id="xdx_806_ecustom--PrepaymentsAndOtherReceivableTextBlock_zIA8xulwGaIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5:</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_82F_z9eVenTQ57eh">PREPAYMENTS AND OTHER RECEIVABLES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--ScheduleOfPrepaymentsAndOtherReceivableTableTextBlock_z1lZEW6j62y5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments and other receivable consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zzWybt0KIRt9" style="display: none">SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20211231_zcq1rmXaFrnl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20201231_zujBbHvLZ8Vc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzA5r_z6YGtViT74tj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Prepayments</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,077</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">7,712</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--OtherDepositsCurrent_iI_pp0p0_maPEAOAzA5r_zmkeyHE9Ozkb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other deposits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0672">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">119</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--RentalDeposits_iI_pp0p0_maPEAOAzA5r_zemGD1QCulS9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Rental deposits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33,961</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherReceivablesNetCurrent_iI_pp0p0_maPEAOAzA5r_zzvktjU2TCea" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Other receivables</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">102,216</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">113,670</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PrepaidExpenseAndOtherAssets_iTI_pp0p0_mtPEAOAzA5r_zIDGYimKGqV8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments and other receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">139,254</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">121,501</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zuimuTCUVqLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase deposits represented deposit payments made to vendors for procurement, which are interest-free, unsecured and relieved against accounts payable when goods are received by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--ScheduleOfPrepaymentsAndOtherReceivableTableTextBlock_z1lZEW6j62y5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments and other receivable consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zzWybt0KIRt9" style="display: none">SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20211231_zcq1rmXaFrnl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20201231_zujBbHvLZ8Vc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzA5r_z6YGtViT74tj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Prepayments</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,077</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">7,712</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--OtherDepositsCurrent_iI_pp0p0_maPEAOAzA5r_zmkeyHE9Ozkb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other deposits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0672">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">119</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--RentalDeposits_iI_pp0p0_maPEAOAzA5r_zemGD1QCulS9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Rental deposits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33,961</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherReceivablesNetCurrent_iI_pp0p0_maPEAOAzA5r_zzvktjU2TCea" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Other receivables</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">102,216</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">113,670</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PrepaidExpenseAndOtherAssets_iTI_pp0p0_mtPEAOAzA5r_zIDGYimKGqV8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments and other receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">139,254</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">121,501</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3077 7712 119 33961 102216 113670 139254 121501 <p id="xdx_809_eus-gaap--InventoryDisclosureTextBlock_zyM0s4fYQoD1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6: <span id="xdx_82E_zJC5iG5o2u1b">INVENTORIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z15lpYKa7Vm6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zxS05nWQccK6" style="display: none">SCHEDULE OF INVENTORIES</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20211231_z1HlffzQ4xQ7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20201231_zMiI975e9Cjb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pp0p0_maINzYFf_zU421XtFLg9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Packing materials</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0688">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">21,527</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_pp0p0_maINzYFf_zxvqZOUahyJl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">327,551</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">184,745</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryNet_iTI_pp0p0_mtINzYFf_zHk7mYWP8VFl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">327,551</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">206,272</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_ziDRz8Lhlsp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, <span id="xdx_904_ecustom--AllowanceForObsoleteInventories_pp0p0_do_c20210101__20211231_zfnOyUkWE5C9" title="Allowance for obsolete inventories"><span id="xdx_90A_ecustom--AllowanceForObsoleteInventories_pp0p0_do_c20200101__20201231_zaqDqcLhwKqi" title="Allowance for obsolete inventories">no</span></span> allowance for obsolete inventories was recorded by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z15lpYKa7Vm6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zxS05nWQccK6" style="display: none">SCHEDULE OF INVENTORIES</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20211231_z1HlffzQ4xQ7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20201231_zMiI975e9Cjb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pp0p0_maINzYFf_zU421XtFLg9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Packing materials</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0688">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">21,527</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_pp0p0_maINzYFf_zxvqZOUahyJl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">327,551</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">184,745</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryNet_iTI_pp0p0_mtINzYFf_zHk7mYWP8VFl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">327,551</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">206,272</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 21527 327551 184745 327551 206272 0 0 <p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z7p2YYUi8Pta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7: <span id="xdx_825_zLURD03JD79h">PLANT AND EQUIPMENT</span></b></span></p> <p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zO3H5jgSBRjh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zV4lLCpKeWu5" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20211231_zo1Qbis2h5G4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20201231_zWs1tL7S7vLh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehicleMember_zxFwLVshaI4b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Motor vehicle</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">311,343</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">311,343</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zaiqa4Q8RnHb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Furniture, fixture and equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,465</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,465</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zbOQR6TAN987" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Leasehold improvement</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,358</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0712">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ForeignTranslationDifferenceMember_zcRJWULdCTTk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Foreign translation difference, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17,603</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10,471</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzr2C_zZxltJ6a6Jhc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment, gross</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">371,769</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">337,279</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzr2C_zRTfjezKV4ij" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Less: accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(228,507</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(137,546</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--ForeignTranslationDifferenceNet_iNI_pp0p0_di_msPPAENzr2C_zKGZhCZnM6Qj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Foreign translation difference, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(10,658</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,112</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzr2C_zQA4aAvB9tIi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Plant and equipment. net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">132,604</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">193,621</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zygVmJMRjJcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the years ended December 31, 2021 and 2020 were $<span id="xdx_900_eus-gaap--Depreciation_pp0p0_c20210101__20211231_z9p7DiI873Z5" title="Depreciation expense">90,961</span> and $<span id="xdx_90A_eus-gaap--Depreciation_pp0p0_c20200101__20201231_zu6NBmGtqDR8" title="Depreciation expense">71,472</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zO3H5jgSBRjh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zV4lLCpKeWu5" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20211231_zo1Qbis2h5G4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20201231_zWs1tL7S7vLh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehicleMember_zxFwLVshaI4b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Motor vehicle</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">311,343</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">311,343</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zaiqa4Q8RnHb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Furniture, fixture and equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,465</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,465</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zbOQR6TAN987" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Leasehold improvement</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,358</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0712">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ForeignTranslationDifferenceMember_zcRJWULdCTTk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Foreign translation difference, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17,603</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10,471</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzr2C_zZxltJ6a6Jhc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment, gross</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">371,769</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">337,279</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzr2C_zRTfjezKV4ij" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Less: accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(228,507</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(137,546</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--ForeignTranslationDifferenceNet_iNI_pp0p0_di_msPPAENzr2C_zKGZhCZnM6Qj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Foreign translation difference, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(10,658</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,112</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzr2C_zQA4aAvB9tIi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Plant and equipment. net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">132,604</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">193,621</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 311343 311343 15465 15465 27358 17603 10471 371769 337279 228507 137546 10658 6112 132604 193621 90961 71472 <p id="xdx_806_ecustom--CustomerDepositsTextBlock_zG4pUfyNxoQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt; text-align: justify; text-indent: -65.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8: <span id="xdx_82F_zWEmggGJ6god">CUSTOMER DEPOSITS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits represented cash paid to the Company from the customers, for which the Company has an obligation to deliver the orders to satisfy with the customers, or to return the funds, within twelve months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 and 2020, the deposit received from customers was $<span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pp0p0_c20211231_zK1vKp8RVmA7" title="Deposit received from customers">340,783</span> and $<span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pp0p0_c20201231_zn4tJIEk3AE6" title="Deposit received from customers">409,924</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 340783 409924 <p id="xdx_80E_ecustom--AmountsDueToDirectorAndRelatedCompanyTextBlock_zJJGTlkuONC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9: <span id="xdx_82E_zBdttFcXLOC7">AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts represented temporary advances to the Company by its director and its related company which were unsecured, interest-free and have no fixed terms of repayments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_zC7T8HQZTl04" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10: <span id="xdx_827_zw1xTJ4vXxEd">LEASE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90E_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231_zqstZSs5F8M9" title="Operaitng lease, description">The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of <span id="xdx_90D_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20211231__srt--RangeAxis__srt--MinimumMember_za6dU0LhopZc" title="Lease term">2</span> to <span id="xdx_909_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember_zAHDSTAVk4Vd" title="Lease term">4</span> year, through <span id="xdx_908_eus-gaap--LeaseExpirationDate1_dd_c20210101__20211231_zlKInzoC07f8" title="Lease expiration date">December 31, 2025</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_896_ecustom--ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock_zQbjhNn3pr2a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Right of use assets and lease liability – right of use are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span id="xdx_8B5_zijl7BNuAHA3" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20211231_zHRXxUekhVlh" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20201231_z0TmhwtI7Mve" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2020</p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_401_ecustom--OperatingLeaseRightOfUseAssetCurrent_iI_pp0p0_zJqp9w8tlcW3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: justify; padding-bottom: 2.5pt">Right-of-use assets</td><td style="width: 2%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; font-size: 10pt; text-align: right">350,563</td><td style="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0754">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The lease liability – right of use is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20211231_zzadaW0BoGCl" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20201231_z7cUMArXWKKf" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2020</p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maOLLzxG3_zWW0MeUsxhw1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Current portion</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">114,132</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0757">-</span></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_maOLLzxG3_zqEfduKHn7Zf" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Non-current portion</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">246,022</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzxG3_zV0bVgn3nEF1" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">360,154</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0763">-</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zrlVJIFoF8g5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of 2 to 4 year, through December 31, 2025. P2Y P4Y 2025-12-31 <p id="xdx_896_ecustom--ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock_zQbjhNn3pr2a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Right of use assets and lease liability – right of use are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span id="xdx_8B5_zijl7BNuAHA3" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20211231_zHRXxUekhVlh" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20201231_z0TmhwtI7Mve" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2020</p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_401_ecustom--OperatingLeaseRightOfUseAssetCurrent_iI_pp0p0_zJqp9w8tlcW3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: justify; padding-bottom: 2.5pt">Right-of-use assets</td><td style="width: 2%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; font-size: 10pt; text-align: right">350,563</td><td style="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0754">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The lease liability – right of use is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20211231_zzadaW0BoGCl" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20201231_z7cUMArXWKKf" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2020</p></td><td style="padding-bottom: 1.5pt; font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maOLLzxG3_zWW0MeUsxhw1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Current portion</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">114,132</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0757">-</span></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_maOLLzxG3_zqEfduKHn7Zf" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Non-current portion</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">246,022</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzxG3_zV0bVgn3nEF1" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">360,154</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0763">-</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> 350563 114132 246022 360154 <p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zf6DQ9b37oj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11:</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_824_zmgYCvsU0LFc">SHAREHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common Stock</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is authorized, subject to limitations prescribed by Delaware law, to issue up to <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211231_z0ZcYj3p9Fi3" title="Common stock, shares authorized">100,000,000</span> shares of common stock with a nominal par value of $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211231_zezw7ViJG1Ld" title="Common stock, par value">0.0001</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend Rights</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and only then at the times and in the amounts that our board of directors may determine.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting Rights</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Under our Certificate of Incorporation, stockholders do not have the right to cumulate votes for the election of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No Preemptive or Similar Rights</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our common stock is not entitled to preemptive rights and is not subject to conversion, redemption or sinking fund provisions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Right to Receive Liquidation Distributions</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon our dissolution, liquidation or winding-up, the assets legally available for distribution to our stockholders are distributable ratably among the holders of our common stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding shares of preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 9, 2020, the Company consummated the Share Exchange Agreement (“the “Share Exchange Agreement”) with Elite Creation Group Limited, a private limited company organized under the laws of British Virgin Islands (“ECGL”), and the shareholders of ECGL. Pursuant to the Share Exchange Agreement, we purchased Fifty Thousand (<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200708__20200709__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--EliteCreationGroupLimitedMember_zxcUGNgdfcNk" title="Number of purchase of shares">50,000</span>) shares of ECGL (the “ECGL Shares”), representing all of the issued and outstanding shares of common stock of ECGL. As consideration, the Company agreed to issue to the shareholders of ECGL Fifteen Million (<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200708__20200709__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--EliteCreationGroupLimitedMember_z3uvTaIZzlRk" title="Number of shares issued">15,000,000</span>) shares of its common stock, at a value of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20200709__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--EliteCreationGroupLimitedMember_zJuLkjXSNZU4" title="Share price per share">0.32</span> per share, for an aggregate value of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200708__20200709__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--EliteCreationGroupLimitedMember_zKpyNotsK8Nk" title="Aggregate fair value of shares issued">4,800,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 and 2020, a total of <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zspsp2RoVrY4" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_c20201231__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zb8D3sfC4bc6" title="Common stock, shares issued">20,252,309</span></span> outstanding shares of common stock were issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred Stock</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is not currently authorized to issue shares of preferred stock. The Certificate of Incorporation however, allows the board of directors to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the common stock in the event that shares of preferred stock are authorized in the future. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and may adversely affect the market price of our common stock and the voting and other rights of the holders of common stock. The Company has no current plans to issue any shares of preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 100000000 0.0001 50000 15000000 0.32 4800000 20252309 20252309 <p id="xdx_807_eus-gaap--EarningsPerShareTextBlock_zhEDY9WWYph8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12: <span id="xdx_82C_zkgSHT6MQpn3">NET LOSS PER SHARE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net loss per share is computed using the weighted average number of common shares outstanding during the year. The dilutive effect of potential common shares outstanding is included in diluted net loss per share. The following table sets forth the computation of basic and diluted net loss per share for the years ended December 31, 2021 and 2020:</span></p> <p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z9AqmC0F1fR5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zKQ2dWjhmLAg" style="display: none">SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210101__20211231_z46CKDJTaaE7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20200101__20201231_zOOfudGJDuWl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zOvNVQMfEO42" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-bottom: 2.5pt">Net loss attributable to common shareholders</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(455,409</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(469,476</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zAQj3lnR93b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted average common shares outstanding – Basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">20,252,309</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">17,525,701</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasic_zMmRohYAnYGj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss per share – Basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.02</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.03</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A0_zDJQrnrotOS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 25.7pt; text-align: justify; text-indent: -25.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, diluted weighted-average common shares outstanding is equal to basic weighted-average common shares, due to the Company’s net loss position. Hence, no common stock equivalents were included in the computation of diluted net loss per share since such inclusion would have been antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z9AqmC0F1fR5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zKQ2dWjhmLAg" style="display: none">SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210101__20211231_z46CKDJTaaE7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20200101__20201231_zOOfudGJDuWl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zOvNVQMfEO42" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-bottom: 2.5pt">Net loss attributable to common shareholders</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(455,409</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(469,476</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zAQj3lnR93b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted average common shares outstanding – Basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">20,252,309</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">17,525,701</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasic_zMmRohYAnYGj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss per share – Basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.02</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.03</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -455409 -469476 20252309 17525701 -0.02 -0.03 <p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zYAXQzL5enJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13: <span id="xdx_82F_zC5O5kyqSLMh">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zRc6LoVeiiik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BA_zT9dfm6TWwxb" style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20210101__20211231_zpSra4tGmKf1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20200101__20201231_zDIZtsLcQ3fk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_403_eus-gaap--CurrentIncomeTaxExpenseBenefit_maITEBzcov_zyWPzSZLQ0B2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Current tax</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">6,671</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">8,215</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredIncomeTaxExpenseBenefit_maITEBzcov_zfN9YR8k77Bg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Deferred tax</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0803">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzcov_zuJQ7iiVEv2f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Income tax expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,671</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8,215</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zvNdI5594Csk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effective tax rate in the years presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rate. The Company operates in various countries: United States of America, Hong Kong and the PRC that are subject to taxes in the jurisdictions in which they operate, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United States of America</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFOO is registered in the State of Delaware and is subject to US federal corporate income tax. The U.S. Tax Cuts and Jobs Act (the “Tax Reform Act”) was signed into law. <span id="xdx_902_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231_zQRd2yEK7fW3" title="Income tax description">The Tax Reform Act significantly revised the U.S. corporate income tax regime by, among other things, lowering the U.S. corporate tax rate from 35% to <span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231_z01MUqBzdrK9" title="Corporate tax rate">21</span>% effective January 1, 2018. The Company’s policy is to recognize accrued interest and penalties related to unrecognized tax benefits in its income tax provision. The Company has not accrued or paid interest or penalties which were not material to its results of operations for the years presented</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, the Company did not have any interest and penalties associated with tax positions. As of December 31, 2021 and 2020, the Company has not accrued any penalties on uncertain tax positions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, the operation in the United States incurred $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_c20211231_zJoPZ4gYpBYl" title="umulative net operating losses">173,076</span> of cumulative net operating losses which can be carried forward to offset future taxable income. <span id="xdx_90B_ecustom--NetOperatingLossCarryforwardsExpiration_c20210101__20211231_zM3yuDtl3t3e" title="Net operating loss carryforwards expiration">The net operating loss carryforwards begin to expire in 2041, if unutilized.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>BVI</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the current BVI law, the Company is not subject to tax on income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hong Kong</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231__srt--StatementGeographicalAxis__country--HK_zpkLGE5zOHqa" title="Income tax description">The Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25% to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax year</span>. The reconciliation of income tax rate to the effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:</span></p> <p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_hsrt--StatementGeographicalAxis__country--HK_z0cWQHvXpPoa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B9_zH3FAAPzjCa3" style="display: none">SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20210101__20211231__srt--StatementGeographicalAxis__country--HK_zSiFvdzaTJw3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20200101__20201231__srt--StatementGeographicalAxis__country--HK_zfphW1cGGnC4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zNYKMVqlbk47" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Income before income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">80,157</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">170,555</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_z8uaZFX5UC85" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Statutory income tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8.25</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8.25</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pid_zJMt0j34fRgg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax expense at statutory rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6,613</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14,070</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_iN_di_zsdGhXLIACTg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tax adjustments</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,345</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,277</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationTaxHolidays_iN_di_zOfv7A6bBDd1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Tax holiday</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(1,287</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,578</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_z94z4F7chCs6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,671</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,215</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_z2hraBpXBkdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The PRC</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231__srt--StatementGeographicalAxis__country--CN_zJaQBY2Azti1" title="Income tax description">The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the People’s Republic of China at a unified income tax rate of 25%</span>. The reconciliation of income tax rate to the effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:</span></p> <p id="xdx_893_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_hsrt--StatementGeographicalAxis__country--CN_zToeSwPeSpcf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zekeUrGZ0EAk" style="display: none">SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20210101__20211231__srt--StatementGeographicalAxis__country--CN_zuOOQODK55pk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20200101__20201231__srt--StatementGeographicalAxis__country--CN_zpWktA1EunXi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zHxwLNuP5ND4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Loss before income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(505,601</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(482,014</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zRUyHV3w0zab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Statutory income tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">25</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">25</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zwGhUSIwg6th" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax expense at statutory rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(126,400</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(120,503</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_zlPiHokiXNg2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Net operating loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">126,400</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">120,503</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_zbf2UsRkbsVd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zGAXMlbMpSta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z1cIoGtppgb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the significant components of the deferred tax assets of the Company as of December 31, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B6_zAUPnvoEPd58" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20211231_zFmfX8GKjgue" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20201231_zPmlz0zvggAe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net operating loss carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_hsrt--StatementGeographicalAxis__country--US_zZBBp50aT9Ag" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">- United States</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">54,747</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">31,454</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_hsrt--StatementGeographicalAxis__country--CN_zWvL0Ov9NbZf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">- PRC</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">246,903</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">120,503</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTANzhD8_zL7YUoYW4cA1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">301,650</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">151,957</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzhD8_zN8OgsG4XSFe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less: valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(301,650</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(151,957</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzhD8_zNX9JxE8z1y8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Deferred tax assets, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zSX44fEqY4L7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zRc6LoVeiiik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BA_zT9dfm6TWwxb" style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20210101__20211231_zpSra4tGmKf1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20200101__20201231_zDIZtsLcQ3fk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_403_eus-gaap--CurrentIncomeTaxExpenseBenefit_maITEBzcov_zyWPzSZLQ0B2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Current tax</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">6,671</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">8,215</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredIncomeTaxExpenseBenefit_maITEBzcov_zfN9YR8k77Bg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Deferred tax</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0803">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzcov_zuJQ7iiVEv2f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Income tax expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,671</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8,215</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6671 8215 6671 8215 The Tax Reform Act significantly revised the U.S. corporate income tax regime by, among other things, lowering the U.S. corporate tax rate from 35% to 21% effective January 1, 2018. The Company’s policy is to recognize accrued interest and penalties related to unrecognized tax benefits in its income tax provision. The Company has not accrued or paid interest or penalties which were not material to its results of operations for the years presented 0.21 173076 The net operating loss carryforwards begin to expire in 2041, if unutilized. The Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25% to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax year <p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_hsrt--StatementGeographicalAxis__country--HK_z0cWQHvXpPoa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B9_zH3FAAPzjCa3" style="display: none">SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20210101__20211231__srt--StatementGeographicalAxis__country--HK_zSiFvdzaTJw3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20200101__20201231__srt--StatementGeographicalAxis__country--HK_zfphW1cGGnC4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zNYKMVqlbk47" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Income before income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">80,157</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">170,555</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_z8uaZFX5UC85" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Statutory income tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8.25</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8.25</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pid_zJMt0j34fRgg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax expense at statutory rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6,613</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14,070</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_iN_di_zsdGhXLIACTg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tax adjustments</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,345</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,277</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationTaxHolidays_iN_di_zOfv7A6bBDd1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Tax holiday</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(1,287</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,578</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_z94z4F7chCs6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,671</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,215</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 80157 170555 0.0825 0.0825 6613 14070 -1345 3277 1287 2578 6671 8215 The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the People’s Republic of China at a unified income tax rate of 25% <p id="xdx_893_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_hsrt--StatementGeographicalAxis__country--CN_zToeSwPeSpcf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zekeUrGZ0EAk" style="display: none">SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20210101__20211231__srt--StatementGeographicalAxis__country--CN_zuOOQODK55pk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20200101__20201231__srt--StatementGeographicalAxis__country--CN_zpWktA1EunXi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zHxwLNuP5ND4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Loss before income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(505,601</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(482,014</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zRUyHV3w0zab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Statutory income tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">25</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">25</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zwGhUSIwg6th" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax expense at statutory rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(126,400</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(120,503</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_zlPiHokiXNg2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Net operating loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">126,400</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">120,503</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_zbf2UsRkbsVd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> -505601 -482014 0.25 0.25 -126400 -120503 126400 120503 <p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z1cIoGtppgb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the significant components of the deferred tax assets of the Company as of December 31, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B6_zAUPnvoEPd58" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20211231_zFmfX8GKjgue" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20201231_zPmlz0zvggAe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net operating loss carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_hsrt--StatementGeographicalAxis__country--US_zZBBp50aT9Ag" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">- United States</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">54,747</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">31,454</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_hsrt--StatementGeographicalAxis__country--CN_zWvL0Ov9NbZf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">- PRC</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">246,903</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">120,503</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTANzhD8_zL7YUoYW4cA1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">301,650</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">151,957</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzhD8_zN8OgsG4XSFe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less: valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(301,650</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(151,957</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzhD8_zNX9JxE8z1y8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Deferred tax assets, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 54747 31454 246903 120503 301650 151957 301650 151957 <p id="xdx_803_eus-gaap--PensionAndOtherPostretirementBenefitsDisclosureTextBlock_zwiBS4pvR1c3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14: <span id="xdx_821_zIPc4AtpXCOd">PENSION COSTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is required to make contributions to their employees under a government-mandated defined contribution pension scheme for its eligible full-times employees in the People’s Republic of China. The Company is required to contribute a specified percentage of the participants’ relevant income based on their ages and wages level. During the years ended December 31, 2021 and 2020, $<span id="xdx_908_eus-gaap--DefinedContributionPlanCostRecognized_c20210101__20211231__us-gaap--RetirementPlanSponsorLocationAxis__us-gaap--ForeignPlanMember_zEqgFUswf8V9" title="Employee Contributions">23,617</span> and $<span id="xdx_902_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20200101__20201231__us-gaap--RetirementPlanSponsorLocationAxis__us-gaap--ForeignPlanMember_zswOe7P2gMW2" title="Employee Contributions">12,284</span> contributions were made accordingly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 23617 12284 <p id="xdx_80A_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zHFZhBnugXra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15: <span id="xdx_821_zGzrkqjw2AI3">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, the Company’s director and related company advanced funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand. As of December 31, 2021 and 2020, the Company owed the balance of $<span id="xdx_903_ecustom--DueToDirectorCurrent_iI_pp0p0_c20211231_ze8imS3bHFm8" title="Amount due to a director">219,461</span> and $<span id="xdx_908_ecustom--DueToDirectorCurrent_iI_pp0p0_c20201231_z0sYE2x4szK3" title="Amount due to a director">68,953</span> to its director, and owed the balance of $<span id="xdx_908_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20211231_zs1d4XDXlgob" title="Due to related company">199,964</span> and $<span id="xdx_90E_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20201231_zpUbyOA4lfTg" title="Due to related company">199,964</span> to a related company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company purchased a motor vehicle from a related company at the carrying value of $<span id="xdx_907_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zgI3K6bsROAb" title="Due from related company">42,966</span> for the year ended December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apart from the transactions and balances detailed elsewhere in these accompanying consolidated financial statements, the Company has no other significant or material related party transactions during the years presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 219461 68953 199964 199964 42966 <p id="xdx_80D_eus-gaap--ConcentrationRiskDisclosureTextBlock_zJwhJqaueUv5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16: <span id="xdx_820_zUCnF02kweHe">CONCENTRATIONS OF RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to the following concentrations of risk:</span></p> <p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zD6D9TJ8Tvqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8BB_zW28fVfvuf9h" style="display: none">SCHEDULE OF CONCENTRATIONS OF RISK</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, the customers who accounts for 10% or more of the Company’s revenues and its outstanding receivable balances as at year-end dates, are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">December 31, 2021</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Percentage of revenues</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Customer C</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zCdlPjvMctqc" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue">165,391</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z7sCW22qgy3f" title="Concentration risk, percentage">46</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFyhH4w6keeb" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl0901">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer D</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z8y6hDRF2Jm9" style="font: 10pt Times New Roman, Times, Serif; text-align: right">103,072</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z2HkPXN7LaA5">29</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Customer E</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zjcdUnLDYrc8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues">51,460</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_z4HTf1Uaek91" title="Concentration risk, percentage">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zOGXyjpjLQ0c" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts receivable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0909">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">TOTAL</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0ZoCnviLGE1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues">319,923</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zbihBJtNnSZ9">89</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zpiUnfsL4CMe" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts receivable, net"><span style="-sec-ix-hidden: xdx2ixbrl0914">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">December 31, 2020</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">Customer</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Percentage of revenues</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Accounts receivable</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">　</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Customer A</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_ztlF2kPNLVC5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue">394,158</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zEUXZXZ5ZPB7" title="Concentration risk, percentage">39</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_985_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20201231__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zdaNuLnxzMtd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Customer B</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5f0LkvptTN4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue">234,547</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zXN1CQjHMzV4" title="Concentration risk, percentage">23</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20201231__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zy9tiJTlfHjh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　　　</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　　　</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">　　　　</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">Total:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zr6cTu7yYa9g" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue">628,705</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zqOWI3wIzPMi" title="Concentration risk, percentage">62</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">$</td> <td id="xdx_989_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zEinwly4QdXe" style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the Company’s customers are located in the People’s Republic of China and Hong Kong.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, the vendor who accounts for 10% or more of the Company’s purchases and its outstanding payable balances as at year-end dates, are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">December 31, 2021</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">Vendor</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Purchases</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Percentage of purchases</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left; padding-bottom: 2.5pt">Vendor D</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzpMzwDu7w4e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenues">195,152</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorDMember_zHYB3v8yzpch" title="Concentration risk, percentage">99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total:</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20211231__srt--MajorCustomersAxis__custom--VendorDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsataUiKm5q6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accounts payable"><span style="-sec-ix-hidden: xdx2ixbrl0938">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">December 31, 2020</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">Vendor</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Purchases</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Percentage of purchases</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Vendor A</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zjfqcWPWUnUk" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenues">219,007</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zt5l1XQtIrt8" title="Concentration risk, percentage">37</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20201231__srt--MajorCustomersAxis__custom--VendorAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsUN5ffaB5m4" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accounts payable"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vendor B</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxGX4PFuD9ub" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues">71,616</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_ziEsYEE6VOxc" title="Concentration risk, percentage">12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20201231__srt--MajorCustomersAxis__custom--VendorBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zg0cCI1jvDe1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vendor C</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRgAO4J5Xhvd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues">61,222</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zs7w4MBkBZw" title="Concentration risk, percentage">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20201231__srt--MajorCustomersAxis__custom--VendorCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJIVFQl1lQ88" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">Total:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzF0C4cainq4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues">351,845</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorMember_z6pIoVTlzLIl" title="Concentration risk, percentage">59</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total:</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20201231__srt--MajorCustomersAxis__custom--VendorMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zWrKnMNTISuh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable"><span style="-sec-ix-hidden: xdx2ixbrl0962">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zDToZK0fHczj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the Company’s vendors are located in the People’s Republic of China.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Credit risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that are potentially subject to credit risk consist principally of trade receivables. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Economic and political risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s major operations are conducted in the People’s Republic of China. Accordingly, the political, economic, and legal environments in PRC, as well as the general state of PRC’s economy may influence the Company’s business, financial condition, and results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 62.9pt; text-align: justify; text-indent: -62.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Exchange rate risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company cannot guarantee that the current exchange rate will remain steady; therefore there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of HKD and RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Risk from COVID</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of COVID-19, the Company has been unable to satisfy certain customer orders for the products. As a result, the customers have experienced delays in receiving the products . There is uncertainty around the duration and breadth of the COVID-19 pandemic, and other actions taken to contain or treat the impact of COVID-19, and the extent of such impact will depend on future developments, which are highly uncertain and cannot be predicted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zD6D9TJ8Tvqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8BB_zW28fVfvuf9h" style="display: none">SCHEDULE OF CONCENTRATIONS OF RISK</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, the customers who accounts for 10% or more of the Company’s revenues and its outstanding receivable balances as at year-end dates, are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">December 31, 2021</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Percentage of revenues</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Customer C</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zCdlPjvMctqc" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue">165,391</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z7sCW22qgy3f" title="Concentration risk, percentage">46</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFyhH4w6keeb" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl0901">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer D</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z8y6hDRF2Jm9" style="font: 10pt Times New Roman, Times, Serif; text-align: right">103,072</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z2HkPXN7LaA5">29</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Customer E</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zjcdUnLDYrc8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues">51,460</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_z4HTf1Uaek91" title="Concentration risk, percentage">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zOGXyjpjLQ0c" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts receivable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0909">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">TOTAL</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0ZoCnviLGE1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues">319,923</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zbihBJtNnSZ9">89</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNet_iI_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zpiUnfsL4CMe" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts receivable, net"><span style="-sec-ix-hidden: xdx2ixbrl0914">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">December 31, 2020</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">Customer</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Percentage of revenues</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Accounts receivable</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">　</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Customer A</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_ztlF2kPNLVC5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue">394,158</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zEUXZXZ5ZPB7" title="Concentration risk, percentage">39</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_985_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20201231__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zdaNuLnxzMtd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Customer B</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5f0LkvptTN4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue">234,547</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zXN1CQjHMzV4" title="Concentration risk, percentage">23</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20201231__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zy9tiJTlfHjh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　　　</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　　　</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">　　　　</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">Total:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zr6cTu7yYa9g" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue">628,705</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zqOWI3wIzPMi" title="Concentration risk, percentage">62</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">$</td> <td id="xdx_989_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zEinwly4QdXe" style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the Company’s customers are located in the People’s Republic of China and Hong Kong.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, the vendor who accounts for 10% or more of the Company’s purchases and its outstanding payable balances as at year-end dates, are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">December 31, 2021</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">Vendor</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Purchases</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Percentage of purchases</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left; padding-bottom: 2.5pt">Vendor D</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzpMzwDu7w4e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenues">195,152</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorDMember_zHYB3v8yzpch" title="Concentration risk, percentage">99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">%</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total:</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20211231__srt--MajorCustomersAxis__custom--VendorDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsataUiKm5q6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accounts payable"><span style="-sec-ix-hidden: xdx2ixbrl0938">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">December 31, 2020</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">Vendor</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Purchases</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Percentage of purchases</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Vendor A</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zjfqcWPWUnUk" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenues">219,007</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zt5l1XQtIrt8" title="Concentration risk, percentage">37</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20201231__srt--MajorCustomersAxis__custom--VendorAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsUN5ffaB5m4" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accounts payable"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vendor B</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxGX4PFuD9ub" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues">71,616</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_ziEsYEE6VOxc" title="Concentration risk, percentage">12</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20201231__srt--MajorCustomersAxis__custom--VendorBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zg0cCI1jvDe1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vendor C</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRgAO4J5Xhvd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues">61,222</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zs7w4MBkBZw" title="Concentration risk, percentage">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20201231__srt--MajorCustomersAxis__custom--VendorCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJIVFQl1lQ88" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">　</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">　</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt">Total:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzF0C4cainq4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues">351,845</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorMember_z6pIoVTlzLIl" title="Concentration risk, percentage">59</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total:</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20201231__srt--MajorCustomersAxis__custom--VendorMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zWrKnMNTISuh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable"><span style="-sec-ix-hidden: xdx2ixbrl0962">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 165391 0.46 103072 0.29 51460 0.14 319923 0.89 394158 0.39 234547 0.23 628705 0.62 195152 0.99 219007 0.37 71616 0.12 61222 0.10 351845 0.59 <p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zdgf6UkbxQQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17: <span id="xdx_824_zD3pw1EJtFl4">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 and 2020, the Company has no material commitments or contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zCKAiT7P3ju1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 18: <span id="xdx_82E_zrayYgBGySx">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC Topic 855, “<i>Subsequent Events</i>”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2021, up through the date the Company issued the audited consolidated financial statements. During the period, the Company did not have any material recognizable subsequent events.</span></p> EXCEL 76 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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⃭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�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end XML 77 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 78 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 79 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 123 216 1 false 48 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://chinafoodsltd.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://chinafoodsltd.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://chinafoodsltd.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://chinafoodsltd.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity Sheet http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity Consolidated Statements of Changes in Shareholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://chinafoodsltd.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND Sheet http://chinafoodsltd.com/role/OrganizationAndBusinessBackground ORGANIZATION AND BUSINESS BACKGROUND Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES Sheet http://chinafoodsltd.com/role/LiquidityAndCapitalResources LIQUIDITY AND CAPITAL RESOURCES Notes 9 false false R10.htm 00000010 - Disclosure - SEGMENT REPORTING Sheet http://chinafoodsltd.com/role/SegmentReporting SEGMENT REPORTING Notes 10 false false R11.htm 00000011 - Disclosure - PREPAYMENTS AND OTHER RECEIVABLES Sheet http://chinafoodsltd.com/role/PrepaymentsAndOtherReceivables PREPAYMENTS AND OTHER RECEIVABLES Notes 11 false false R12.htm 00000012 - Disclosure - INVENTORIES Sheet http://chinafoodsltd.com/role/Inventories INVENTORIES Notes 12 false false R13.htm 00000013 - Disclosure - PLANT AND EQUIPMENT Sheet http://chinafoodsltd.com/role/PlantAndEquipment PLANT AND EQUIPMENT Notes 13 false false R14.htm 00000014 - Disclosure - CUSTOMER DEPOSITS Sheet http://chinafoodsltd.com/role/CustomerDeposits CUSTOMER DEPOSITS Notes 14 false false R15.htm 00000015 - Disclosure - AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY Sheet http://chinafoodsltd.com/role/AmountsDueToDirectorAndRelatedCompany AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY Notes 15 false false R16.htm 00000016 - Disclosure - LEASE Sheet http://chinafoodsltd.com/role/Lease LEASE Notes 16 false false R17.htm 00000017 - Disclosure - SHAREHOLDERS??? EQUITY Sheet http://chinafoodsltd.com/role/ShareholdersEquity SHAREHOLDERS??? EQUITY Notes 17 false false R18.htm 00000018 - Disclosure - NET LOSS PER SHARE Sheet http://chinafoodsltd.com/role/NetLossPerShare NET LOSS PER SHARE Notes 18 false false R19.htm 00000019 - Disclosure - INCOME TAXES Sheet http://chinafoodsltd.com/role/IncomeTaxes INCOME TAXES Notes 19 false false R20.htm 00000020 - Disclosure - PENSION COSTS Sheet http://chinafoodsltd.com/role/PensionCosts PENSION COSTS Notes 20 false false R21.htm 00000021 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://chinafoodsltd.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 21 false false R22.htm 00000022 - Disclosure - CONCENTRATIONS OF RISK Sheet http://chinafoodsltd.com/role/ConcentrationsOfRisk CONCENTRATIONS OF RISK Notes 22 false false R23.htm 00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://chinafoodsltd.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 23 false false R24.htm 00000024 - Disclosure - SUBSEQUENT EVENTS Sheet http://chinafoodsltd.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 24 false false R25.htm 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables) Sheet http://chinafoodsltd.com/role/OrganizationAndBusinessBackgroundTables ORGANIZATION AND BUSINESS BACKGROUND (Tables) Tables http://chinafoodsltd.com/role/OrganizationAndBusinessBackground 26 false false R27.htm 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPolicies 27 false false R28.htm 00000028 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://chinafoodsltd.com/role/SegmentReportingTables SEGMENT REPORTING (Tables) Tables http://chinafoodsltd.com/role/SegmentReporting 28 false false R29.htm 00000029 - Disclosure - PREPAYMENTS AND OTHER RECEIVABLES (Tables) Sheet http://chinafoodsltd.com/role/PrepaymentsAndOtherReceivablesTables PREPAYMENTS AND OTHER RECEIVABLES (Tables) Tables http://chinafoodsltd.com/role/PrepaymentsAndOtherReceivables 29 false false R30.htm 00000030 - Disclosure - INVENTORIES (Tables) Sheet http://chinafoodsltd.com/role/InventoriesTables INVENTORIES (Tables) Tables http://chinafoodsltd.com/role/Inventories 30 false false R31.htm 00000031 - Disclosure - PLANT AND EQUIPMENT (Tables) Sheet http://chinafoodsltd.com/role/PlantAndEquipmentTables PLANT AND EQUIPMENT (Tables) Tables http://chinafoodsltd.com/role/PlantAndEquipment 31 false false R32.htm 00000032 - Disclosure - LEASE (Tables) Sheet http://chinafoodsltd.com/role/LeaseTables LEASE (Tables) Tables http://chinafoodsltd.com/role/Lease 32 false false R33.htm 00000033 - Disclosure - NET LOSS PER SHARE (Tables) Sheet http://chinafoodsltd.com/role/NetLossPerShareTables NET LOSS PER SHARE (Tables) Tables http://chinafoodsltd.com/role/NetLossPerShare 33 false false R34.htm 00000034 - Disclosure - INCOME TAXES (Tables) Sheet http://chinafoodsltd.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://chinafoodsltd.com/role/IncomeTaxes 34 false false R35.htm 00000035 - Disclosure - CONCENTRATIONS OF RISK (Tables) Sheet http://chinafoodsltd.com/role/ConcentrationsOfRiskTables CONCENTRATIONS OF RISK (Tables) Tables http://chinafoodsltd.com/role/ConcentrationsOfRisk 35 false false R36.htm 00000036 - Disclosure - SCHEDULE OF SUBSIDIARIES INFORMATION (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails SCHEDULE OF SUBSIDIARIES INFORMATION (Details) Details 36 false false R37.htm 00000037 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails SCHEDULE OF ESTIMATED USEFUL LIVES (Details) Details 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details) Details 38 false false R39.htm 00000039 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) Details 39 false false R40.htm 00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables 40 false false R41.htm 00000041 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) Sheet http://chinafoodsltd.com/role/LiquidityAndCapitalResourcesDetailsNarrative LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) Details http://chinafoodsltd.com/role/LiquidityAndCapitalResources 41 false false R42.htm 00000042 - Disclosure - SUMMARY OF GEOGRAPHIC SEGMENTS (Details) Sheet http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails SUMMARY OF GEOGRAPHIC SEGMENTS (Details) Details 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE (Details) Details 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 44 false false R45.htm 00000045 - Disclosure - INVENTORIES (Details Narrative) Sheet http://chinafoodsltd.com/role/InventoriesDetailsNarrative INVENTORIES (Details Narrative) Details http://chinafoodsltd.com/role/InventoriesTables 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Details 46 false false R47.htm 00000047 - Disclosure - PLANT AND EQUIPMENT (Details Narrative) Sheet http://chinafoodsltd.com/role/PlantAndEquipmentDetailsNarrative PLANT AND EQUIPMENT (Details Narrative) Details http://chinafoodsltd.com/role/PlantAndEquipmentTables 47 false false R48.htm 00000048 - Disclosure - CUSTOMER DEPOSITS (Details Narrative) Sheet http://chinafoodsltd.com/role/CustomerDepositsDetailsNarrative CUSTOMER DEPOSITS (Details Narrative) Details http://chinafoodsltd.com/role/CustomerDeposits 48 false false R49.htm 00000049 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details) Details 49 false false R50.htm 00000050 - Disclosure - LEASE (Details Narrative) Sheet http://chinafoodsltd.com/role/LeaseDetailsNarrative LEASE (Details Narrative) Details http://chinafoodsltd.com/role/LeaseTables 50 false false R51.htm 00000051 - Disclosure - SHAREHOLDERS??? EQUITY (Details Narrative) Sheet http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative SHAREHOLDERS??? EQUITY (Details Narrative) Details http://chinafoodsltd.com/role/ShareholdersEquity 51 false false R52.htm 00000052 - Disclosure - SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details) Details 52 false false R53.htm 00000053 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) Details 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details) Details 54 false false R55.htm 00000055 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails SCHEDULE OF DEFERRED TAX ASSETS (Details) Details 55 false false R56.htm 00000056 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://chinafoodsltd.com/role/IncomeTaxesTables 56 false false R57.htm 00000057 - Disclosure - PENSION COSTS (Details Narrative) Sheet http://chinafoodsltd.com/role/PensionCostsDetailsNarrative PENSION COSTS (Details Narrative) Details http://chinafoodsltd.com/role/PensionCosts 57 false false R58.htm 00000058 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://chinafoodsltd.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://chinafoodsltd.com/role/RelatedPartyTransactions 58 false false R59.htm 00000059 - Disclosure - SCHEDULE OF CONCENTRATIONS OF RISK (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails SCHEDULE OF CONCENTRATIONS OF RISK (Details) Details 59 false false All Reports Book All Reports form10-ka.htm cfoo-20211231.xsd cfoo-20211231_cal.xml cfoo-20211231_def.xml cfoo-20211231_lab.xml cfoo-20211231_pre.xml ex31-1.htm ex32-1.htm ex4-2.htm form10-ka_001.jpg form10-ka_002.jpg form10-ka_003.jpg form10-ka_004.jpg form10-ka_005.jpg form10-ka_006.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 81 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-ka.htm": { "axisCustom": 0, "axisStandard": 16, "baseTaxonomies": { "http://fasb.org/us-gaap/2021-01-31": 491, "http://xbrl.sec.gov/dei/2021q4": 35 }, "contextCount": 123, "dts": { "calculationLink": { "local": [ "cfoo-20211231_cal.xml" ] }, "definitionLink": { "local": [ "cfoo-20211231_def.xml" ] }, "inline": { "local": [ "form10-ka.htm" ] }, "labelLink": { "local": [ "cfoo-20211231_lab.xml" ] }, "presentationLink": { "local": [ "cfoo-20211231_pre.xml" ] }, "schema": { "local": [ "cfoo-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 378, "entityCount": 1, "hidden": { "http://chinafoodsltd.com/20211231": 7, "http://fasb.org/us-gaap/2021-01-31": 65, "http://xbrl.sec.gov/dei/2021q4": 3, "total": 75 }, "keyCustom": 29, "keyStandard": 187, "memberCustom": 30, "memberStandard": 16, "nsprefix": "CFOO", "nsuri": "http://chinafoodsltd.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://chinafoodsltd.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - SEGMENT REPORTING", "menuCat": "Notes", "order": "10", "role": "http://chinafoodsltd.com/role/SegmentReporting", "shortName": "SEGMENT REPORTING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:PrepaymentsAndOtherReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - PREPAYMENTS AND OTHER RECEIVABLES", "menuCat": "Notes", "order": "11", "role": "http://chinafoodsltd.com/role/PrepaymentsAndOtherReceivables", "shortName": "PREPAYMENTS AND OTHER RECEIVABLES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:PrepaymentsAndOtherReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - INVENTORIES", "menuCat": "Notes", "order": "12", "role": "http://chinafoodsltd.com/role/Inventories", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - PLANT AND EQUIPMENT", "menuCat": "Notes", "order": "13", "role": "http://chinafoodsltd.com/role/PlantAndEquipment", "shortName": "PLANT AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:CustomerDepositsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - CUSTOMER DEPOSITS", "menuCat": "Notes", "order": "14", "role": "http://chinafoodsltd.com/role/CustomerDeposits", "shortName": "CUSTOMER DEPOSITS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:CustomerDepositsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:AmountsDueToDirectorAndRelatedCompanyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY", "menuCat": "Notes", "order": "15", "role": "http://chinafoodsltd.com/role/AmountsDueToDirectorAndRelatedCompany", "shortName": "AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:AmountsDueToDirectorAndRelatedCompanyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - LEASE", "menuCat": "Notes", "order": "16", "role": "http://chinafoodsltd.com/role/Lease", "shortName": "LEASE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - SHAREHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "17", "role": "http://chinafoodsltd.com/role/ShareholdersEquity", "shortName": "SHAREHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - NET LOSS PER SHARE", "menuCat": "Notes", "order": "18", "role": "http://chinafoodsltd.com/role/NetLossPerShare", "shortName": "NET LOSS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "19", "role": "http://chinafoodsltd.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://chinafoodsltd.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "CFOO:PrepaymentsAndOtherReceivablesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - PENSION COSTS", "menuCat": "Notes", "order": "20", "role": "http://chinafoodsltd.com/role/PensionCosts", "shortName": "PENSION COSTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "21", "role": "http://chinafoodsltd.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - CONCENTRATIONS OF RISK", "menuCat": "Notes", "order": "22", "role": "http://chinafoodsltd.com/role/ConcentrationsOfRisk", "shortName": "CONCENTRATIONS OF RISK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "23", "role": "http://chinafoodsltd.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "24", "role": "http://chinafoodsltd.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:BasisOfPresentationAndConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "25", "role": "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:BasisOfPresentationAndConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:ScheduleOfSubsidiariesInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)", "menuCat": "Tables", "order": "26", "role": "http://chinafoodsltd.com/role/OrganizationAndBusinessBackgroundTables", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:ScheduleOfSubsidiariesInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "27", "role": "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - SEGMENT REPORTING (Tables)", "menuCat": "Tables", "order": "28", "role": "http://chinafoodsltd.com/role/SegmentReportingTables", "shortName": "SEGMENT REPORTING (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "CFOO:PrepaymentsAndOtherReceivableTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:ScheduleOfPrepaymentsAndOtherReceivableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - PREPAYMENTS AND OTHER RECEIVABLES (Tables)", "menuCat": "Tables", "order": "29", "role": "http://chinafoodsltd.com/role/PrepaymentsAndOtherReceivablesTables", "shortName": "PREPAYMENTS AND OTHER RECEIVABLES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "CFOO:PrepaymentsAndOtherReceivableTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:ScheduleOfPrepaymentsAndOtherReceivableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://chinafoodsltd.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockSharesIssued", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - INVENTORIES (Tables)", "menuCat": "Tables", "order": "30", "role": "http://chinafoodsltd.com/role/InventoriesTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - PLANT AND EQUIPMENT (Tables)", "menuCat": "Tables", "order": "31", "role": "http://chinafoodsltd.com/role/PlantAndEquipmentTables", "shortName": "PLANT AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - LEASE (Tables)", "menuCat": "Tables", "order": "32", "role": "http://chinafoodsltd.com/role/LeaseTables", "shortName": "LEASE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - NET LOSS PER SHARE (Tables)", "menuCat": "Tables", "order": "33", "role": "http://chinafoodsltd.com/role/NetLossPerShareTables", "shortName": "NET LOSS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "34", "role": "http://chinafoodsltd.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - CONCENTRATIONS OF RISK (Tables)", "menuCat": "Tables", "order": "35", "role": "http://chinafoodsltd.com/role/ConcentrationsOfRiskTables", "shortName": "CONCENTRATIONS OF RISK (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "CFOO:ScheduleOfSubsidiariesInformationTableTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_custom_EliteCreationGroupLimitedMember", "decimals": null, "first": true, "lang": "en-US", "name": "CFOO:EntityPlaceOfIncorporationAndKindOfLegalEntity", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - SCHEDULE OF SUBSIDIARIES INFORMATION (Details)", "menuCat": "Details", "order": "36", "role": "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails", "shortName": "SCHEDULE OF SUBSIDIARIES INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "CFOO:ScheduleOfSubsidiariesInformationTableTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_custom_EliteCreationGroupLimitedMember", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "CFOO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_custom_FurnitureFixtureAndEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details)", "menuCat": "Details", "order": "37", "role": "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "CFOO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_custom_FurnitureFixtureAndEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details)", "menuCat": "Details", "order": "38", "role": "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "shortName": "SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "CFOO:DisaggregationOfRevenuePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_custom_ConsultancyServiceFeeIncomeMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31_custom_YearEndHKUSExchangeRateMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)", "menuCat": "Details", "order": "39", "role": "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails", "shortName": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31_custom_YearEndHKUSExchangeRateMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://chinafoodsltd.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:InterestIncomeExpenseNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "Integer", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "40", "role": "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "Integer", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://chinafoodsltd.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "shortName": "LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SUMMARY OF GEOGRAPHIC SEGMENTS (Details)", "menuCat": "Details", "order": "42", "role": "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails", "shortName": "SUMMARY OF GEOGRAPHIC SEGMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_country_HK", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "CFOO:ScheduleOfPrepaymentsAndOtherReceivableTableTextBlock", "CFOO:PrepaymentsAndOtherReceivableTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE (Details)", "menuCat": "Details", "order": "43", "role": "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails", "shortName": "SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "CFOO:ScheduleOfPrepaymentsAndOtherReceivableTableTextBlock", "CFOO:PrepaymentsAndOtherReceivableTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "menuCat": "Details", "order": "44", "role": "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails", "shortName": "SCHEDULE OF INVENTORIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "CFOO:AllowanceForObsoleteInventories", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - INVENTORIES (Details Narrative)", "menuCat": "Details", "order": "45", "role": "http://chinafoodsltd.com/role/InventoriesDetailsNarrative", "shortName": "INVENTORIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "CFOO:AllowanceForObsoleteInventories", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "menuCat": "Details", "order": "46", "role": "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "shortName": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - PLANT AND EQUIPMENT (Details Narrative)", "menuCat": "Details", "order": "47", "role": "http://chinafoodsltd.com/role/PlantAndEquipmentDetailsNarrative", "shortName": "PLANT AND EQUIPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - CUSTOMER DEPOSITS (Details Narrative)", "menuCat": "Details", "order": "48", "role": "http://chinafoodsltd.com/role/CustomerDepositsDetailsNarrative", "shortName": "CUSTOMER DEPOSITS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "CFOO:OperatingLeaseRightOfUseAssetCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details)", "menuCat": "Details", "order": "49", "role": "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails", "shortName": "SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "CFOO:ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity", "shortName": "Consolidated Statements of Changes in Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - LEASE (Details Narrative)", "menuCat": "Details", "order": "50", "role": "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "shortName": "LEASE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - SHAREHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "51", "role": "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative", "shortName": "SHAREHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockSharesIssued", "span", "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2020-12-31_custom_ShareExchangeAgreementMember_us-gaap_CommonStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details)", "menuCat": "Details", "order": "52", "role": "http://chinafoodsltd.com/role/ScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "shortName": "SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details)", "menuCat": "Details", "order": "53", "role": "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "shortName": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details)", "menuCat": "Details", "order": "54", "role": "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "shortName": "SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_country_HK", "decimals": "0", "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)", "menuCat": "Details", "order": "55", "role": "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExaminationDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "56", "role": "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExaminationDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_ForeignPlanMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanCostRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - PENSION COSTS (Details Narrative)", "menuCat": "Details", "order": "57", "role": "http://chinafoodsltd.com/role/PensionCostsDetailsNarrative", "shortName": "PENSION COSTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_ForeignPlanMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanCostRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "CFOO:DueToDirectorCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://chinafoodsltd.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "AsOf2021-12-31_custom_MotorVehiclesMember", "decimals": "0", "lang": null, "name": "us-gaap:DueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_custom_CustomerCMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - SCHEDULE OF CONCENTRATIONS OF RISK (Details)", "menuCat": "Details", "order": "59", "role": "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails", "shortName": "SCHEDULE OF CONCENTRATIONS OF RISK (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-012021-12-31_custom_CustomerCMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://chinafoodsltd.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND", "menuCat": "Notes", "order": "7", "role": "http://chinafoodsltd.com/role/OrganizationAndBusinessBackground", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES", "menuCat": "Notes", "order": "9", "role": "http://chinafoodsltd.com/role/LiquidityAndCapitalResources", "shortName": "LIQUIDITY AND CAPITAL RESOURCES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-ka.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 48, "tag": { "CFOO_AllowanceForObsoleteInventories": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Allowance for obsolete inventories.", "label": "Allowance for obsolete inventories" } } }, "localname": "AllowanceForObsoleteInventories", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/InventoriesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CFOO_AlphaWellnessHKLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alpha Wellness (HK) Limited [Member]", "label": "Alpha Wellness (HK) Limited [Member]" } } }, "localname": "AlphaWellnessHKLimitedMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "xbrltype": "domainItemType" }, "CFOO_AmountsDueToDirectorAndRelatedCompanyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amounts due to director and related company [Text Block]", "label": "AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY" } } }, "localname": "AmountsDueToDirectorAndRelatedCompanyTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/AmountsDueToDirectorAndRelatedCompany" ], "xbrltype": "textBlockItemType" }, "CFOO_AnnualAverageHKUSExchangeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Annual Average HK$:US$ Exchange Rate [Member]", "label": "Annual Average HK$:US$ Exchange Rate [Member]" } } }, "localname": "AnnualAverageHKUSExchangeRateMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "CFOO_AnnualAverageRMBUSExchangeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Annual Average RMB:US$ Exchange Rate [Member]", "label": "Annual Average RMB:US$ Exchange Rate [Member]" } } }, "localname": "AnnualAverageRMBUSExchangeRateMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "CFOO_BasisOfPresentationAndConsolidationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis of presentation and consolidation [Policy Text Block]", "label": "Basis of presentation and consolidation" } } }, "localname": "BasisOfPresentationAndConsolidationPolicyTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CFOO_ConsultancyServiceFeeIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultancy Service Fee Income [Member]", "label": "Consultancy Service Fee Income [Member]" } } }, "localname": "ConsultancyServiceFeeIncomeMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "CFOO_ConsultingServiceIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting Service Income [Member]", "label": "Consulting Service Income [Member]" } } }, "localname": "ConsultingServiceIncomeMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "CFOO_CustomerAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer A [Member]", "label": "Customer A [Member]" } } }, "localname": "CustomerAMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer B [Member]", "label": "Customer B [Member]" } } }, "localname": "CustomerBMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_CustomerCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer C [Member]", "label": "Customer C [Member]" } } }, "localname": "CustomerCMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_CustomerDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer D [Member]", "label": "Customer D [Member]" } } }, "localname": "CustomerDMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_CustomerDepositsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer deposits [Text Block]", "label": "CUSTOMER DEPOSITS" } } }, "localname": "CustomerDepositsTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/CustomerDeposits" ], "xbrltype": "textBlockItemType" }, "CFOO_CustomerEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer E [Member]", "label": "Customer E [Member]" } } }, "localname": "CustomerEMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer [Member]", "label": "Customer [Member]" } } }, "localname": "CustomerMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_DisaggregationOfRevenuePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disaggregation of revenue [Policy Text Block]", "label": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenuePolicyTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CFOO_DisclosureAmountsDueToDirectorAndRelatedCompanyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amounts Due To Director And Related Company" } } }, "localname": "DisclosureAmountsDueToDirectorAndRelatedCompanyAbstract", "nsuri": "http://chinafoodsltd.com/20211231", "xbrltype": "stringItemType" }, "CFOO_DisclosureCustomerDepositsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer Deposits" } } }, "localname": "DisclosureCustomerDepositsAbstract", "nsuri": "http://chinafoodsltd.com/20211231", "xbrltype": "stringItemType" }, "CFOO_DisclosureLeaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease", "verboseLabel": "Schedule Of Right Of Use Assets And Liability" } } }, "localname": "DisclosureLeaseAbstract", "nsuri": "http://chinafoodsltd.com/20211231", "xbrltype": "stringItemType" }, "CFOO_DisclosurePrepaymentsAndOtherReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepayments And Other Receivables", "verboseLabel": "Schedule Of Prepayments And Other Receivable" } } }, "localname": "DisclosurePrepaymentsAndOtherReceivablesAbstract", "nsuri": "http://chinafoodsltd.com/20211231", "xbrltype": "stringItemType" }, "CFOO_DueToDirectorCurrent": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Due to director current.", "label": "Amount due to a director" } } }, "localname": "DueToDirectorCurrent", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CFOO_EffectiveInterestHeldPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective interest held percentage.", "label": "Effective interest held percentage" } } }, "localname": "EffectiveInterestHeldPercentage", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "xbrltype": "percentItemType" }, "CFOO_EliteCreationGroupLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Elite Creation Group Limited [Member]", "label": "Elite Creation Group Limited [Member]" } } }, "localname": "EliteCreationGroupLimitedMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails", "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CFOO_EntityPlaceOfIncorporationAndKindOfLegalEntity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Place of incorporation and kind of legal entity.", "label": "Place of incorporation and kind of legal entity" } } }, "localname": "EntityPlaceOfIncorporationAndKindOfLegalEntity", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "xbrltype": "stringItemType" }, "CFOO_EntityPrincipalActivities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Principal activities.", "label": "Principal activities" } } }, "localname": "EntityPrincipalActivities", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "xbrltype": "stringItemType" }, "CFOO_ForeignTranslationDifferenceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Translation Difference [Member]", "label": "Foreign Translation Difference [Member]" } } }, "localname": "ForeignTranslationDifferenceMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "CFOO_ForeignTranslationDifferenceNet": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Foreign translation difference, net.", "label": "Foreign translation difference, net", "negatedLabel": "Foreign translation difference, net" } } }, "localname": "ForeignTranslationDifferenceNet", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "CFOO_FurnitureFixtureAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Furniture, Fixture and Equipment [Member]", "label": "Furniture, Fixture and Equipment [Member]" } } }, "localname": "FurnitureFixtureAndEquipmentMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "CFOO_GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guangzhou Xiao Xiang Health Industry Company Limited [Member]", "label": "Guangzhou Xiao Xiang Health Industry Company Limited [Member]" } } }, "localname": "GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "xbrltype": "domainItemType" }, "CFOO_HealthcareSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare Segment [Member]", "label": "Healthcare Segment [Member]" } } }, "localname": "HealthcareSegmentMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "CFOO_IncreaseDecreaseInLeaseLiabilities": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in lease liabilities.", "label": "Increase decrease in lease liabilities", "negatedLabel": "Lease liabilities" } } }, "localname": "IncreaseDecreaseInLeaseLiabilities", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CFOO_IncreaseDecreaseInPrepaymentsAndOtherReceivables": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in prepayments and other receivables.", "label": "Increase decrease in prepayments and other receivables", "negatedLabel": "Prepayments and other receivables" } } }, "localname": "IncreaseDecreaseInPrepaymentsAndOtherReceivables", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CFOO_MotorVehicleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Motor Vehicle [Member]", "label": "Motor Vehicle [Member]" } } }, "localname": "MotorVehicleMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "CFOO_MotorVehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Motor Vehicles [Member]", "label": "Motor Vehicles [Member]" } } }, "localname": "MotorVehiclesMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "CFOO_NetOperatingLossCarryforwardsExpiration": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net operating loss carry forwards expiration.", "label": "Net operating loss carryforwards expiration" } } }, "localname": "NetOperatingLossCarryforwardsExpiration", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "CFOO_NonCashLeaseExpenses": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non cash lease expenses.", "label": "Non-cash lease expense" } } }, "localname": "NonCashLeaseExpenses", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CFOO_OperatingLeaseRightOfUseAssetCurrent": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating lease right of use asset current.", "label": "Right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetCurrent", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "CFOO_OtherDepositsCurrent": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other deposits, current.", "label": "Other deposits" } } }, "localname": "OtherDepositsCurrent", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails" ], "xbrltype": "monetaryItemType" }, "CFOO_PrepaymentsAndOtherReceivableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepayments and other receivable [Text Block].", "label": "PREPAYMENTS AND OTHER RECEIVABLES" } } }, "localname": "PrepaymentsAndOtherReceivableTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/PrepaymentsAndOtherReceivables" ], "xbrltype": "textBlockItemType" }, "CFOO_PrepaymentsAndOtherReceivablesCurrent": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayments and other receivables current.", "label": "Prepayments and other receivables" } } }, "localname": "PrepaymentsAndOtherReceivablesCurrent", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "CFOO_ProceedsFromAdvancesDirector": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from advances director.", "label": "Advance from a director" } } }, "localname": "ProceedsFromAdvancesDirector", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CFOO_ProductSalesReturns": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Product sales returns.", "label": "Product sales returns" } } }, "localname": "ProductSalesReturns", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CFOO_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related parties [Policy Text Block]", "label": "Related parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CFOO_RentalDeposits": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Rental deposits.", "label": "Rental deposits" } } }, "localname": "RentalDeposits", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails" ], "xbrltype": "monetaryItemType" }, "CFOO_RetirementPlanCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Retirement plan costs [Policy Text Block]", "label": "Retirement plan costs" } } }, "localname": "RetirementPlanCostsPolicyTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CFOO_SaleOfWineProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Wine Products [Member]", "label": "Sale Of Wine Products [Member]" } } }, "localname": "SaleOfWineProductsMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "CFOO_SaleofHealthcareProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of Healthcare Products [Member]", "label": "Sale of Healthcare Products [Member]" } } }, "localname": "SaleofHealthcareProductsMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "CFOO_SalesTaxPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales tax percentage.", "label": "Sales tax percentage" } } }, "localname": "SalesTaxPercentage", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "CFOO_SalesofHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales of Healthcare [Member]", "label": "Sales of Healthcare [Member]" } } }, "localname": "SalesofHealthcareMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "CFOO_ScheduleOfEstimatedUsefulLivesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of estimated useful lives [TableTextBlock]", "label": "SCHEDULE OF ESTIMATED USEFUL LIVES" } } }, "localname": "ScheduleOfEstimatedUsefulLivesTableTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "CFOO_ScheduleOfPrepaymentsAndOtherReceivableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of prepayments and other receivable [TableTextBlock]", "label": "SCHEDULE OF PREPAYMENTS AND OTHER RECEIVABLE" } } }, "localname": "ScheduleOfPrepaymentsAndOtherReceivableTableTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/PrepaymentsAndOtherReceivablesTables" ], "xbrltype": "textBlockItemType" }, "CFOO_ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of right of use assets and liability [TableTextBlock]", "label": "SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY" } } }, "localname": "ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/LeaseTables" ], "xbrltype": "textBlockItemType" }, "CFOO_ScheduleOfSubsidiariesInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of subsidiaries information [Table Text Block]", "label": "SCHEDULE OF SUBSIDIARIES INFORMATION" } } }, "localname": "ScheduleOfSubsidiariesInformationTableTextBlock", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/OrganizationAndBusinessBackgroundTables" ], "xbrltype": "textBlockItemType" }, "CFOO_ShareExchangeAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Exchange Agreement [Member]", "label": "Share Exchange Agreement [Member]" } } }, "localname": "ShareExchangeAgreementMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CFOO_TaxRecoverable": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax recoverable.", "label": "Tax recoverable" } } }, "localname": "TaxRecoverable", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "CFOO_VendorAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor A [Member]", "label": "Vendor A [Member]" } } }, "localname": "VendorAMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_VendorBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor B [Member]", "label": "Vendor B [Member]" } } }, "localname": "VendorBMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_VendorCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor C [Member]", "label": "Vendor C [Member]" } } }, "localname": "VendorCMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_VendorDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor D[Member]", "label": "Vendor D[Member]" } } }, "localname": "VendorDMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_VendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor [Member]", "label": "Vendor [Member]" } } }, "localname": "VendorMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "CFOO_WineSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wine Segment [Member]", "label": "Wine Segment [Member]" } } }, "localname": "WineSegmentMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "CFOO_YearEndHKUSExchangeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year-end HK$:US$ Exchange Rate [Member]", "label": "Year-end HK$:US$ Exchange Rate [Member]" } } }, "localname": "YearEndHKUSExchangeRateMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "CFOO_YearEndRMBUSExchangeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year-end RMB:US$ Exchange Rate [Member]", "label": "Year-end RMB:US$ Exchange Rate [Member]" } } }, "localname": "YearEndRMBUSExchangeRateMember", "nsuri": "http://chinafoodsltd.com/20211231", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CHINA" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "country_HK": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "HONG KONG" } } }, "localname": "HK", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r534", "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r534", "r536", "r537" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r534", "r536", "r537" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r534", "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r542" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r541" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r188", "r423", "r424", "r427", "r428", "r453", "r499", "r558", "r561", "r562" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r188", "r423", "r424", "r427", "r428", "r453", "r499", "r558", "r561", "r562" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r188", "r225", "r243", "r244", "r245", "r246", "r247", "r249", "r253", "r281", "r282", "r283", "r284", "r286", "r287", "r289", "r291", "r292", "r559", "r560" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r188", "r225", "r243", "r244", "r245", "r246", "r247", "r249", "r253", "r281", "r282", "r283", "r284", "r286", "r287", "r289", "r291", "r292", "r559", "r560" ], "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r259", "r512", "r564", "r585" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r391", "r457", "r474", "r500", "r501", "r509", "r516", "r522", "r563", "r578", "r579", "r580", "r581", "r582", "r583" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r391", "r457", "r474", "r500", "r501", "r509", "r516", "r522", "r563", "r578", "r579", "r580", "r581", "r582", "r583" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r259", "r512", "r564", "r585" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r255", "r463", "r510", "r520", "r564", "r584" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r255", "r463", "r510", "r520", "r564", "r584" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r342", "r391", "r456", "r457", "r474", "r500", "r501", "r509", "r516", "r522", "r563", "r579", "r580", "r581", "r582", "r583" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r342", "r391", "r456", "r457", "r474", "r500", "r501", "r509", "r516", "r522", "r563", "r579", "r580", "r581", "r582", "r583" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r256", "r257", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r511", "r521", "r564" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r256", "r257", "r482", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r511", "r521", "r564" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accrued liabilities and other payables" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r36", "r519" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "auth_ref": [ "r143", "r154" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r164", "r469", "r483" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "verboseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r19", "r140", "r149" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Tax payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r35", "r94" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r46", "r47", "r48", "r165", "r470", "r479", "r480" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r171", "r172", "r433", "r434", "r435", "r436", "r437", "r438" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r45", "r48", "r123", "r475", "r476", "r502", "r543", "r544", "r545", "r551", "r552", "r553" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r22" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r393", "r394", "r395", "r551", "r552", "r553", "r572" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r61", "r90" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r547" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of adjustments to net income or loss necessary to remove the effects of all items whose cash effects are investing or financing cash flows. The aggregate amount also includes all noncash expenses and income items which reduce or increase net income and are thus added back or deducted when calculating cash provided by or used in operating activities.", "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities", "totalLabel": "Total adjustments to reconcile net income to net cash (used in) generated from operating activities" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash (used in) generated from operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r263", "r267", "r268", "r269" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r61", "r87", "r90" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r139", "r148", "r185", "r233", "r245", "r251", "r265", "r281", "r282", "r284", "r285", "r286", "r288", "r290", "r292", "r293", "r423", "r427", "r432", "r519", "r559", "r560", "r576" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r7", "r42", "r185", "r265", "r281", "r282", "r284", "r285", "r286", "r288", "r290", "r292", "r293", "r423", "r427", "r432", "r519", "r559", "r560", "r576" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r11", "r12", "r13", "r14", "r15", "r16", "r17", "r18", "r185", "r265", "r281", "r282", "r284", "r285", "r286", "r288", "r290", "r292", "r293", "r423", "r427", "r432", "r559", "r560", "r576" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total Non-Current Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Current Assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r514", "r515" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r118", "r119", "r514", "r515" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r56" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash from acquisition of legal acquirer" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r32", "r63" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r10", "r64" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r58", "r63", "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "CASH AND CASH EQUIVALENTS, END OF YEAR", "periodStartLabel": "CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r58", "r137" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "negatedLabel": "Net cash", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r38", "r99", "r144", "r153" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitment and contingents" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r98", "r100", "r279", "r280", "r485" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r101", "r486" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r551", "r552", "r572" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative", "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheetsParenthetical", "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheetsParenthetical", "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheetsParenthetical", "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r21", "r102" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r21", "r519" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock $0.0001 par value, 100,000,000 shares authorized, 20,252,309 and 20,252,309 shares issued and outstanding as of December 31, 2021 and 2020 respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r120", "r125", "r167", "r169", "r175", "r465", "r471" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive income" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r72", "r73", "r134", "r135", "r259", "r484" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r72", "r73", "r134", "r135", "r259", "r481", "r484" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r72", "r73", "r134", "r135", "r259", "r484", "r586" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS OF RISK" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r72", "r73", "r134", "r135", "r259" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r70", "r72", "r73", "r74", "r134", "r136", "r484" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r72", "r73", "r134", "r135", "r259", "r484" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": { "auth_ref": [ "r124", "r126" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r307", "r308", "r319" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Customer deposits", "verboseLabel": "Deposit received from customers" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/CustomerDepositsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r53", "r185", "r265", "r281", "r282", "r284", "r285", "r286", "r288", "r290", "r292", "r293", "r432", "r559" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "negatedLabel": "Cost of revenue", "negatedTerseLabel": "Total cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r117", "r407", "r415", "r549" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current tax" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r71", "r259" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r61", "r117", "r408", "r414", "r415", "r549" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred tax" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r569" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r115", "r570" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r404" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Less: valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/PensionCostsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r390" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Employee Contributions" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/PensionCostsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r61", "r92" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/PlantAndEquipmentDetailsNarrative", "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r128", "r129", "r130", "r131", "r503" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DueFromRelatedParties": { "auth_ref": [ "r142", "r155", "r283", "r284", "r285", "r291", "r292", "r293", "r450", "r550" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.", "label": "Due from related company" } } }, "localname": "DueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r36", "r283", "r284", "r285", "r291", "r292", "r293", "r450", "r550" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Amount due to a related company", "verboseLabel": "Due to related company" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r176", "r194", "r195", "r196", "r197", "r198", "r202", "r204", "r207", "r208", "r209", "r213", "r430", "r431", "r466", "r472", "r507" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic and diluted", "verboseLabel": "Net loss per share \u2013 Basic and diluted" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss per common share" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of common share" } } }, "localname": "EarningsPerShareBasicOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r68", "r69" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net loss per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r210", "r211", "r212", "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "NET LOSS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/NetLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r574" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Foreign currency translation adjustment" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r186", "r400", "r416" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Statutory income tax rate", "verboseLabel": "Corporate tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r102", "r161", "r171", "r172", "r173", "r189", "r190", "r191", "r193", "r199", "r201", "r216", "r266", "r306", "r393", "r394", "r395", "r410", "r411", "r429", "r433", "r434", "r435", "r436", "r437", "r438", "r475", "r476", "r477", "r502" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative", "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r132", "r133" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r443", "r446" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedLabel": "Payment of lease liabilities" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r89", "r464" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Intangible assets amortization period" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r439", "r440" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign currency translation exchange rates" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign currencies translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r565", "r566", "r567" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/PensionCostsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r54" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses", "negatedLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r52", "r185", "r233", "r244", "r250", "r253", "r265", "r281", "r282", "r284", "r285", "r286", "r288", "r290", "r292", "r293", "r432", "r508", "r559" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r91", "r96" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment of long-lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r49", "r138", "r145", "r157", "r233", "r244", "r250", "r253", "r467", "r508" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Loss before income tax", "verboseLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r186", "r401", "r402", "r406", "r412", "r417", "r419", "r420", "r421" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income tax description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "auth_ref": [ "r110", "r112" ], "lang": { "en-us": { "role": { "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.", "label": "Income tax likelihood, description" } } }, "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r187", "r200", "r201", "r231", "r399", "r413", "r418", "r473" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax expense", "negatedLabel": "Income tax expenses", "totalLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r170", "r397", "r398", "r402", "r403", "r405", "r409" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r400" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Income tax expense at statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r568" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "negatedLabel": "Tax adjustments" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "auth_ref": [ "r568" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.", "label": "Net operating loss" } } }, "localname": "IncomeTaxReconciliationOtherReconcilingItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxHolidays": { "auth_ref": [ "r568" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income exempt from income tax because of a tax holiday.", "label": "Effective Income Tax Rate Reconciliation, Tax Holiday, Amount", "negatedLabel": "Tax holiday" } } }, "localname": "IncomeTaxReconciliationTaxHolidays", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r65" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r60" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r60" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r60" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "verboseLabel": "Tax payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r458", "r546" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Customer deposits" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r60" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r60" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "verboseLabel": "Accrued liabilities and other payables" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r88", "r460", "r461", "r462", "r464", "r504" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "verboseLabel": "Intangible assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r147" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r178", "r181", "r182" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r27", "r85" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r40", "r519" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories", "totalLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r8", "r41", "r215", "r270", "r271", "r272", "r459", "r505" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r28", "r85" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Packing materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.", "label": "Lease expiration date" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseDescription": { "auth_ref": [ "r445" ], "lang": { "en-us": { "role": { "documentation": "Description of lessee's operating lease.", "label": "Operaitng lease, description" } } }, "localname": "LesseeOperatingLeaseDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lease term" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "LEASE" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/Lease" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r141", "r151", "r519", "r548", "r557", "r573" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r37", "r185", "r265", "r281", "r282", "r284", "r285", "r286", "r288", "r290", "r292", "r293", "r424", "r427", "r428", "r432", "r519", "r559", "r576", "r577" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current-Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Current Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r180" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash generated from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flow from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r180" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flow from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r58", "r59", "r62" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash (used in) generated from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flow from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r50", "r62", "r146", "r156", "r163", "r166", "r168", "r173", "r185", "r192", "r194", "r195", "r196", "r197", "r200", "r201", "r205", "r233", "r244", "r250", "r253", "r265", "r281", "r282", "r284", "r285", "r286", "r288", "r290", "r292", "r293", "r431", "r432", "r508", "r559" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss for the year", "totalLabel": "NET LOSS" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity", "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r194", "r195", "r196", "r197", "r202", "r203", "r206", "r209", "r233", "r244", "r250", "r253", "r508" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net loss attributable to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r55" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "integerItemType" }, "us-gaap_OffsettingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Assets [Line Items]" } } }, "localname": "OffsettingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTable": { "auth_ref": [ "r43", "r44" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Assets [Table]" } } }, "localname": "OffsettingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "negatedLabel": "Total operating expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses", "verboseLabel": "Operating Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r233", "r244", "r250", "r253", "r508" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Loss from operation", "verboseLabel": "Segment loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r442" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r442" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Lease liabilities", "verboseLabel": "Current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r442" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liabilities \u2013 non-current portion", "verboseLabel": "Non-current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r114" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "umulative net operating losses" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r127" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "ORGANIZATION AND BUSINESS BACKGROUND" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/OrganizationAndBusinessBackground" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r120", "r121", "r122" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Foreign currency adjustment gain", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity", "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r177" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Sundry income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other receivables" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r57" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r342", "r344", "r350", "r368", "r370", "r371", "r372", "r373", "r374", "r388", "r389", "r390", "r392", "r513" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "PENSION COSTS" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/PensionCosts" ], "xbrltype": "textBlockItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expense and Other Assets", "totalLabel": "Prepayments and other receivable" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r6", "r273", "r274" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepayments" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPrepaymentsAndOtherReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Advance from (repayment to) a related company" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r163", "r166", "r168", "r179", "r185", "r192", "r200", "r201", "r233", "r244", "r250", "r253", "r265", "r281", "r282", "r284", "r285", "r286", "r288", "r290", "r292", "r293", "r422", "r425", "r426", "r431", "r432", "r467", "r508", "r517", "r518", "r545", "r559" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r35", "r95" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r97", "r487", "r488", "r489" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PLANT AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/PlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r34", "r93" ], "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r14", "r15", "r95", "r152", "r468", "r519" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Plant and equipment", "totalLabel": "Plant and equipment. net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r33", "r95", "r487", "r488" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.", "label": "Residual value" } } }, "localname": "PropertyPlantAndEquipmentSalvageValuePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r14", "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/PlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r14", "r93" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r448", "r449", "r450", "r451", "r452" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r23", "r103", "r150", "r396", "r478", "r480", "r519" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r161", "r189", "r190", "r191", "r193", "r199", "r201", "r266", "r393", "r394", "r395", "r410", "r411", "r429", "r475", "r477" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r369", "r372", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r565", "r566", "r567" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/PensionCostsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r369", "r372", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r565", "r566", "r567" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/PensionCostsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r224", "r225", "r243", "r248", "r249", "r255", "r256", "r259", "r317", "r318", "r463" ], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue, net", "terseLabel": "Total revenue", "verboseLabel": "TOTAL" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "http://chinafoodsltd.com/role/StatementsOfOperations", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r320", "r506" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r174", "r185", "r224", "r225", "r243", "r248", "r249", "r255", "r256", "r259", "r265", "r281", "r282", "r284", "r285", "r286", "r288", "r290", "r292", "r293", "r432", "r467", "r559" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r259", "r555" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r105", "r106", "r107", "r108", "r109" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/PensionCostsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/NetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.", "label": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES" } } }, "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r8", "r29", "r30", "r31" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "SCHEDULE OF INVENTORIES" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r35", "r95" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": { "auth_ref": [ "r51", "r83" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]", "verboseLabel": "SUMMARY OF GEOGRAPHIC SEGMENTS" } } }, "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r79", "r80", "r81", "r86" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r79", "r80", "r81", "r86" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "SUMMARY OF GEOGRAPHIC SEGMENTS" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r70", "r72", "r73", "r74", "r134", "r136" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "SCHEDULE OF CONCENTRATIONS OF RISK" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r221", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r253", "r259", "r277", "r278", "r584" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r221", "r222", "r223", "r233", "r236", "r247", "r251", "r252", "r253", "r254", "r255", "r258", "r259", "r260" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "SEGMENT REPORTING" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SegmentReporting" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r237", "r238", "r239", "r240", "r241", "r242", "r256" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and distribution expenses", "negatedLabel": "Selling and distribution" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperations", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Share price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r67", "r183" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r162", "r221", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r253", "r259", "r275", "r276", "r277", "r278", "r584" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r39", "r102", "r161", "r171", "r172", "r173", "r189", "r190", "r191", "r193", "r199", "r201", "r216", "r266", "r306", "r393", "r394", "r395", "r410", "r411", "r429", "r433", "r434", "r435", "r436", "r437", "r438", "r475", "r476", "r477", "r502" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative", "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r189", "r190", "r191", "r216", "r463" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r20", "r21", "r103" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Shares issued for acquisition of legal acquirer, shares", "verboseLabel": "Number of purchase of shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative", "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r20", "r21", "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "verboseLabel": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails", "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r39", "r102", "r103" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "negatedLabel": "Shares issued for acquisition of legal acquirer" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r20", "r21", "r102", "r103" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "verboseLabel": "Aggregate fair value of shares issued" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails", "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r21", "r24", "r25", "r84", "r519", "r548", "r557", "r573" ], "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r104", "r184", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r454", "r455" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "LIQUIDITY AND CAPITAL RESOURCES" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/LiquidityAndCapitalResources" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r158", "r159", "r160", "r261", "r262", "r264" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r75", "r76", "r77", "r217", "r218", "r219", "r220" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r202", "r209" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average common shares outstanding \u2013 Basic and diluted", "verboseLabel": "Basic and diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "http://chinafoodsltd.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121825205&loc=d3e27249-109313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4M", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10(3))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123366838&loc=d3e3073-115593", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r523": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r524": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r525": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r526": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r527": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r528": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r529": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r531": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r532": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r533": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r534": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r535": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r536": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r537": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r538": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r539": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r541": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r542": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 82 0001493152-23-003859-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-003859-xbrl.zip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